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Abstract 
By the end of 2012, Zimbabwe had enrolled more than half a million patients on free 
antiretroviral treatment (ART). Reviews of ART programmes in sub-Saharan Africa 
revealed that one third of the patients drop out of the programme during the first three 
years of treatment. I explored reasons for programme attrition in an NGO-supported 
ART programme in rural Zimbabwe. 
In a mixed-methods design, I combined a retrospective cohort study among 8425 adult 
patients who initiated ART from 2005 to 2012, with a qualitative inquiry including 44 
interviews, 8 focus group discussions with 78 participants, and participant observation 
during two months of field work. 
Programme retention at three years was 75%. Tracing of patients lost to follow-up 
revealed that mortality at 12 months was 1.8 times higher than reported before tracing: 
corrected mortality was 11.5%, 18.8% and 21.3% after 12, 36 and 60 months. 
574/1055 (54.4%) deaths occurred before the next ART appointment, 481/1055 
(45.6%) after missing the appointment. Programme retention did not imply consistent 
adherence to ART: 1780/6291 (28.3%) retained patients temporarily interrupted ART at 
least once for more than seven days. 
Qualitative data showed that patients temporarily interrupted ART for different reasons 
rooted in social, cultural and gender conflicts and related to mobility. ART restart was 
facilitated by social capital in family and kinship networks, decentralised access to ART 
and trusting patient-health worker relationships. Social isolation and discrimination of 
HIV-positive women by partner and in-laws, health workers blaming patients for 
missing an ART appointment and distance to the initiation site were the main reasons 
for prolonged and potentially fatal ART discontinuation. 
Our findings suggest that ART re-engagement after interruption is key for long-term 
retention. Programmes can prevent attrition from ART by decentralising their services, 
supportive management by health workers, and early tracing of medically- and socially-
vulnerable treatment interrupters.  
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DrPH integrating statement 
In September 2008, I attended the symposium “The Future of Primary Health Care: 
Alma Ata 30 Years On” of the London School of Hygiene and Tropical Medicine 
(LSHTM). This conference was a key moment in my professional career in two ways. 
Firstly, in my job as project manager for the Swiss organisation for international health, 
SolidarMed, I had experienced the pros and cons of donor-funded, vertical HIV/AIDS 
programmes in Tanzania, where I worked for two years. The LSHTM symposium, 
accompanied by a series of articles on Primary Health Care in The Lancet, was an eye-
opener to me because it advocated for renewed efforts to strengthen primary health 
care services through a more horizontal than vertical approach – a statement that 
made a lot of sense to me from what I have seen in rural Tanzania. The symposium 
was a key moment to me in a second way: between two sessions, I picked up a flyer 
on the Doctor of Public Health (DrPH) programme at the LSHTM. As I wanted to stay a 
practitioner in international development, a PhD had not been an option. A professional 
doctorate, however, was different. On my way home from the symposium, I felt 
reassured that I wanted to develop my public health career, and that the DrPH 
programme would be my choice.  
DrPH programme core modules 
During my first two years at the LSHTM, I attended the two core modules Leadership, 
Management and Personal Development (LMPD) and Evidence-Based Public Health 
Policy (EBPHP). As I was about to re-orient my professional career, the LMPD core 
module was an excellent opportunity to reflect on my professional strengths and 
weaknesses, to acquire concepts and skills on management and leadership, and to 
develop a career plan. I was lucky to be part of an enthusiastic and inspiring bunch of 
class mates. I used our three-day retreat to reflect my personal development and to 
relate my psychometric profile to the potential tasks in my future career. In the LMPD 
module, I submitted three assignments: in an essay “Change in SolidarMed 2007-2010: 
from authoritative leadership to recipe management”, I used change management 
concepts to analyse a process my organisation had recently gone through under a new 
leadership. The second assignment was a reflective commentary on my profile as 
“introverted thinker” (Myers-Briggs type indicator INTJ). The third assignment was an 
enjoyable exercise to establish a personal development plan. After ten years of job 
experience in health projects at micro level, I had developed a critical view on the 
rationale and effectiveness of development interventions. I became more and more 
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interested in the evidence-base of health policy and programming, and linked to it, in 
the domain of implementation research.  
EBPHP, the second core module, equipped me with some essential concepts and 
methods I would need in any future position as public health programme manager or 
policy maker. Our first assignment was a systematic literature review to find the best 
available evidence on the effectiveness of health warnings on tobacco products. The 
assignment was a learning experience in two respects: firstly, it was an opportunity to 
familiarise myself and critically reflect the theoretical assumptions of health promotion 
campaigns. I find tobacco control an excellent example to illustrate how ideational 
paradigms rather than scientific evidence can influence health policy. Even though I 
found no evidence on the impact of graphic warnings on successful smoke cessation, 
this measure has in the meantime been introduced in many countries – I guess mainly 
due to the common-sense assumption that people’s behaviour is determined by their 
knowledge, beliefs and attitudes. In a second assignment related to the systematic 
review, I applied the tool of a policy brief to translate the evidence into 
recommendations to the Ministry of Health in India. I learnt that scientific evidence does 
not “automatically” inform health policy and programming. Putting research into action 
requires an understanding of the policy process and a clear strategy on how to 
influence the process. Designing such an influential strategy for a fictional health 
organisation in Tanzania was our third EBPHP assignment. I chose the case of 
community case management of pneumonia in children under five years. The aim was 
to design a strategy how to bring this intervention on the public health agenda in 
Tanzania, given the scientific evidence that it could save the lives of 45’000 children 
every year. I conducted a stakeholder analysis, a tool we studied during the EBPHP 
module and which I think is inevitable for any strategy development.  
Organisational and policy analysis at the Lighthouse, Malawi 
Through the core modules during the first two years of the DrPH programme, I had 
agreed with my supervisor Professor Alison Grant to conduct the research project on 
loss to follow-up in an antiretroviral treatment (ART) programme in Zimbabwe. With my 
previous employer, I had been involved in developing and managing an ART support 
programme in Mozambique, Lesotho, Tanzania and Zimbabwe. Growing numbers of 
patient drop-outs by national ART programmes and NGOs made SolidarMed suggest I 
could explore the underlying reasons why patients discontinue ART. The Ministry of 
Health and Child Welfare in Zimbabwe was interested to host the study. In the role of a 
consultant, I advised SolidarMed and the Ministry on the design of the patient tracing 
scheme which the parties implemented as from 2011. The data collected through 
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tracing were later analysed by our study. Yet, before launching the research project, I 
undertook the organisational and policy analysis (OPA) project of the DrPH 
programme. Given my interest in operational research under “real world” conditions, 
my supervisor suggested I conduct my OPA project at the Lighthouse Trust in 
Lilongwe, Malawi, a proposal which the organisation accepted. The Lighthouse is a 
NGO running a public HIV/AIDS clinic with a large patient cohort on ART. I spent three 
months in the monitoring and evaluation department of the Lighthouse clinic to study 
how the organisation develops innovative services and interventions, conducts 
operational research, and informs HIV/AIDS policy and programming. I found that a 
motivating organisational culture and a unique electronic patient data management 
system – based on real-time data entry at touch-screen terminals throughout the entire 
clinic pathway – were key success factors for innovation and operational research at 
the Lighthouse. I identified 25 operational studies Lighthouse conducted between 2005 
and 2010, amongst them studies on integrated treatment of HIV/AIDS and tuberculosis 
and on prevention of vertical HIV-transmission that both influenced policy and 
programming in Malawi and beyond. Inspired by the work of my OPA co-supervisor, 
Professor Nigel Crisp, on the spread of healthcare improvements, I reflected the 
Lighthouse experience in my OPA report.  
Implementation research in Zimbabwe 
A key lesson of my OPA project was that scaling-up of successful health care 
innovations not only requires sound scientific evidence, but, even more importantly, 
collaboration between programme managers, policy makers and researchers working 
together throughout the entire process of developing, researching and scaling-up 
innovative health services. My experience in the study project presented in this thesis 
demonstrated potential gains of implementation research through the research 
process. The stakeholders confirmed that the research process impacted the quality of 
the ART programme in Zaka and Bikita, and facilitated the dialogue on how to improve 
the programme between health workers, public health officials at district and provincial 
level, policy makers at national level, and NGO project managers. Our quantitative 
research relied entirely on programme data. Data quality was a central aspect of the 
collaboration between the mentioned stakeholders. In the course of the research 
project, the study team raised questions with regard to medical recording practices and 
data management procedures that were discussed and addressed between the 
partners. The tracing intervention led to a major cleaning exercise of the entire cohort 
data, and to a re-organisation of paper-based and electronic recording procedures. The 
study also facilitated utilisation of the data by the health facilities and the district 
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authorities for monitoring purposes. The study team trained the hospital and district 
data managers in how to run queries and how to prepare reports, and the health 
officials used the data for monthly and quarterly feedback discussions with the ART 
nurses throughout the district. We also facilitated online courses in Good Clinical 
Practice with programme staff and selected personnel of the ART clinics to develop 
their scientific skills and qualifications for future operational research projects. 
After completion of the DrPH programme, I will be working as Head of Policy 
Department for the Swiss Red Cross (SRC). I am confident that thanks to the DrPH 
programme, I will be in a good position to advocate for evidence-based programming 
and implementation research throughout the international health programme of the 
SRC. 
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1 Introduction 
I first visited Zimbabwe in 2005. In my role as coordinator of the multi-country 
antiretroviral treatment (ART) support programme of the Swiss non-governmental 
organisation (NGO) SolidarMed – the SMART programme – I spent two weeks at 
Musiso Mission Hospital in Zaka district. The hospital wards were crowded with 
patients in an advanced stage of the HIV disease. Pain management was the only 
thing the hospital staff could do for these patients, but morphine was regularly out of 
stock. Nurses said it had been utterly frustrating to see people dying in their hands 
having nothing to offer but prayers. Why test for HIV if no treatment was available? The 
announcement that an ART clinic would be established soon was a motivational boost 
to Musiso’s health workers, and everybody participated in the preparation of the 
programme. During my visit, I helped establish SMART’s first yearly action plan and 
budget. The support package included physical expansion of the hospital facility to 
accommodate an outpatient HIV/AIDS clinic, provision of laboratory equipment and 
reagents, training of hospital personnel in HIV medicine, and establishing an electronic 
database for programme monitoring. Fixed-dose combination ART drugs were 
provided free of charge by the Ministry of Health and Child Welfare (MOHCW) if the 
doctor drove to Harare to collect them at the national pharmacy. In April 2005, the first 
patients were initiated on ART at Musiso hospital. Consultations were conducted by the 
Swiss doctors. By the end of the year, around hundred patients had been enrolled. 
However, out there in the district, thousands of people were still dying of AIDS with no 
access to lifesaving ART. This was the picture not only in Zimbabwe, but across sub-
Saharan Africa.  
Since 2005, the response to the HIV/AIDS pandemic has been dramatic. Thanks to an 
unprecedented effort of national ART programmes and global funding initiatives, out of 
25.2 million people living with HIV/AIDS in the sub-Saharan region, 7.5 million were 
receiving free ART by 2012 (UNAIDS, 2013). Yet, the burden of HIV/AIDS to 
communities and health systems remains enormous: in 2012, 13.7 million people living 
with HIV in sub-Saharan Africa – representing 65% of those in need – did not have 
access to ART, and 1.2 million died of AIDS related causes (ibid.).  
As more and more people were enrolled on life-long ART, retention became a growing 
concern of policy makers and programme managers. Failed retention on ART can lead 
to treatment failure and can cause resistance to ART drugs (Aghokeng, 2014). In 2011, 
the United Nations declared retention at 12 months on ART a core indicator for the 
 17 
 
effectiveness of national ART programmes (UNAIDS, 2011b) and an early warning 
indicator for HIV drug resistance (WHO, 2012).  
Seven years after the launch of SMART in Zimbabwe, I returned to Zaka and Bikita in 
April 2012 to conduct this study. Since 2005, the SMART programme in Zimbabwe had 
enrolled more than 9,000 patients. In 2010 – I had left SolidarMed and was in my 
second year of the DrPH programme – I agreed with SolidarMed to conduct my DrPH 
research project as an operational study in the SMART programme in Zimbabwe. 
SolidarMed was just about to embark on a major exercise to trace patients who had 
been recorded as lost to follow-up. It was arranged that I would analyse the tracing 
data, train the programme personnel in research methods and Good Clinical Practice, 
and help local data managers run queries and establish reports for the purpose of 
patient and programme monitoring. In turn, I benefitted from the SolidarMed 
infrastructure, logistics and partnerships in Zaka and Bikita. After an extended period of 
preparatory work and obtaining ethical clearance, I formed a study team and 
commenced the field research in April 2012. The study team comprised the SMART 
programme manager (a Canadian expatriate with an MSc in international health) as co-
investigator and her data managers, three Zimbabwean scientific collaborators, and 
two community facilitators of the local NGO Batanai HIV/AIDS Support Organisation 
(BHASO). The research protocol defined the division of roles between SMART and the 
study, as described in detail in the chapters 5 to 7: patient and tracing data were 
collected by SMART and analysed by the study, whilst the qualitative study component 
was conducted exclusively by the study team. Overall, field work lasted four months, 
including stakeholder workshops towards the end in both districts where preliminary 
study findings were disseminated.  
Figure 1-1 summarizes the evolution of the Zimbabwean ART programme, the SMART 
programme and my changing role as SMART programme coordinator and DrPH 
research degree student between 2005 and 2012.  
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Figure 1-1: History of the national ART programme, SMART and my role 
 
 
The thesis is structured as follows: chapter 2 gives general information on Zimbabwe 
and the study setting Zaka and Bikita. A review of literature on quantitative and 
qualitative research is presented in chapter 3, including the most relevant and latest 
studies on retention, loss to follow-up and treatment interruption. After defining the aim 
and objectives and explaining the mixed-methods design in chapter 4, the SMART 
programme is described in chapter 5, including the patient-tracing scheme. Chapters 6 
and 7 present the findings of the quantitative and qualitative study components, each 
including sections on methodology, results, and discussion. In the final chapter 8, the 
quantitative and qualitative findings are integrated and discussed. 
 
  
Milestones 2004 2005 2006 2007 2008 2009 2010 2011 2012
Launch of the national ART programme
Decentralisation of ART follow-up to rural health centres
519,000 patients on ART at 141 initiation and 449 follow-up sites
Launch of SMART at the hospitals Musiso and Silveira 
Decentralisation of SMART in Zaka and Bikita district
Launch of Community HIV/AIDS Support Agents (CHASA programme)
Launch of the Patient Tracing Scheme
9,500 patient enrolled at 2 initiation and 20 follow-up sites
SMART programme coordinator (based in Switzerland)
DrPH programme at LSHTM
Research project in collaboration with SolidarMed and the Ministry of Health
National 
ART 
programme
SMART
My role
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2 The study setting 
This chapter gives an outline on the geographical and demographic setting where the 
study was conducted. 2.1 presents general facts and figures on Zimbabwe, section 2.2 
gives an introduction on HIV/AIDS in the country, and section 2.3 provides information 
and maps on the study area. 
 
2.1 Zimbabwe, recovering from a series of crises 
Zimbabwe is a land-locked country in Southern Africa with a population of 13 million, of 
whom 61% live in rural areas (GoZ, 2012a). The population of Zimbabwe has gone 
through a series of economic, political and social crises since the beginning of the new 
millennium. The country’s economy has declined dramatically, with a fall of the per 
capita gross domestic product from US$574 in 1998 to US$284 in 2008 (GoZ, 2012c). 
In 2008, the country drifted into a humanitarian calamity characterised by violence, 
hyperinflation, a major cholera outbreak, and a temporary breakdown of public 
services, including health care (Barclay, 2010). During the years of crisis, to work 
outside the country became an important livelihood strategy and source of income for 
many Zimbabweans. Between 2000 and the peak of the crisis in 2008, it was estimated 
that one to five million Zimbabweans migrated to South Africa, and that Zimbabwean 
households received annual median remittances of US$165 in cash and goods (Polzer, 
2008). In spite of a moderate socio-economic and political recovery since  the 
formation of the Government of National Unity in 2009, Zimbabwe remains one of the 
poorest countries in the world, ranking 172nd out of 187 countries on the scale of the 
Human Development Index (UNDP, 2013). In 2012, 72% of the population lived below 
the total consumption poverty line, 23% below the food poverty line, and 19% of the 
households were considered food-insecure (GoZ, 2012c). The socio-economic crisis 
counteracted the government’s development efforts. Zimbabwe is off-track with respect 
to the health related Millennium Development Goals (ibid.): In 2011, the mortality rate 
in children under the age of five was 84 per 1000 live births, the 2015 target being 
34/1000. Most frequent causes of death were HIV/AIDS, neonatal complications, 
pneumonia, and diarrhoea. Maternal mortality has increased from 612 in 2006 to 960 
deaths per 100,000 live births in 2011, which is one of the highest worldwide.  
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2.2 HIV/AIDS in Zimbabwe 
The socio-economic decline Zimbabwe has undergone since the late 1990s has been 
aggravated by one of the harshest HIV/AIDS epidemics worldwide. There are reports of 
a devastating adult HIV prevalence of 29% in 1997 and 24% in 2001 (Halperin, 2011). 
Besides the natural dynamic of the epidemic, behavioural changes such as a reduction 
in multiple sexual partners have contributed to a slight decrease in HIV incidence and 
prevalence subsequently (ibid.). In 2012, UNAIDS reported an adult prevalence of 
14.7% in Zimbabwe (UNAIDS, 2013b). Yet, with 1.4 million people living with 
HIV/AIDS, Zimbabwe remains one of the countries most affected by the epidemic on 
the African continent, as shown in figure 2-1. Given the fact that transmission is on-
going and AIDS related deaths have diminished thanks to ART, HIV prevalence is on 
the rise again. In 2012, 189 Zimbabweans became infected with HIV and 107 died with 
advanced HIV disease every day (ibid.). Closely linked with the HIV epidemic is 
Zimbabwe’s high burden of tuberculosis, representing the country’s leading cause of 
mortality and morbidity (GoZ, 2012c). Although HIV prevalence among people with 
tuberculosis was 70%, only 18% were on ART in 2012 (WHO, 2013b). 
Given these challenging circumstances, the roll-out of ART for people living with 
HIV/AIDS through the national programme has been a true success story. In 2012, 
519,000 HIV-positive adults and children received ART (GoZ, 2012c), representing 
47% of the projected number of people eligible (ibid.).  
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Figure 2-1: HIV prevalence on the African continent 2009 (WHO, 2011) 
 
 
 
 
2.3 Zaka and Bikita 
The study was conducted in the two rural districts of Zaka and Bikita in the province of 
Masvingo in the Southeast of Zimbabwe, shown in figure 2-2. The 2012 population was 
181,000 in Zaka and 162,000 in Bikita (GoZ, 2012a).  
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Figure 2-2: The provinces of Zimbabwe (source: Wikimedia Commons)  
 
The area is semi-arid and mountainous with poor soils and seasonal rainfall. The large 
majority of people are subsistence farmers. Outside of the two semi-urban centres 
Jerera and Nyika, people live as extended families in so-called homesteads, scattered 
across the districts. Many households in Zaka and Bikita rely on the support by family 
members working in the big towns and in South Africa. Christianity is the predominant 
religion in the area, mostly of the Catholic Church. However, a growing number of 
Zimbabweans are members of an Apostolic Church.  
As everywhere in Zimbabwe, health care services in Zaka and Bikita are organised in a 
district referral system, comprising health facilities at three levels: rural health centres, 
rural hospitals, and district referral hospitals. In Zaka, there are two referral hospitals, 
two rural hospitals and nineteen rural health centres, as shown in figure 2-3. Musiso 
Mission Hospital is the biggest hospital in Zaka, run by the Masvingo Catholic Diocese. 
In Bikita, there are two referral hospitals, two rural hospitals and 21 rural health 
centres, as shown in figure 2-4. The referral hospital in Silveira also belongs to the 
Catholic Diocese. Health services are supervised by the authorities of the MOHCW. 
Under the Provincial Medical Director, there are District Health Executives, comprising 
the District Medical Officer and his team. The role of the health facilities and other 
stakeholders in the provision of ART is described in detail in chapter 5 on the SMART 
programme.  
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Figure 2-3:  Health facilities in Zaka district (source: Swiss Agency for Development 
and Cooperation)  
         24 
 
Figure 2-4: Health facilities in Bikita district (source: Swiss Agency for Development and Cooperation)
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3 Literature review 
This chapter gives an overview of the current literature on ART retention from 
quantitative epidemiological and qualitative social science research. Section 3.1 
describes the methodology of the literature review; quantitative findings are presented 
in section 3.2, qualitative literature in section 3.3. 
 
3.1 Review method and search strategy 
I conducted the literature search in the databases CINAHL Plus, Global Health, 
MEDLINE, Africa-Wide Information, and Web of Science, last updated on 15 August 
2013. Search terms were antiretroviral treatment, retention, loss to follow-up, 
adherence, patient tracing, qualitative research, anthropology, interview, focus group 
discussion, sub-Saharan Africa (and synonyms).  
The World Health Organization (WHO) defined adherence as “the extent to which a 
person’s behaviour – taking medication, following a diet, and/or executing lifestyle 
changes – corresponds with agreed recommendations from a health care provider” 
(WHO, 2003). There is a vast body of literature on medication adherence in ART, 
looking at the behavioural, cognitive, affective, biological and structural dimensions of 
patients’ pill-taking behaviour (Baernighausen, 2011). Since the present study 
investigated adherence to follow-up appointments with a focus on long-term 
programme retention, literature on medication adherence was excluded from the 
review.  
Whilst adherence to ART describes therapy practice at individual level, ART retention 
is a programme level concept, defined as “proportion of ART patients who are still alive 
and on ART at a given time after initiating treatment” (UNAIDS, 2011b).  
 
Figure 3-1 shows the results of the literature search. Based on the above stated 
inclusion criteria, 363 potentially relevant citations were identified. I excluded articles if 
they focused on the following topics: 
- medication adherence (as opposed to appointment adherence),  
- the pre-ART phase,  
- antiretroviral prevention of mother-to-child transmission,  
- paediatric ART, and 
- ART in conflict zones. 
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After excluding for topic, I undertook full-text screening of 117 articles and excluded 36 
studies due to poor quality (see quality criteria in appendix 1). After excluding for 
quality, I reviewed 52 quantitative studies (including 7 reviews) and 29 qualitative 
studies (including 2 reviews). 
 
Figure 3-1: Results of the literature search 
 
 
 
 
3.2 Review of quantitative research  
Responding to the concerns about programme losses and the risk of drug resistance 
development, a large number of retention studies have been conducted in recent 
years. I reviewed the quantitative literature relevant to the following questions: 
- what is the magnitude of retention, death and loss to follow-up in sub-Saharan 
Africa at different ART time points? 
- Which factors are associated with retention, loss to follow-up and death? 
- What is known about the real outcomes of patients classified as lost to follow-up? 
- What is the magnitude and length of temporary ART treatment interruptions, and 
which factors are associated with interruption and restart? 
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3.2.1 Retention, death and loss to follow-up on ART 
There are five large studies available on ART retention in sub-Saharan Africa, shown in 
table 3-1: two cohort studies from South Africa, Cornell (2010) and Fatti (2010); a 
meta-analysis of 39 cohorts in sub-Saharan Africa (Fox and Rosen, 2010); a review of 
national ART data reported to WHO (Tassie, 2010); and a cohort study of the national 
ART programme of Malawi (Weigel, 2012). Retention at 12, 24, and 36 months, 
defined as proportion of enrolled ART patients who were neither classified as dead nor 
lost to follow-up after excluding transfers to another clinic, ranged between 75-80%, 67-
76%, and 64-72% respectively. The cited studies defined loss to follow-up as a 
category of patients who missed their scheduled ART consultation for a defined period 
of time, but were neither reported dead nor transferred out to another ART clinic. 
Across the five studies, the threshold for loss to follow-up ranged from 60 days to six 
months. The WHO and most national ART programs define patients lost to follow-up if 
they are not seen for more than 90 days after a scheduled appointment (WHO, 2010).   
Table 3-1:  Studies on the magnitude of retention, death and loss to follow-up in ART 
programs in sub-Saharan Africa 
Study Context 
(year of study) 
Design Population Retention Attrition 
causes 
Cornell 
2010 
8 public sector 
ART programs 
in South Africa 
(2008) 
Retrospective 
cohort analysis of 
routine data 
LFU definition: 6 
months after last 
contact 
44,177 ART 
patients 
12 months: 80% 
24 months: 71% 
36 months: 64% 
At 12 months: 
Death: 6.6% 
LFU: 14.4% 
Fox & 
Rosen
2010 
39 cohorts of 
government 
(53%) and 
NGO (41%) 
facilities in 
SSA (2009) 
Systematic review 
and meta-
analysis; pooled 
estimates 
LFU definition: 
ranging from 30 
days to 6 months 
after missed 
appointment 
226,307 ART 
patients 
6 months: 86% 
12 months: 80% 
24 months: 76% 
36 months: 72% 
Total: 
Death: 9.1% 
LFU: 13.0% 
Tassie 
2010 
national 
programmes in 
13 countries in 
sub-Saharan 
Africa (2008) 
Aggregation of 
national cohort 
data reported to 
the WHO 
LFU definition: 90 
days after missed 
appointment 
ART patients: 
at 12 mts: 144,038 
at 24 mts: 39,017 
at 36 mts: 12,523  
at 48 mts: 2,973  
 
12 months: 75% 
24 months: 67% 
36 months: 66% 
48 months: 67% 
- 
Fatti  
2010 
59 NGO 
supported, 
public facilities 
in 4 Provinces 
of South Africa 
(2008) 
Retrospective 
cohort analysis 
LFU definition: 90 
days after missed 
appointment 
29,203 ART 
patients 
24 months: 76% At 24 months: 
Death: 7.4% 
LFU: 12% 
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Weigel 
2012 
148 public 
sector clinics 
in Malawi 
(2008) 
Cohort study on 
routine data 
LFU definition: 60 
days after missed 
appointment 
117,945 12 months: 78% At 12 months: 
Death: 12.2% 
LFU: 10% 
ART=Antiretroviral treatment; SSA=Sub Saharan Africa; LFU=lost to follow-up 
The cohort studies of Cornell (2010) and Tassie (2010) reported the lowest retention 
proportions at 24 months, namely 71% in South Africa and 67% in 13 countries of sub-
Saharan Africa. The cohort study by Fatti (2010) and the meta-analysis by Fox and 
Rosen (2010) found 76% retained at the same time point. A comparison of the ART 
programme settings shows that the first two studies used routine data from government 
programmes that were compiled in standardized data management systems using 
consistent definitions of treatment endpoints, such as loss to follow-up. In contrast, 
ART provision in the latter two studies was supported by research projects or NGOs, 
and the meta-analysis included mainly urban cohorts and relied on published data only, 
both factors limiting generalizability. The data analysed by Tassie (2010) are as 
inconsistent as the national cohort analysis schemes across the reviewed countries. 
Moreover, this study did not include data from South Africa, the largest ART 
programme worldwide. A major limitation of the cited large-scale studies is that ART 
programme outcomes have grown and outcomes changed over time. As the reviewed 
studies were conducted in 2008 and 2009, their findings do not reflect the most recent 
trends. Cornell (2010) reported a continuously deteriorating 12-months retention 
between 2003 (90%) and 2007 (72%), mainly due to increasing losses to follow-up. 
According to the authors, two reasons contributed to the decline: Firstly, ART 
programmes expanded and patient numbers increased hugely during the study period, 
overwhelming scarce health personnel and affecting the quality of ART follow-up and 
clinical care. Secondly, the authors attribute a proportion of the losses to care to 
erroneous recording systems. Findings from more recent studies are inconsistent: in 
their cohort study on 1794 ART patients in South Africa, Fox (2012) reported an 
increase in retention at 12 months from 58% in 2007 to 71% in 2010. In contrast, in 
their study among 4674 ART patients in South Africa, Mutevedzi (2013) found that risk 
of losses to follow-up adjusted for mortality was more than twice as high in patients 
enrolled 2010-2011 as those enrolled 2004-2006. There are no large-scale studies 
available on temporal changes of retention since the WHO revised the ART guidelines 
in 2010, recommending earlier ART initiation for people living with HIV with a CD4 cell 
count above 350. Given that a low CD4 cell count and an advanced clinical stage of the 
disease at baseline are key risks factors for mortality on ART (Lawn, 2008), one would 
expect improved ART retention since 2010. 
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In summary, there is robust evidence that attrition is highest during the first year of 
treatment, and that more than a third of all enrolled ART patients are no longer in care 
after three years. There is, however, no clear evidence available on the trend in ART 
retention since 2010.  
Only two retention studies were found from Zimbabwe, both from multi-country 
programmes, comparing outcomes of the Zimbabwe sites with other countries. The 
Zimbabwean sites reported excellent retention rates. Rasschaert (2012) compared 
retention rates of two ART programmes supported by the NGO Médecins sans 
Frontières: in the Zimbabwean site, retention at 24 months was 80.1%, compared with 
75.8% in the Malawian site. Similar findings were reported by a comparative study of 
ART programmes supported by the Swiss NGO SolidarMed (Wandeler, 2012): 
retention at 3 years was 75.1% at the Zimbabwean site, whilst similarly supported sites 
in Lesotho and Mozambique reported retention rates of 55.4% and 51.6% respectively. 
The proportion of deaths contributing to attrition was 31% (measured at 12 months) in 
Cornell (2010), 38% (measured at 24 months) in Fatti (2010), 41% (of the total) in Fox 
and Rosen (2010), and 55% (at 12 months) in Weigel (2012). The reasons for the 
relatively wide range of deaths contributing to programme attrition are much more 
related to the phenomena of unreported deaths across the ART programmes than to 
truly varying mortalities, as will be discussed in section 3.2.4. 
The studies of Cornell (2010) and Fatti (2010) highlighted how the proportion of deaths 
versus loss to follow-up changed over time on ART. Cornell (2010) reported that 6 
months after initiation of ART, 34% of attrition was attributable to deaths and 66% to 
loss to follow-up, whilst at 36 months, mortality declined to 25% and the loss to follow-
up proportion climbed to 75%. The findings of Fatti (2010) confirmed this pattern: figure 
3-2 shows hazard estimates of death and loss to follow-up by time of ART (ibid.). After 
an initially identical shape, the death curve falls dramatically during the first six months 
of treatment, whilst the loss to follow-up curve decreases steadily during the first 36 
months of ART. Again, it is important to add that the curves are strongly biased by a 
supposedly high proportion of unreported deaths among the patients classified lost. 
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Figure 3-2: Death and loss to follow-up according to duration of ART (Fatti 2010) 
 
 
ART=antiretroviral treatment 
3.2.2 Factors associated with retention and attrition 
The large-scale retention studies presented above showed that programme attrition is 
a growing concern of ART programmes. A vast body of studies have since explored the 
factors associated with retention and attrition. This review identified factors associated 
with retention and attrition in the following five domains: 
Personal characteristics: Boyles (2011), Charurat (2010), Ekouevi (2010) and Weigel 
(2012) showed that young age, male sex and a low educational level were associated 
with attrition, whilst living with a partner facilitated retention. A large multivariate 
analysis of ART outcomes among 46,201 adult ART patients in South Africa showed 
that attrition was more frequent in men because they were more likely to initiate ART at 
an advanced stage of HIV than women, and because of different mortality between 
men and women in the general population, caused by reasons other than the HIV/AIDS 
epidemic (Cornell, 2012).  
Clinical characteristics at initiation: Unfavourable clinical factors, such as a low CD4 
cell count (<50), ART initiation as an in-patient, and low haemoglobin were key factors 
associated with attrition in various studies, such as Boyles (2011), Ekouevi (2010), 
Cornell (2009), and Charurat (2010). Less expectedly, and linked to losses to follow-up 
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more than to death, high CD4 cell counts (>350) were also associated with attrition, as 
shown by Boyles (2011) and Charurat (2010). Boyles (2011) found that patients who 
were in HIV care before initiating ART were twice more likely to be retained than 
patients with no pre-ART care.  
Medication: Charurat (2010) showed that the type of drug regimen can influence 
retention. In a cohort of 5760 patients in Nigeria, the study found a lower risk (adjusted 
hazard ratio 0.76) of loss to follow-up in patients using zidovudine compared to patients 
using stavudine.  
Social and economic background: Several studies found that patients facing social 
and economic problems were at higher risk of attrition from ART. Boyer (2011) found 
that financial difficulties (adjusted odds ratio 11.73) and binge drinking (adjusted odds 
ratio 4.19) were strongly associated with ART interruption. Cornell (2009) found that 
the risk of being lost to follow-up was twice as high in patients earning no income 
compared with patients earning any income (adjusted hazard ratio 0.56). 
Health care system: A variety of recent studies assessed how retention was 
influenced by different ART intervention models, ranging from hospital- and doctor-
based ART provision to nurse-, primary care facility- and community-based service 
delivery. A retrospective study across 59 health facilities in South Africa showed that 
retention at 24 months was 80.1% at primary care facilities compared to 71.5% at 
district hospitals and 68.7% at regional hospitals, despite primary care facilities 
receiving more advanced disease stages at ART initiation (Fatti, 2010). Similarly, 
another study from urban South Africa revealed a four times lower risk of attrition in 
stable down-referred patients compared to stable patients attending ART consultations 
at the initiation site (Long, 2011). Research has increasingly been conducted lately on 
various models of community-based ART interventions complementing facility-based 
service provision. The largest available research on community-based adherence 
support was the observational study by Fatti (2012), assessing the effect of adherence 
and psychosocial support through home visits by community health workers in South 
Africa. Among 66,953 ART patients, 29% received the intervention, 71% did not. 
Community-based adherence support reduced mortality by 35% and loss to follow-up 
by 37%. Patients receiving the intervention also had better viral suppression, with an 
increasing effect over therapy time, reaching an adjusted odds ratio of 2.66 after 5 
years compared to patients not receiving the intervention. An ecological study found 
similar results: the secondary analysis of aggregated routine data from 349 clinics and 
232,389 patients in sub-Saharan Africa by Lamb (2012) demonstrated that clinics with 
community-based interventions, such as support groups and peer educators, had lower 
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programme attrition than clinics without community interventions. Similarly, a 
comparative retrospective study among 13,400 ART patients across 27 NGO 
supported cohorts in sub-Saharan Africa and the Caribbean (Etienne, 2010) showed 
two to three times lower loss to follow-up proportions in programmes with community-
based adherence support through home visits as compared to programmes which 
apply facility-based counselling only. The findings of the three cited studies must, 
however, be interpreted with caution mainly due to information bias and unmeasured 
confounding. In all three studies, the allocation of the patients to the intervention arms 
was not randomized so that other factors than community-based adherence 
counselling could have influenced the outcomes, such as geographic distance or the 
socio-economic status of the patients. Likewise importantly, the studies by Lamb 
(2012) and Etienne (2010) were of ecologic design and could therefore not factor in 
patient characteristics at ART initiation. Moreover, generalizability might be limited 
since the three studies investigated NGO supported ART programmes. There is, 
however, a cluster-randomized trial from Uganda among 1336 patients that found a 
50% decrease of virological failures among patients receiving adherence support by 
community-based peer health workers compared to patients not receiving this 
intervention (Chang, 2010).   
As health systems are struggling to cope with ever-growing ART patient numbers, 
decentralized ART follow-up at primary health care facilities have become good 
practice. Two recent studies explored ART outcomes in settings where stable ART 
patients were further down-referred to community-based models of non-clinical, “self-
managed” ART provision. Decroo (2012) reported excellent retention rates from a 
cluster-randomized trial in Kenya where ART was provided by community care 
coordinators to 8-20 ART patients and a cohort study in Mozambique where patients 
obtained their drugs through community ART groups of 6 members each. Similarly, a 
study from South Africa among 2829 ART patients introduced ART provision in 
“adherence clubs” and found better retention among the 502 self-selected club 
members (Luque-Fernandez, 2013). 
3.2.3 True outcomes of losses to follow-up after tracing 
As shown in 3.2.1, routine ART information systems usually report loss to follow-up as 
the major reason for programme attrition. Based on routine data, retention studies such 
as Cornell (2010) and Fox and Rosen (2010) attributed 69% and 59% of programme 
attrition to losses to follow-up. This section shows that tracing of lost ART patients and 
linking ART medical records with vital registration data reveals that significant 
proportions of patients classified as “lost” are unreported deaths. Correcting ART 
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programme mortality for loss to follow-up considerably changes the shape of the 
survival curve, as Verguet (2013) illustrated in figure 3-3. Their meta-analysis of 34 
cohort studies from sub-Saharan Africa including 102,306 ART patients found that if 
only reported deaths were considered, life-years gained through ART were 
overestimated by 14% (ibid.). 
Figure 3-3:  Estimated survival from a regression model based on data from 34 
cohorts in sub-Saharan Africa, corrected for mortality among patients lost 
to follow-up compared to proportions of 0% and 100% mortality among 
patients lost to follow-up (source: Verguet et al, 2013). 
 
LTFU=lost to follow-up 
 
To determine the ART outcomes of patients recorded as lost to follow-up, Brinkhof 
(2009) undertook a systematic review of studies which ascertained the vital status of 
lost patients through tracing. The meta-analysis of 17 studies revealed a combined 
mortality of 46% among all patients classified as lost to follow-up (ibid.). The study by 
Van Cutsem (2011) discovered that the mortality of patients lost to follow-up is closely 
associated with the duration of time after the last ART follow-up consultation: 23% died 
1 month after the last visit, 31% 12 months after the last visit, and 44% 24 months after 
the last visit (ibid.). On the basis of a meta-regression analysis of available tracing data 
in similar settings, Brinkhof (2010) estimated hazard mortality ratios comparing patients 
lost to follow-up with those not lost to follow-up for five cohorts in sub-Saharan cohorts. 
The likelihood of death was estimated between 6 and 23 times in patients lost to follow-
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up compared to patients not lost to follow-up. Based on these ratios, corrected 
programme mortality estimates increased between 27% and 73%.  
Unreported transfer to another ART programme was the second most common reason 
for loss to follow-up, ranging from 12% to 54% of all lost cases, as reported by Brinkhof 
(2009), Thomson (2011) and Geng (2011). 
Patient tracing does not only allow programme managers to ascertain unknown 
treatment outcomes. From a large cohort in urban Malawi, Tweya (2010) reported that 
74% of the patients found alive actually returned back to care after being traced soon 
after missing the appointment. From the same site, Weigel (2011) reported that having 
a phone contact doubled tracing success and the odds of identifying deaths. The study 
by Thomson (2011) on an ART programme supported by Médecins sans Frontières in 
Kenya found that three months after missing the appointment, 60% patients traced and 
found returned to the ART programme. The systematic literature review by McMahon 
(2013) found that tracing contributes to improved retention. The authors compared 
treatment outcomes between 25 cohorts with tracing (62,791 participants) and 29 
cohorts without tracing (124,875 participants). Median retention proportions were 80% 
(IQR 76-84%) with tracing and 73% (IQR 69-80%) without tracing. Tracing contributed 
to an increased ART re-engagement of patients who interrupted ART, thus preventing 
losses to follow-up and deaths. Interpretation of these findings must, however, take into 
consideration the fact that there are no randomized controlled trials available on ART 
patient tracing, and that tracing schemes are often performed in NGO or research 
supported ART programmes disposing of extra resources for enhanced adherence and 
retention. Also, there are no common standards on when, how, by whom and how 
often to trace ART patients.  
Tracing of lost patients and linking vital registration data with ART records revealed that 
mortality on ART in sub-Saharan Africa is prominently higher than officially reported by 
national ART programmes and WHO. A better understanding of loss to follow-up 
therefore requires first and foremost a shift of focus from loss to follow-up to death on 
ART. Although this subject was beyond the scope of the present literature review, the 
findings from recent studies are worth mentioning. As Lawn (2008) and Fatti (2010) 
have shown (see figure 3-2), death on ART occurs for the most part during the first six 
months after treatment initiation, mortality rates being more than five times higher 
during this period than between 6 and 24 months (ibid). In their systematic review on 
early mortality on ART, Gupta (2011) found the highest pooled early (12-months) 
mortality probability in sub-Saharan Africa (0.17), as compared to Asia (0.11) and the 
Americas (0.07). The factors associated with early mortality were low baseline CD4 cell 
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count, male sex, advanced WHO clinical stage, low body mass index, anaemia, and 
age greater than 40 years (ibid.). On the basis of verbal autopsy, tuberculosis, 
advanced HIV, and chronic diarrhoea were found to be the most commonly reported 
causes of death. Wong (2012) conducted the first post-mortem study on mortality 
during ART in sub-Saharan Africa, using needle autopsy. Tuberculosis was the leading 
cause of death, with 19/25 (76%) of the deaths on ART being associated with a 
mycobacterial infection. Immune Reconstitution Inflammatory Syndrome was 
implicated in 73% of the early ART-deaths, a finding that contradicts earlier studies 
based on verbal autopsy, reporting an association of Immune Reconstitution 
Inflammatory Syndrome with only 7% of early deaths (ibid.).    
3.2.4 Treatment interruption 
Retention studies from sub-Saharan Africa have often neglected unstructured 
treatment interruption, meaning a therapy stop not agreed with the ART provider. The 
reason for this research gap has probably been a lack of patient-based electronic data 
in resource-poor settings that would allow accounting for missed visits and number of 
days a patient remains without drugs. A systematic review of ART treatment 
interruptions worldwide revealed that interruptions are a frequent phenomenon, 
resulting in opportunistic infections, increased risk of virological failure, poor 
immunological recovery, and ultimately, increased mortality (Kranzer and Ford, 2011). 
Only 16 out of 70 reviewed studies were from sub-Saharan Africa, and only four of 
them reported reasons for treatment interruptions, namely treatment costs and 
pharmacy stock-outs. The review determined a median proportion of 23% patients 
interrupting treatment and a median duration of 150 days between therapy stop and 
restart. Brennan (2010) found that 35% patients of a South African ART cohort missed 
one or more visits by more than 7 days in the first six months of treatment, and that 
treatment interruption was associated with an increased risk of death and loss to 
follow-up. In their research on treatment failure in a South African cohort, Kranzer 
(2010) found that men and patients with high CD4 cell count were more likely to 
interrupt ART, interruption defined as being without drugs for more than 30 days. The 
study calculated a 42% probability of restart after discontinuation, factors associated 
with restart were female sex, older age, and less than 6 months of treatment 
discontinuation. In their recent study from Uganda, Mills (2013) found that 11.2% of 
6970 ART patients had a treatment interruption of more than 12 months, before 
returning back to care. Factors associated with treatment interruption were high CD4 
cell count at initiation and low level of education. Having a partner was associated with 
ART restart, whilst adolescents were more likely to stay away from care and getting 
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lost to follow-up. Mutevedzi (2013) reported worryingly increasing rates of ART 
disengagement over calendar time in South Africa (see figure 3-4), disengagement 
defined as missing a clinic visit for 180 days and still being alive at this time point. 68% 
of the treatment interrupters remained resident within their local community.  
 
Figure 3-4:  Rates of disengagement from care, stratified by calendar year of ART 
initiation (Mutevedzi 2013) 
 
ART=antiretroviral treatment 
 
This section started with an overview on the current literature on quantitative research 
of retention in ART programmes, defined as patients being alive and on ART after a 
certain time period. It was found that in the Southern African region, more than one 
third of ART patients drop out of therapy within the first three years. Data corrected for 
mortality among patients lost to follow-up revealed that the majority of programme 
attrition is due to death, a phenomenon which is being underreported by national and 
global routine programme data. There is robust evidence from quantitative research 
about factors associated with good retention. Female sex, adult age, education, 
income, treatment literacy, living with the partner and certain ARV regimens are 
associated with retention. Evidence is growing that community-based interventions, 
such as community-based adherence supporters, support groups and patient tracing, 
can improve retention and other ART outcomes. Factors associated with attrition – 
comprising death and loss to follow-up – were young age, male sex, low CD4 cell count 
and advanced WHO stage at initiation, food shortages, discrimination in the family, 
financial difficulties, hospital-centred ART provision, long distance to the ART clinic, 
and drug stock-outs. Eventually, there is new evidence suggesting that unreported 
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deaths classified as lost to follow-up might be due to undiagnosed tuberculosis to a 
much greater extent than previously known. 
 
3.3 Review of qualitative research  
In this section, the state of qualitative social science research on retention will be 
presented with the aim to understand in more depth the barriers to and facilitators of 
retention. Qualitative research looks at retention as a social process rather than a 
therapy outcome, and attempts to understand why patients interrupt ART.  
Castro’s bio-social approach on factors influencing adherence to ART care (Castro, 
2005) provides a useful framework to organize the review of qualitative research 
around topics related to the individual as well as the structural spheres of retention. At 
the individual level, qualitative studies investigated 
1. personal characteristics, such as gender and age;  
2. psychological factors, such as self-esteem, motivation, and identity; 
3. clinical factors, such as opportunistic infections and side effects.  
At the structural level, qualitative research explored  
4. socio-economic factors, such as poverty and all sorts of costs including 
transportation; 
5. health system related factors, such as the health worker-patient interaction or 
health financing;  
6. social capital factors, such as family and community networks;  
7. cultural factors related to religion and models of health and illness other than 
the biomedical. 
Table 3-2 shows the reviewed studies, indicating  
- study aim (which aspect related to retention);  
- country; 
- methodology (data collection method and study population);  
- the focus on retention outcomes (to what extent the study findings relate to ART 
outcomes, such as retention, interruption, loss, death or transfer); 
- thematic scope by the categories personal, psychological, clinical, socio-economic, 
health system, social capital, cultural models; and 
- quality, defined as high, medium or low as per CASP criteria (CASP 2013) stated in 
appendix 1. 
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Table 3-2: Characteristics of the 29 reviewed qualitative studies 
Study / 
Year 
Study aim Country Methodology Focus
1
 Scope
2
 Quality
3 
Agnarson 
2010 
to explore attitudes, perceptions and practices among 
health care workers, ART patients and community 
members regarding ART care and the social 
consequences of ART roll-out 
Tanzania 15 FGDs (93 participants) and 25 IDIs with health care 
workers, community members, ART patients, religious 
leaders, and social workers; field observations and 
ethnographic assessments 
none 5,7 ++ 
Aspeling 
2008 
to identify factors that could influence adherence to ART South 
Africa 
4-8 SSIs during a follow-up period of 8 months with 11 
female ART patients who had interrupted ART 
strong 1,4,5,6 ++ 
Campbell 
2011a 
to understand patient and healthcare staff perceptions of 
good clinical ART care 
Zimbabwe 58 IDIs and 8 FGDs (60 participants) with health workers, 
ART users, and carers of children on ART. 100 hours 
ethnographic observation at healthcare sites 
none 5 +++ 
Campbell 
2011c 
to study the impact of antiretroviral treatment availability 
on HIV/AIDS stigma 
Zimbabwe 58 IDIs and 8 FGDs (60 participants) with health workers, 
ART users, and carers of children on ART. 100 hours 
ethnographic observation at healthcare sites. 
none 2,7 +++ 
Dahab 
2011 
to investigate reasons for clinical follow-up and treatment 
discontinuation among HIV-infected individuals receiving 
ART 
South 
Africa 
27 SSIs with ART patients who had discontinued treatment strong 2,3,4,5,
7 
++ 
Fitzgerald 
2010 
to examine the way gender shapes the health 
behaviours, health care experiences and narratives of 
HIV-positive men initiating ART 
South 
Africa 
IDIs with 30 patients initiating ART, of which SSI with 26 
patients four months after initiation, 9 IDIs with family 
members, 5 IDIs with health workers; participant 
observation 
weak 1,2,6 ++ 
Goudge 
2011 
to explore the reasons for poor adherence among poor 
urban ART users 
South 
Africa 
4 IDIs during 4 months follow-up with 22 adherent and non-
adherent ART patients 
strong 1,2,4 ++ 
Grant  
2008 
to gain patient perceptions on factors that facilitate and 
challenge access and adherence to ART 
Zambia 2 SSIs 12 months apart with 40 ART patients; 1 FGD with 
12 ART patients 
strong 4,6 ++ 
Gusdal 
2009 
to explore HIV patients' adherence to ART in resource-
limited contexts 
Ethiopia, 
Uganda 
SSIs with 79 ART patients, 17 peer counsellors, and 22 
ART providers 
strong 4,5 +++ 
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Study / 
Year 
Study aim Country Methodology Focus
1
 Scope
2
 Quality
3 
Gusdal 
2011 
to explore peer counsellors’ work and their role in 
supporting patients' adherence to ART in resource-
limited settings in Ethiopia and Uganda 
Ethiopia, 
Uganda 
SSIs with 79 ART patients, 17 peer counsellors, and 22 
ART providers 
weak 5 +++ 
Kagee  
2012 
to identify the structural barriers that influenced 
adherence among ART patients 
South 
Africa 
SSIs with 10 ART patients strong 4,5 + 
Mattes 
2011 
to investigate the implementation of ART Tanzania ethnographic case studies from IDIs with 26 non-compliant 
ART patients, SSIs with family members and 27 health 
workers; extensive participant observation 
strong 5,6 + 
Merten 
2010 
to provide a synthesis and an interpretation of the 
findings of recent qualitative social science research on 
the questions of retention in ART programmes in sub-
Saharan Africa 
various systematic literature review and meta-ethnography of 31 
qualitative studies on barriers to adherence in sub-Saharan 
Africa 
strong 1,2,4,5,
6,7 
+++ 
Miller  
2010 
to better understand the reasons why patients default 
from ART to help design interventions that improve 
treatment retention and ultimately, patient outcomes 
South 
Africa 
SSIs with 14 patients who interrupted ART and 16 patients 
who transferred out (in a mixed-methods design) 
strong 5 ++ 
Murray 
2009 
to gain local insight into potentially important factors 
affecting HIV-infected women's decision to accept or 
continue with ART 
Zambia 47 interviews with ART patients (free listing technique) and 
33 SSIs with key informants 
strong 1,2 ++ 
Nam  
2008 
to identify the psycho-social factors related to adherence 
behaviour  
Botswana 32 IDIs with ART patients  strong 2,6,7 +++ 
Nguyen 
2007 
to examine adherence in the historical and ethnographic 
context of access to ART 
Burkina 
Faso, 
Ivory 
Coast, 
Mali 
ethnographic methods, not specified strong 5 + 
O'Laughlin 
2012 
to describe the additional social functions that ART 
treatment partners serve and shows how these functions 
contribute to health and survival for patients 
Tanzania 3 IDIs with 20 ART patients and their treatment partners weak 1,2,6 ++ 
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Study / 
Year 
Study aim Country Methodology Focus
1
 Scope
2
 Quality
3 
Rachlis 
2013 
to explore why patients on ART are lost to follow-up 
(LTFU) by identifying: (1) factors that influence patient 
losses to follow-up and (2) barriers to effective and 
efficient tracing 
Malawi group discussions with 90 ART patients and ART providers, 
using the Concept Mapping technique 
strong 2,5 ++ 
Roura  
2009 
to identify factors affecting sustained attendance at 
treatment clinics  
Tanzania SSIs with 42 ART patients and 11 providers, and 4 
participatory group activities with ART patients 
strong 1,2,6 ++ 
Sanjobo 
2008 
to explore patients' and health care professionals' 
perceived barriers and facilitators to patients' adherence 
to ART 
Zambia IDIs with 10 ART patients and 12 health workers; 5 FGDs 
with 50 ART patients 
strong 2,4,5,6 + 
Sankar 
2006 
to understand how qualitative methods have been used 
in ART adherence research and the contributions they 
have made 
various systematic literature review of 66 qualitative studies from 
1995 to 2006 on adherence to ART 
strong 1,2,3,4,
5,6,7 
+++ 
Scott  
2013 
to determine how indigenous resources were enabling 
people to achieve optimal ART access and adherence 
Zimbabwe 58 IDIs and 8 FGDs (60 participants) with health workers, 
ART users, and carers of children on ART. 100 hours 
ethnographic observation at healthcare sites 
weak 6 +++ 
Skovdal 
2011a 
to explore how male denial of HIV/AIDS impacts on their 
female partners' ability to access and adhere to ART. 
Zimbabwe 58 IDIs and 8 FGDs (60 participants) with health workers, 
ART users, and carers of children on ART. 100 hours 
ethnographic observation at healthcare sites 
strong 1,2,6 +++ 
Skovdal 
2011b 
to systematically categorise the spectrum of factors that 
influence ART.  
Zimbabwe 58 IDIs and 8 FGDs (60 participants) with health workers, 
ART users, and carers of children on ART. 100 hours 
ethnographic observation at healthcare sites 
weak 2,4,5,6 +++ 
Tuller  
2009 
to understand structural barriers to ARV adherence and 
clinical care 
Uganda 41 IDIs with ART patients strong 4 ++ 
Ware  
2009 
to examine determinants of ART adherence for HIV 
infected persons in sub-Saharan Africa 
Nigeria, 
Tanzania, 
Uganda 
IDIs with 252 persons taking ART, their treatment partners, 
and health care professionals; 136 field observations of 
clinic activities were also conducted 
strong 4,6 +++ 
Ware  
2013 
to identify reasons for missed visits and to assemble 
them into a broader explanation of how missed visits 
may develop into disengagement 
Nigeria, 
Tanzania, 
Uganda 
IDIs with 91 ART patients who had extended treatment 
interruptions 
strong 1,4,5 +++ 
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Study / 
Year 
Study aim Country Methodology Focus
1
 Scope
2
 Quality
3 
Weiser 
2010 
to understand and contextualize food insecurity in the 
lives of PLH; to investigate pathways and mechanisms 
through which food insecurity leads to missed doses and 
treatment interruptions 
Uganda 47 IDIs with ART users  strong 4 ++ 
 
ART = antiretroviral treatment, FGD = focus group discussion, IDI = in-depth interview, PLH = people living with HIV, SSI = semi-structured interview 
1 
Focus of the study on retention / adherence outcomes 
2 
Thematic scope of the study on the following biosocial dimensions (Castro 2005): 1 = personal; 2 = psychological; 3 = clinical; 4 = socio-economic; 5 = health system; 6 = social 
capital; 7 = cultural models 
3 
Quality appraisal according to the Qualitative Research criteria of the Critical Appraisal Skills Programme (CASP): aim, methodology, design, recruitment of participants, data 
collection methods, researcher-participant relation, ethical issues, data analysis, statement of findings, value; + = low quality, ++ = medium quality, +++ = high quality
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3.3.1 Personal characteristics 
Studies exploring personal characteristics of ART patients revealed that gender and 
the marital status of patients strongly influence retention on ART. Fitzgerald (2010), 
Murray (2009) and Skovdal (2011a) uncovered gender specific retention barriers that 
were deeply rooted in autochthonous conceptions of “hegemonic masculinity” (ibid.) 
and marriage, shaped by inequalities and dependencies between men and women.  
For men, HIV/AIDS bore the threat that the disease could undermine their status and 
dignity as bread-winners and heads of families, households and kin. Fear of 
embarrassment for not meeting the expectations of their families prevented many men 
from testing and disclosing their status to their kin, leading to delayed ART uptake and 
consequently to high attrition. Men needed pressure to start treatment, either from 
friends or through the experience of suffering from an opportunistic infection. Alcohol 
often played a role, either as a strategy to cope with denial, or as an excuse to delay 
ART. On a promising note, though, some men realised that ART provided an 
opportunity to reconstruct their masculinity (ibid.). After disclosing and initiating ART, 
men considered themselves as role models for other men, developing a strong sense 
of responsibility towards their families by adhering to drugs and consultations. 
Fitzgerald (2010) reported on men’s great fear of gossip and their strong opinion about 
confidentiality issues in respect to the health workers. In contrast to older men who 
were more confident in their social role, young men were vulnerable to denial of their 
HIV status even after initiating ART. Young men often abruptly stopped ART due to a 
perceived breach of confidentiality or other behaviour of health workers perceived as 
hostile. Men’s fears and inability to accept HIV did not only influence their own pathway 
of care, but they also strongly impacted their spouses’ health and adherence to ART. 
Murray (2009), Goudge and Ngoma (2011) and Skovdal (2011a) underlined women’s 
distress to disclose their HIV status to their boy-friends or partners and reported that 
many women took ART secretly or even stopped ART to hide their status. Whilst HIV 
and ART can potentially destroy partnership and marriage, several studies showed that 
spouses played a key role in keeping their partners on ART, such as Aspeling and van 
Wyk (2008), O'Laughlin (2012), Roura (2009), and Ware (2013). 
3.3.2 Psychological factors 
Adherence and retention have often been studied from a behaviourist perspective. 
From this perspective, individual attitudes, beliefs, and motivations are the key 
determinants for retention (see section 7.1 on the conceptual framework). Many studies 
therefore focussed on the psychological factors of adherence and retention. Campbell 
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(2011c) and Murray (2009) described the process how people living with HIV escape 
hopelessness and depression by constructing a new social identity as ART patients. 
The ART programme allowed patients to regain social value through participation in 
self-help groups and through economic activities. The availability of ART massively 
reduced stigma attached to HIV/AIDS due to its link with perceived sexual promiscuity, 
social embarrassment, and the fear of the terrifying course of the untreated disease. 
Stigma that is linked to fear and denial nonetheless remained a major obstacle to 
adherence and retention, as Rachlis (2013) observed in Malawi. 
Nam (2008) described adherence as psychological process requiring the individual’s 
acceptance of the positive HIV status. Disclosure led to the patient’s new perception 
and image of “self”, including the desire not to be thin and thus visibly identifiable as 
HIV-positive. Treatment partners as “encouraging confidantes” (ibid.) facilitated 
adherence by transmitting messages of hope and reversing social isolation 
(O'Laughlin, 2012). In turn, denial caused self-stigmatisation and depression, identified 
as major obstacles to adherence and retention.  
Personal motivation was identified as key factor for retention by Dahab (2011) who 
compared ART provision at a workplace setting in comparison with a community 
setting. At the workplace setting, ART coverage was higher but patients discontinued 
ART more frequently than in the community setting. The authors explained high 
attrition from ART at the workplace by a lack of adherence motivation caused by fear of 
discrimination by the employer and co-workers, and doubts about the HIV status and 
the effects of ART. In contrast, attrition in the community setting was not a motivational 
problem, but due to death, migration or high transport costs (ibid.). The study 
concluded that the “first generation” of ART patients was a selection of self-motivated 
people living with HIV, many of whom having gone through an illness episode before 
initiating ART. The workplace setting showed that the “second generation” of healthier 
people living with HIV who are expected to start in an earlier stage of the disease might 
be less self-motivated and thus more prone to attrition.  
3.3.3 Clinical factors 
In line with epidemiological research, there is robust evidence from qualitative studies 
that the patient’s clinical stage at treatment initiation influences adherence and 
retention. The studies of Nam (2008) and Dahab (2011) found that patients with a low 
CD4 cell count who started ART only after getting very sick were more motivated to 
adhere to the drugs and consultations than patients who were still relatively healthy at 
the time of starting ART. The authors reported that going through an AIDS-related 
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illness episode facilitated the patients’ ability and willingness to accept their HIV status, 
which was shown to be a mental prerequisite of adherence and retention in the section 
above. Roura (2009) identified that it was rather the perceived disease severity and the 
experienced health gain of ART than the medical condition itself that influenced the 
patient’s capacity to continue ART. Nam (2008) found that it is not only the medical 
recovery, but also the weight gain and changing physical appearance that motivated 
ART patients to stay on long-term treatment. 
Whilst ill-health at treatment start and the dramatic effects of ART on the patient’s 
health and wellbeing were recognized as a motivational factor for retention, the 
occurrence of adverse effects, opportunistic infections, mental illness or other medical 
conditions caused therapy interruptions. The qualitative research of Goudge and 
Ngoma (2011), Kagee (2012), Grant (2008) and Weiser (2010) confirmed findings of 
clinical studies about patients reporting growing appetite and hunger requiring more 
food after the initiation of ART. The studies found that nausea, vomiting and dizziness 
caused by insufficient nutrition made patients stop ART. These findings underlined that 
ill-health during ART made patients vulnerable for treatment discontinuation, if the 
episode coincided with other adherence threatening influences, such as money 
shortage to seek treatment, food insecurity, or gender-based discrimination.  
3.3.4 Socio-economic factors 
The roll out of free ART through public health programmes in sub-Saharan Africa has 
changed the scientific perception on adherence and retention on ART. Out of 66 
adherence studies between 1995 and 2005 reviewed by Sankar (2006), only 4 were 
from sub-Saharan Africa, and 56 were from the USA. The review of Sankar (ibid.) 
identified mostly individual-level adherence factors, as have been presented above. 
Prior to the era of free ART in sub-Saharan Africa, adherence was mainly perceived 
from a health behaviour point of view. Structural barriers and facilitators to adherence 
were rarely explored nor reported. This picture has changed in recent years since an 
increasing number of studies on adherence and retention have been carried out in sub-
Saharan Africa. Based on their large study in Nigeria, Tanzania and Uganda, Ware 
(2009) found that in sub-Saharan Africa, most adherence and retention obstacles were 
related to resource constraints rather than to personal motivation. Merten (2010) 
reviewed 31 qualitative adherence studies from sub-Saharan Africa between 2000 and 
2008. The authors of this review argued that in the context of sub-Saharan Africa, the 
ability and willingness to continue ART in the long term was largely determined by the 
patient’s structural context, such as the social, economic, institutional and cultural 
environment. 
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There is strong evidence from numerous studies that high opportunity cost of attending 
recurrent ART consultations is the single most important structural barrier to retention. 
Merten (2010) described adherence largely as the patient’s act to balance and 
negotiate between his individual health needs and the collective livelihood and material 
needs in his immediate environment. Especially in poor households and in the absence 
of social security schemes, there were often immediate competing livelihood needs, not 
allowing a family member to spend money for transport to reach the ART clinic 
(Aspeling and van Wyk, 2008). Besides housing and schooling, food was identified the 
major competing family need, aggravated by the fact that reasonable nutrition was an 
imperative for ART patients, as the studies by Weiser (2010) and Kagee (2012) 
showed. Households also considered travel for an ART consultation a burden because 
it not only created costs, but it also prevented the family member from undertaking 
income-generating activities. In the context of free ART, there were numerous indirect 
costs creating a financial burden to the ART patient’s household. Gusdal (2009) 
identified transportation as a key cost driver. Depending on the distance from home to 
the nearest ART clinic, ART patients had to pay substantial amounts for transportation. 
Referral to another health facility caused additional costs for further transport and for 
accommodation (Tuller, 2010). Ware (2009) found that ART patients took loans, sold 
assets, or cut on household expenses to make money available to cover these indirect 
costs of ART. They took this decision not just for the sake of their individual wellbeing, 
but to sustain their workforce, to avoid becoming a burden to their family, and to fulfil 
the duties vis-à-vis their household and community. Nguyen (2007), Mattes (2011) and 
Merten (2010) suggested that ART programmes offered access not only to treatment, 
but also to other benefits, such as food aid and income generating projects. These 
studies found that poor households with several HIV-positive members took a strategic 
choice as to who should be kept on ART. In such cases of social triage, family 
members were supported in their efforts to adhere often not on the basis of their 
vulnerability, but on the basis of the economic needs of the family. 
3.3.5 Health care system  
The reviewed studies show that the structure, services, and performance quality of the 
health care system can influence ART retention. The above-mentioned comparative 
study of Dahab (2011) of ART at workplace and community settings reported 95% ART 
coverage at the workplace. Whilst access to ART was not reported a problem in this 
setting, attrition from ART was very high. Patients had immediate and free access to 
care, but poor patient-health worker relationship undermined the gains of free access. 
Gusdal (2009) investigated the association of the patient-provider relationship with the 
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patient’s capacity to adhere. The study found that the patients’ trust in the ART drugs 
and in the ART provider were an important factor influencing the degree of the patient’s 
personal responsibility to adhere to ART. Two studies from Tanzania reported widely 
spread negative attitudes, perceptions and practices of both ART patients as well as 
providers. Agnarson (2010) observed mistrust towards the ART programme among the 
community as well as lacking commitment by health workers for the ART programme. 
In his fundamental critique of the Tanzanian ART programme, the ethnography by 
Mattes (2011) described ART as a rigid, authoritarian system that promoted adherence 
on the basis of obedience, stimulus and punishment. The author found that patients 
experienced adherence as a disciplinary behaviour protocol they often could not 
comply with due to constraints or conflicting norms in their social and cultural 
environment. During individual and group adherence sessions, ART nurses educated 
future ART patients on adherence behaviour, how to “live positively” and the “lifelong 
contract” on therapy (ibid.). ART patients found it difficult to comply with some of the 
“contract” conditions. For example, nurses taught that concealment of the HIV status 
was the result of “self-stigma” and disclosure thus a pre-requisite for ART. Yet, some 
HIV-positive women decided not to disclose their status to their husband and in-laws 
because they felt guilty or feared rejection. Other potentially conflicting imperatives 
were reduced sexual intercourse and refusal of herbal medicine, both behavioural 
instructions that interfered with culturally shaped expectations and practices of the 
patients (ibid.). The author’s rich insights into the “disempowering” Tanzanian ART 
programme were limited by insufficient information on methods of data collection and 
analysis.  
A similar analysis was presented under the notion of “therapeutic citizenship” by 
Nguyen (2007) and in a monograph by the same author (Nguyen, 2010). The concept 
of therapeutic citizenship implies that ART provided people living with HIV not just with 
medical treatment, but with a far reaching social security system that is usually offered 
by governments to its citizens. In the absence of government social security, the author 
argued that ART represented a set of rights and benefits that are linked with the 
obligation to adhere (ibid.). In settings where government social security is absent and 
not even kinship systems can provide social protection, ART programmes, often 
supported by international organisations, can offer an alternative. ART programmes did 
not only provide access to material goods to its “therapeutic citizens”, ART 
programmes also mobilised patients for national and even transnational advocacy 
purposes, for example to claim equitable access to free drugs and CD4 cell counts. As 
“therapeutic citizens”, ART patients were exposed to conflicting “moral economies”, as 
they were at the same time members and subordinates of a kinship system which did 
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not necessarily consider adherence to ART by one of its members a priority. The cited 
author has been widely recognized for establishing the concept of “therapeutic 
citizenship” and launching a critical debate on the political economy of large-scale 
HIV/AIDS programmes. His publications are based on his personal experience as 
medical doctor and anthropologist in West African ART programme, but do not declare 
the methodology of his qualitative research.  
The impact of the patient-health worker relationship on ART retention appears to be a 
critical, yet poorly studied aspect. Negative experiences of patients with the ART 
programme were also reported from South Africa and Zambia, where Kagee (2012) 
and Sanjobo (2008) found poor patient-health worker relationships, related to health 
workers breaching confidentiality. These two studies, though, were of low quality. The 
study of Campbell (2011a) drew a much more positive picture from rural Zimbabwe, 
reporting great adherence commitment of patients and nurses dedicated to provide 
patient-oriented ART services. The authors, however, also found mismatching 
expectations and priorities in the patient-provider relationship that affected the quality 
of care. Patients claimed a lack of confidentiality, kindness and acceptance by some 
ART nurses, who allegedly misconceived adherence to ART as the patients’ obedience 
to their authority. Long waiting times, high visit frequencies, and unpredictable clinical 
pathways were further noted as issues affecting client satisfaction.  
3.3.6 Social capital  
In their ethnography on adherence in Nigeria, Tanzania and Uganda, Ware (2009) 
explored why and how ART patients in sub-Saharan Africa adhered to ART in spite of 
the massive structural obstacles and resource constraints, such as poverty, weak 
health systems, large distances to ART clinics, and considerable indirect costs related 
to attending regular and life-long ART consultations. The study found that ART patients 
made huge sacrifices to attend ART consultations, often to the extent of selling assets 
or borrowing money to pay for transport. The authors suggested that adherent ART 
patients did not aim at their individual wellbeing, they rather responded to obligations to 
preserve their social capital, a concept that is described in more detail in section 7.1. 
The systematic review of Merten (2010) and a large social capital study from 
Zimbabwe conducted by the London School of Economics and Political Science for the 
World Bank (Campbell, 2011b) suggested that adherence in sub-Saharan Africa 
cannot be understood without reference to extended families and community networks 
serving as social security systems. Whilst the cited studies underlined that ART 
patients ultimately adhered to fulfil their social obligations, Aspeling and van Wyk 
(2008), Foster (2010), Grant (2008), and O'Laughlin (2012) described social capital not 
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as a collective imperative, but as a resource for emotional and functional adherence 
support. These studies presented “treatment partners”, “medical companions”, spouses 
and family members as key facilitators for retention. Especially during the initial stage 
of ART and during crisis, these encouraging “confidantes” (Nam, 2008) reminded ART 
patients to take pills, provide nutritional support, and accompanied them on ART follow-
up consultations.  
In resource-poor health systems, community health workers have become increasingly 
involved in the promotion of adherence and retention. A growing number of qualitative 
studies describe the significance of community-based lay health workers in bridging the 
gap between the ART patient and the health system, such as “peer counsellors” 
(Gusdal, 2011), “expert patients” in Malawi (Tenthani, 2012), and various other types 
(Hermann, 2009). Complementing the findings of quantitative studies which found 
considerably better retention in ART programs with community-based adherence 
support (Fatti, 2012), qualitative studies provided valuable insight into the relationship 
between such lay counsellors and ART patients. Especially in the early stage after 
initiation, ART patients considered these lay workers as “living testimonies”, “roles 
models”, and “models of hope”.  “Expert patients”, lay counsellors who are on ART 
themselves, were particularly well accepted by ART patients, trusted for respecting 
confidentiality, and for having a positive influence on the patient’s relationship with the 
professional health worker (Tenthani, 2012). Rachlis (2013) reported that community-
health workers were increasingly engaged in tracing of patients who missed their ART 
follow-up appointments.  
3.3.7 Cultural models of health, illness and treatment 
Several of the reviewed studies investigated how adherence and retention on ART is 
influenced by the patients’ cultural explanatory models of health, HIV/AIDS, and 
treatment. Traditional African medicine and faith provide powerful and potentially 
complementary or alternative explanatory models to Western biomedicine, as Aspeling 
and van Wyk (2008), Nam (2008), Dahab (2011), Sanjobo (2008), and Roura (2009) 
pointed out. Dahab (2011) found that sick patients in South Africa who tested HIV-
positive often rejected the diagnosis, arguing they were “bewitched”. In contrast, study 
participates who were tested HIV-positive in an early stage of the disease who felt 
perfectly healthy often also rejected their status arguing HIV/AIDS was a visible 
disease of “thinness” which they neither felt nor saw in their own case. Roura (2009) 
reported widespread believes in Tanzania that spiritual healing and traditional medicine 
can cure HIV/AIDS, thus fuelling rumours and insecurity in the communities and 
potentially affecting the ART patients willingness to stay on treatment. The study also 
 49 
 
reported misconceptions on ART that are not necessarily rooted in cultural models, 
such as the incompatibility of alcohol or smoking with ART (ibid.). Nevertheless, 
cultural and religious models were not only identified as potential barriers, but also as 
powerful facilitators of adherence. Sanjobo (2008) and Scott (2013) revealed that 
prayers and church communities had a positive influence on the patients’ retention on 
ART. Nam (2008) found that patients who had dramatically recovered on ART often 
referred to their faith in God who healed them through ART, whilst ART patients who 
were experiencing health problems on treatment often blamed biomedicine and turned 
away from ART, seeking treatment by traditional healers.  
Merten (2010) offered an insightful reasoning why patients on ART, in spite of the 
visible and striking evidence on the efficacy of ART, sometimes rejected the biomedical 
medicine and got attracted by traditional healing. Contrary to ART which entirely 
centres at the individual’s health and treatment, traditional African medicine 
understands health and illness in social and spiritual terms.  From this perspective, the 
illness of an individual was perceived as a potential social or spiritual conflict or threat 
to the community (ibid.). Traditional healing in this view represented social healing, 
meaning that it aims at collective reconciliation rather than just at individual healing. 
Taylor (2010) explored the traditional system of health in Zimbabwe, and how the 
traditional healers, n’anga, provided a complementary rather than opposing model for 
the diagnosis and healing of HIV-related illness. The study found that ART patients had 
pluralistic treatment seeking strategies, pursuing “multiple avenues of therapeutic relief” 
by changing back and forth between Christian faith healers, n’anga, and biomedicine 
(ibid.). Most Zimbabweans knew and accepted that HIV/AIDS was a sexually 
transmitted disease and that ART was effective. However, the n’anga were considered 
particularly competent to identify the underlying cause of the disease, responding to the 
question “why me?”. Also, traditional healers were respected to be confidential, non-
judgemental, and discrete, which made them particularly attractive for ART patients 
who experienced discriminatory conduct and treatment by health workers in hospitals 
and clinics (ibid.). 
In summary, the recent qualitative social science research emphasises that in the 
context of sub-Saharan Africa, ART patients are highly motivated to adhere to ART 
drugs and consultations. Programme attrition is not primarily caused by a lack of 
motivation but rather by barriers in the social, economic, institutional and cultural 
environment of the ART patient. High opportunity costs, particularly related to 
transportation, strongly influence decision making in households as to whether or not a 
family member can be retained on ART. Barriers in the health care system, such as 
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long distance to the nearest ART site, waiting times, and conflicting patient-health 
worker relationships, are contributing factors for attrition. The review of qualitative 
studies also showed that gendered perceptions and power relationships create 
dominant barriers to retention.  
Qualitative studies found a number of facilitators to ART retention that are rooted in the 
concept of agency (see section 7.1). The evidence shows that patients develop coping 
strategies that allow them to retain on ART under extremely demanding circumstances. 
Social networks, starting with the partner and extending to relatives and community 
organisations are vital facilitators for retention on ART. ART programmes themselves 
can help patients overcome social isolation and stigma through material benefits, 
regained self-esteem and identity, and new social relationships in support groups or 
with caring health workers.  
The majority of the reviewed studies were conducted on the basis of data collected 
among retained ART patients. Only very few studies explored perceptions and lived 
experience of patients who actually interrupted ART. Whilst facilitators for and barriers 
to adherence and retention are well documented, temporal dimensions of retention 
were often undervalued, including the question why some patients who interrupt ART 
return to care, and others do not. Most of the qualitative research has focused on 
reasons related to the patient and his or her immediate environment. A smaller number 
of studies, some of them however of limited quality, suggest that barriers and 
facilitators related to the health system and the ART programmes itself might critically 
influence retention on ART.  
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4 Aim, objectives and study design 
The aim of this study was to explore ART programme retention and reasons for loss to 
follow-up and treatment interruption of ART patients in the SMART programme in Zaka 
and Bikita district, Zimbabwe. The study pursued the following two primary objectives: 
1. to describe and quantify retention, loss to follow-up and death in the SMART 
programme 2006-2012 before and after tracing of patients lost to follow-up; 
2. to understand facilitators for and barriers to retention and treatment interruption 
from the perspective of ART patients who interrupted therapy.  
A secondary objective of the study was to describe how the patients and health 
workers perceived and experienced the SMART tracing intervention. 
I chose a mixed-methods approach – combining quantitative and qualitative research –
for two reasons: firstly, the involved parties of the ART programme in Zaka and Bikita – 
the Ministry of Health, the two hospitals, and SolidarMed – had established a tracing 
scheme to find out the status of the lost patients. The tracing scheme allowed updating 
and correcting ART patient outcomes in the electronic programme database. Good 
quality routine data had been stored electronically since the ART programme start, and 
yet, the data had not been exploited for monitoring and operational research purposes. 
The quantitative study component would fill this gap. Secondly, understanding the 
underlying causes of attrition from the patients’ perspectives in view of future 
programme interventions required a qualitative approach. The added value of the 
mixed-methods is based on combining different data collection methods and 
techniques, collecting different kind of data on the same subjects, and increasing the 
depths and credibility of the findings through integration of qualitative and quantitative 
results (Green and Thorogood, 2009). Mixed-methods did not only refer to the 
combination of a qualitative and quantitative research, it also included a mix of 
qualitative approaches, namely in-depth interviews, focus group discussions and 
participatory observation.  
In contrast to mixed-methods studies that follow a principally quantitative or qualitative 
approach (Ulin, 2005), this study considered both components to be equally important. 
Also, the two methods were not applied sequentially, but simultaneously, as shown in 
figure 4-1 and as discussed in chapter 8. Whilst the two research processes evolved 
independently during data collection, they were connected during analysis. Some 
quantitative findings raised additional research questions to be addressed during the 
qualitative content analysis. Equally, some of the qualitative in-sights suggested an 
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additional statistical query of the available data. To integrate the results of the two 
individual study components, the findings were synthesised and interpreted in the final 
stage of the research process. 
Figure 4-1: The mixed-methods research process 
 
 
 
The research methods and techniques are described in more detail in chapter 6 on the 
quantitative and in chapter 7 on the qualitative study component.  
The study was approved by the Medical Research Council of Zimbabwe (MRCZ) on 
the 19th of January 2012 (reference number MRCZ/A/1650) and by the Ethics 
Committee of the London School of Hygiene and Tropical Medicine on 28th of March 
2012 (reference number 6140), see appendix 2. 
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5 The SMART programme 
As described in the introduction (chapter 1), this research project was conducted as an 
operational study, embedded in the ART support programme SMART. This chapter 
describes the framework of the national ART programme and the intervention package 
of SMART. Section 5.1 gives a brief history of the SMART programme and explains 
how it complemented the national ART programme. Section 5.2 presents the tracing 
scheme implemented between September 2011 and July 2012, an intervention of 
particular interest for the present study.  
 
5.1 Description of the programme interventions 
5.1.1 The Zimbabwean ART programme 
In 2004, the MOHCW launched free ART for eligible patients throughout the country. 
During the first four years, the programme accredited ART clinics at the referral 
hospitals of the 59 districts, such as Musiso and Silveira. With the aim to bring ART 
services closer to the patients, the MOHCW started in 2008 accrediting rural hospitals 
and health centres as ART follow-up sites. By the end of 2011, the national ART 
programme covered 141 ART initiation sites and 449 ART follow-up sites (GoZ, 
2012b).  
The Zimbabwean ART treatment protocol was standardized and regularly updated. 
When the present study was conducted, ART was provided under the 2010 guidelines, 
adapted from the revised 2010 ART guidelines of the WHO (GoZ, 2010). ART was 
initiated in patients with WHO clinical stage 3 or 4, or if they had a CD4 cell count of 
less than 350. First-line regimens were fixed-dose combinations of tenofovir, 
lamivudine and nevirapine or zidovudine, lamivudine and nevirapine (ibid.). Although 
the MOHCW planned to phase out stavudine containing regimens, according to 
monitoring reports provided by the SMART database, more than 50% of SMART 
patients were still on stavudine at the time of the study. 
Whilst ART consultations and drugs were provided free against a very small annual fee 
throughout the country, health facilities were allowed to charge for laboratory tests 
(CD4 cell count, haematology and blood chemistry), X-rays, and drugs for opportunistic 
infections and other conditions.  
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5.1.2 History and scope of the SMART programme 
SMART originated at the two hospitals of the Catholic Diocese, Musiso and Silveira. In 
Zimbabwe, like in many other African countries, faith-based hospitals provide public 
health services, receiving government grants for salaries and essential drugs. Unlike 
government health facilities, faith-based hospitals often have access to donor funding 
thanks to their historic links to foreign missionary institutions. SolidarMed had been 
supporting these mission hospitals and sending foreign doctors for many decades. The 
SMART programme interventions targeted three intervention levels: 
District health authorities: The programme supported the HIV/AIDS prevention and 
treatment activities of the district health authorities. SMART provided funding and 
transport for supervisory visits by the district authorities; it also financed district ART 
coordination and stakeholder meetings. 
Health facilities: SMART strengthened hospitals and health centres in the areas of 
infrastructure, equipment, training, logistics and technical expertise. All personnel were 
employed by the MOHCW or by the Diocese of Masvingo. The programme also 
contributed salary components (overtime payments, top-ups, locums and allowances 
for outreaches to rural health centres) to key ART personnel such as the ART nurses, 
primary care counsellors, and laboratory technicians. SMART funded reagents for the 
hospital CD4, haematology and biochemistry machines and a limited number of drugs 
to treat opportunistic infections.  
Community: Through the Zimbabwean partner NGO “Batanai HIV/AIDS Support 
Organisation” (BHASO), the programme strengthened support groups of people living 
with HIV and a network of “Community HIV/AIDS Support Agents” (CHASA). The 
CHASA were people living with HIV, who were on ART themselves and actively 
involved in local HIV/AIDS support groups. Under the SMART programme, BHASO 
recruited, trained and supervised two CHASA per each health facility. CHASA assisted 
health facility staff in pre-ART group counselling and individual adherence counselling 
of ART patients. CHASAs were also used as tracers of patients lost to follow-up. The 
CHASA received a monthly remuneration of US$15, a robust bicycle and spare parts, 
T-shirts and a bag through the SMART programme. 
In summary, in 2012, people living with HIV/AIDS in Zaka and Bikita were provided with 
the following services on the HIV/AIDS care and treatment pathway: 
- Free HIV testing and counselling at all health facilities in the district; 
- Free prevention of mother-to-child transmission services at all health facilities in the 
district; 
 55 
 
- Free initiation of first-line and second-line ART at hospitals according to MOHCW 
protocol, outreach initiation at selected local health centres in Zaka district; 
- After 6-12 months stable and adherent ART at hospital level, down-referral to local 
health centre for ART follow-up if the local health centre was an accredited ART 
site; 
- Free treatment of tuberculosis at all health facilities; 
- Treatment of other opportunistic infections at patient’s expense at hospitals; 
- Treatment of other conditions as well as ART side effects at patient’s expense; 
- Free CD4 cell counts after testing HIV-positive and every 12 months thereafter at 
hospital and health centres (blood samples sent to hospital laboratory); 
- Free laboratory tests during ART treatment according to MOHCW protocol; 
- Other diagnostic investigations (for example X-ray) at patient’s expense; 
- Free co-trimoxazole prophylaxis at all health facilities. 
In its first phase (2005-2007), SMART established an ART clinic at Musiso and Silveira 
hospitals, and introduced an electronic ART patient database. In the second phase 
(2008-2010), the programme expanded from hospital- and doctor-centred ART 
provision to health centre and nurse-delivered ART provision. In 2009, the hospitals 
started referring ART patients to their nearest rural health centre. Eligible for such 
down-referral were patients who the hospital nurse considered adherent and stable for 
at least 6 months. The decentralization process was slowed down by the crisis in 2008 
and 2009. As the country recovered from the turmoil from 2010 onwards, more and 
more rural health centres in both districts became accredited ART follow-up sites. By 
June 2012, seven rural health facilities in Zaka and 13 rural health facilities in Bikita 
provided decentralised ART follow-up consultations under SMART. In Zaka, Musiso 
hospital conducted outreach ART initiations at selected health facilities. Otherwise, 
therapy initiation was restricted to the hospitals.  
Between 1 January 2005 and 30 June 2012, 9455 patients were enrolled on ART in the 
SMART programme. Figure 5-1 shows the rapid growth of patient numbers since 2009. 
The rapid increase of ART enrolment numbers since 2009 coincided with the 
acceleration of decentralized ART provision.  
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Figure 5-1:  Number of enrolled ART patients 2005-2011 in the programme SMART in 
Zaka and Bikita district (cumulative) 
 
 
5.2 Patient tracing: A SMART pilot intervention 
Concerned by the increasing numbers of patients lost to follow-up and the little 
knowledge about the reasons behind the losses, SMART launched a patient tracing 
scheme in 2011. 
5.2.1 Design and aim of the tracing intervention 
There are largely two types of ART patient tracing schemes: tracing through outreach 
and decentralised tracing. Outreach schemes send professional tracers on motorbikes 
from the ART initiation site, usually a hospital, to the patient’s homes. The tracers 
usually travel long distances and do not know the patient personally. In decentralised 
schemes, peripheral health centre send community health workers to trace the patients 
at their homes, usually on bicycle or on foot. Tracers in this scheme often know the 
patient or at least his treatment partner or relatives. SMART decided to conduct a 
decentralized tracing scheme with an outreach component to trace those patients who 
have been lost for many years or whose address was in long distance from the nearest 
rural health centre.   
With regard to the time point of tracing after a missed ART appointment, again, two 
approaches can be distinguished: interrupter tracing (after 7-14 days) and loss to 
follow-up tracing (after 90 days). When to trace depends primarily on the aim of the 
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tracing scheme. If the scheme primarily aims at ascertaining the patients’ vital status 
for monitoring, evaluation and research reasons, tracing of losses after 90 days is 
appropriate. If the scheme aims to bring patients back to care, tracing is initiated early 
after a missed appointment. Given a primary interest in monitoring and research, and 
owed to doubts on the logistical and organisational feasibility of interrupter tracing, 
SolidarMed decided to pilot a loss to follow-up tracing scheme.  
Loss to follow-up tracing started in September 2011 and included tracing of all patients 
since 2005 who had missed their last ART follow-up appointment for more than 90 
days without being recorded dead or transferred out.  
5.2.2 Operational procedures 
It is a key challenge of tracing schemes how patients qualified for tracing can be 
identified in the record system and located geographically. To identify patients lost to 
follow-up, SMART used the electronic programme database, as shown in appendix 3. 
Starting from September 2011, the SMART data managers once a month established a 
list of patients lost to follow-up. The rural health facility nurses were responsible for 
tracing the listed patient through any health worker cadre locally available. The health 
centre nurse filled in a tracing form according to the information provided, as shown in 
appendix 4. The forms were returned to the ART clinics at the referral hospitals Musiso 
and Silveira, where the tracing outcomes were recorded in the ART follow-up forms, 
the SMART patient database, and the tracing database.  
5.2.3 Health worker cadres used for tracing 
The Provincial Medical Director decided that for this pilot, any of the following health 
worker cadres would be allowed to perform tracing, depending on their availability at 
the respective rural health centre: 
- Environmental health technicians: In the Zimbabwean health system, 
environmental health technicians provide preventative health care such as disease 
control and hygiene inspections. They are linked to health facilities and use 
motorbikes. Environmental health technicians are used by several health 
programmes, for example by the HIV/AIDS programme as “riders” for transport of 
blood samples and by the tuberculosis programme for patient tracing. 
- Village Health Workers: In 2000, the MOHCW re-launched the Village Health 
Worker scheme to contribute community-based health workforce to achieve the 
health related MDGs. Village health workers are volunteers accredited by the 
MOHCW and trained in HIV/AIDS, tuberculosis, maternal and neonatal care, 
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community and home-based care, malaria, and disaster risk reduction. They are 
supervised by the health authorities and receive a small remuneration. 
- Community HIV/AIDS Support Agents: The CHASA, as described in section 
5.1.2, were a SMART programme intervention in collaboration with BHASO. As 
from 2011, patient tracing was included in the training curriculum for new CHASAs.  
- Other community health workers: The Provincial Medical Director agreed that 
any other types of formally recognized and trained community health workers could 
be used as tracers as well, provided the nurse instructed them. In Zaka, for 
example, the NGO CARE International had trained care facilitators for home-based 
care before the era of ART. They were now used for tracing. 
It was agreed that during the initial stage of the tracing pilot, motorized environmental 
health technicians would be prioritized to trace the large backlog of patients lost to 
follow-up since 2005. To compensate the involved tracers for their extra work during 
the initial phase of the tracing scheme (September 2011 – March 2012), SMART paid 
US$2 for each correctly filled and returned tracing form  to the ART nurse, and US$1 
was paid to the tracer. From April 2012, when the backlog of lost patients had been 
traced, these payments were ceased. 
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6 Retention, loss to follow-up and mortality: 
quantitative findings 
The objective of the quantitative research component was to describe and quantify 
retention, loss to follow-up and death in the SMART programme 2006-2012 before and 
after tracing of patients lost to follow-up. Section 6.1 describes the methodology of this 
study component, section 6.2 presents the results, and 6.3 includes a discussion of the 
findings in the light of the existing literature. 
 
6.1 Methodology 
6.1.1 Design 
I conducted a retrospective cohort study using electronically available patient level data 
that was supplemented with data collected through the SMART tracing intervention. 
Patient level routine data and tracing data were linked to update and correct patient 
outcomes. 
6.1.2 Study population 
The study included adults in the age of 18 years and older in Zaka and Bikita who were 
enrolled on ART for their own health between 1 January 2005 and 28 February 2012. 
ART follow-up data was included until 30 June 2012. ART patients who were 
transferred in from outside the districts of Zaka and Bikita were excluded. 
Figure 6-1 shows that after exclusions, 8425 ART patients were included in the study. 
From the included population, a sub-group of 946 patients was traced by the SMART 
programme. Their tracing data were included in the study. 
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Figure 6-1: Flow chart on the study population 
 
ART=antiretroviral treatment; WHO=World Health Organization 
6.1.3 Procedures 
The SMART programme collected and recorded patient and tracing data electronically 
as described in chapter 5. I obtained the electronic patient and tracing data from 
SolidarMed as per 31st July 2012. Prior to handing out the data sets as Microsoft 
Access 2003 files, the SMART data managers had replaced the national ART number 
variable with a non-identifying study number. We cleaned and linked the data sets and 
prepared them for analysis in Stata 12.  
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6.1.4 Statistical analysis 
I used descriptive statistics to analyse frequency distributions of selected 
characteristics of the study population at the first ART visit, which was the defined 
cohort entry date. After excluding ART patients who were transferred in, the first ART 
visit was for all patients the date when they started ART, meaning that the patient 
obtained the first ART drug supply. The cohort exit date was defined as last visit date in 
retained patients, and date of death or date of loss to follow-up (90 days after the 
missed appointment) in non-retained patients. Treatment outcomes were measured 
using programme data before and after updating with tracing data. To analyse retention 
outcomes over calendar time, I conducted a cohort analysis. Cohort analysis is a 
simplified ART patient monitoring tool suggested by WHO (WHO, 2006). A cohort is 
defined as a group of ART patients starting treatment in the same time period, e.g. 
month, quarter or year. Cohort analysis compares treatment outcomes at specified time 
points after enrolment between ART enrolment groups, thus showing trends in 
programme progress. Retention proportions were determined at different time points 
between 12 and 72 months after initiation, as defined in section 6.1.5 below. Treatment 
interruptions were calculated as number of days between the date of a missed 
appointment and the date of the subsequent ART visit, if the gap was more than seven 
days. The frequency of treatment interruptions was described irrespective of the 
patients’ duration on ART. I explored associations between baseline characteristics 
and the ART outcomes death and loss to follow-up using risk ratios. The relative risk 
for death was calculated among all patients who initiated ART, the relative risk for loss 
to follow-up among all patients who did not die. Exposures of interest were sex, age, 
WHO stage, CD4 baseline, tuberculosis diagnosis at ART initiation, health facility type 
at last visit, site, and haemoglobin. I conducted and plotted a survival analysis using 
Kaplan-Meier estimates with the survival time measured from the first ART visit, the 
event date being the date of death, and the censors being the date of loss to follow-up, 
calculated as 90 days after the missed appointment, or the date of transfer to another 
health facility. All statistical analysis was performed in Stata 12.  
6.1.5 Definitions 
The following definitions were used: 
Retention and attrition: These two terms are mutually exclusive categories related to 
a patient’s status in the ART programme. Retention refers to all ART patients who are 
alive and on treatment due to the fact that they adhere to follow-up appointments. 
Attrition, as the opposite term, includes all patients who are registered dead or lost to 
 62 
 
follow-up. Gross enrolment included patients transferred out, net enrolment excludes 
them. To calculate retention and attrition proportions, transfers out of the programme 
are excluded. Retention proportions were calculated on the basis of the following 
formula suggested by Fox and Rosen (2010): %RTt=(I0-Tt-Dt-LFUt)/( I0-Tt). I0 is all 
patients enrolled on ART; Tt is all patients transferred out by time point t; Dt is all 
patients who died by time point t; LFUt is all patients lost to follow-up by time point t. 
UNAIDS (2011a) considers retention at 12 months an ART core indicator. This study 
calculated retention proportions at 12, 24, 36, 48, 60 and 72 months. 
Loss to follow-up: In accordance with the WHO definition, patients were classified lost 
to follow-up if they initiated ART at the site and neither attended a clinical consultation 
nor picked up ARV drugs within 90 days after the date of their last missed appointment 
(WHO, 2010). The loss to follow-up definition includes patients who were initiated on 
ART and never came back for their first follow-up consultation. The definition excludes 
patients who were reported dead or transferred out. 
Death: Patients were classified dead if their death was reported (before or after tracing) 
and recorded in the medical records. 
Treatment interruption: WHO considers an ART visit “on time” if the patient came 
within seven days after the scheduled appointment (WHO, 2010). Given that patients in 
the ART programme in Zaka and Bikita are provided a supply of ART drugs for five 
extra days, it can be assumed that they run out of drugs from day six after missing an 
appointment. I therefore considered missing an appointment for more than seven days 
an appropriate definition for treatment interruption.  
Figure 6-2 gives an overview of the definitions for hypothetical patients at time point t. 
Patients A, B and C are classified as retained since they were considered alive and on 
ART at time point t. Patient A has continuously been classified retained, since he never 
missed a visit. Patient B missed a visit, was temporarily an interrupter or classified lost 
to follow-up, if the interruption lasted for more than 90 days. Since he restarted after 
interruption or loss, he is classified retained at time point t. Patient C missed his last 
visit more than 7 and less than 90 days ago, and is therefore considered an interrupter, 
but still classified as retained. Patient D is classified lost to follow-up, since his missed 
appointment is more than 90 days ago at time point t.  
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Figure 6-2: Definitions of retention, interruption and loss to follow-up on the timeline 
 
6.1.6 Roles 
Two study team members assisted me in cleaning and preparing data sets for analysis: 
a study statistician (Zvikomborero Madari, ZM) and a research assistant (Jabulani 
Toringa, JT). After obtaining the two anonymised data sets from SMART, I gave ZM 
and JT the task to clean the data for missing and erroneous values and 
inconsistencies. ZM and JT reviewed and verified the data sets in quality feedback 
sessions together with the SMART data clerks. After obtaining the cleaned data sets 
from ZM, I imported them into Stata 12 where I linked the patient data with the tracing 
data and prepared the entire data for analysis. I analysed the quantitative data on my 
own after completion of the field work. 
6.1.7 Confidentiality 
The data sets I obtained from SolidarMed on 31st of July 2012 did not include unique 
identifiers. Prior to handing over the data files to the study team, the national patient ID 
was replaced by a study number, and the date of birth was replaced by age. The 
electronic data has been kept password protected and safely in my computer. 
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6.2 Results 
6.2.1 Characteristics at ART initiation 
Data of 8425 adult patients initiated on ART were analysed. Table 6-1 shows the 
characteristics of the study population at the first ART visit. The median (IQR) age was 
40 (34-49) years, 68.6% were female. Patients had a median (IQR) CD4 cell count of 
149 (76-230). 67.4% were in WHO stage III, 5.7% in WHO stage IV. 19.5% patients 
were on tuberculosis treatment at ART initiation. 64.8% of the patients were initiated 
after 2009. The comparison between the two site cohorts show that Zaka and Bikita 
had largely similar socio-demographic characteristics, but they slightly differed with 
regard to clinical characteristics: the median CD4 cell count was lower in Zaka (137 
versus 157 in Bikita), and the proportion of patients in WHO stage IV was higher in 
Zaka (8.9% versus 2.8% in Bikita).  
Table 6-1:  Socio-demographic and clinical characteristics of study participants at ART 
initiation 
    Zaka   Bikita   Total   
Total patients   4073   4352   8425   
Females (%)   2782 (68.3) 2999 (68.9) 5781 (68.6) 
Age median (IQR) 40 (34-49) 40 (34-49) 40 (34-49) 
in years (%) 18-24 years  147 (3.6) 200 (4.6) 347 (4.1) 
 
25-34 years 1209 (29.7) 1242 (28.5) 2451 (29.1) 
 
35-44 years  1513 (37.1) 1618 (37.2) 3131 (37.2) 
 
>45 years 1204 (29.6) 1292 (29.7) 2496 (29.6) 
WHO stage (%) I 238 (5.8) 383 (8.8) 621 (7.4) 
 
II 729 (17.9) 909 (20.9) 1638 (19.4) 
 
III 2743 (67.3) 2939 (67.5) 5682 (67.4) 
 
IV 363 (8.9) 121 (2.8) 484 (5.7) 
CD4 cell count at  
1st visit 
per mm3 (%) 
N 3013   3598   6611   
median (IQR) 137 (70-212) 157 (80-240) 149 (76-230) 
1-49 497 (16.5) 523 (14.5) 1020 (15.4) 
50-99 553 (18.4) 584 (16.2) 1137 (17.2) 
 
100-199 1113 (36.9) 1188 (33.0) 2301 (34.8) 
 
200-349 783 (26.0) 1175 (32.7) 1958 (29.6) 
 
>350 67 (2.2) 128 (3.6) 195 (2.9) 
On TB treatment  
at first visit (%) 
  
683 (16.8) 961 (22.1) 1644 (19.5) 
Year of first  
visit (%) 
2005 105 (2.6) 3 (0.1) 108 (1.3) 
2006 178 (4.4) 4 (0.1) 182 (2.2) 
 
2007 182 (4.5) 303 (7.0) 485 (5.8) 
 
2008 263 (6.5) 569 (13.1) 832 (9.9) 
 
2009 523 (12.8) 836 (19.2) 1359 (16.1) 
 
2010 1034 (25.4) 1160 (26.7) 2194 (26.0) 
 
2011 1528 (37.5) 1278 (29.4) 2806 (33.3) 
 
2012 260 (6.4) 199 (4.6) 459 (5.4) 
ART=antiretroviral treatment; IQR=interquartile range; WHO= World Health Organisation; TB=tuberculosis 
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6.2.2 Outcomes at last visit before tracing 
The median (IQR) follow-up time from the first to the last ART visit was 15 (6-28) 
months. 431 (5%) patients attended the first visit only and did not come back for a 
follow-up visit. By 30 June 2012, 6291 patients (3105 in Zaka and 3186 in Bikita) were 
alive and on ART and 442 (163 and 273) were transferred out. The retention proportion 
was 78.8%. Before SMART started tracing patients lost to follow-up, attrition comprised 
590 (7.4%) deaths and 1102 (13.8%) patients lost to follow-up. In Zaka, the proportion 
of reported deaths was 6.1%, in Bikita 8.6%.  
By 30 June 2012, 2457/8004 (31%) patients had at least one follow-up visit at a 
decentralized health facility. The proportion of decentralized patients was higher in 
Zaka (35%) than in Bikita (27%).  
6.2.3 Tracing results 
Between January 2005 and 30 June 2012, a total of 1102 patients were classified lost 
to follow-up in both districts. Correct tracing data were available from the SMART 
programme for 946/1102 (86%) patients.  
Table 6-2 shows that 42% of the cases were traced by environmental health 
technicians, 37% by different types of community health workers (mostly CHASAs and 
village health workers), and 20% by nurses. Between February and June 2012, the 
period when community health workers were allowed to trace, the proportion was 
inverted: community health workers traced 52% of the cases, environmental health 
technicians 25%. 38% of the patients were traced in the framework of a community-
based HIV/AIDS intervention, using Community HIV/AIDS Support Agents on bicycles 
and other community health workers as tracers. The data shows that after SMART had 
ceased payment of US$3 per traced patient, the motorized environmental health 
technicians were rarely involved in tracing: in the first two months of tracing, 87% and 
84% of the patients were traced by environmental health technicians. Thereafter, the 
environmental health technicians’ contribution to tracing ranged between 0% and 45%, 
whilst more patients were traced by community health workers.  
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Table 6-2: Health worker cadres used for tracing by site 
Type of health worker cadre Zaka % Bikita % Total % 
Environmental health technicians 197 40 199 46 396 42 
Nurse 66 13 123 28 189 20 
Village Health Worker 104 21 60 14 164 18 
Community HIV/AIDS Support Agents 43 9 48 11 91 10 
Care facilitator 84 17 0 0 84 9 
Primary Care Counsellor 4 1 7 2 11 1 
Total 498  437  935  
 
Figure 6-3 shows the tracing outcomes. Out of 946 traced ART patients, 156 (16.5%) 
turned out to be misclassified losses to follow-up on the grounds of incorrect 
documentation: according to the medical records kept in the health facility, these 156 
patients had missed their scheduled ART visit for more than 90 days, were therefore 
recorded lost to follow-up, and traced. Yet, the tracers found them alive and on ART. It 
turned out that the ART records had not been filled in properly at the patients’ last visit. 
Eventually, tracing data of 790 patients who were genuinely “lost to follow-up” were 
included in the study. The median time between the missed appointment and the date 
of tracing was 461 days (IQR 256-793), ranging from 98 days to more than six years.  
In 490 (62.1%) cases, the patient was found to have died. The proportion of deaths 
was higher in Zaka (64.7%) than in Bikita (59.3%). For 463 deceased patients, the 
informant – a close relative – gave a credible account of the date of death. 236 (29.9%) 
patients moved away (in Zaka 27.4% and in Bikita 30.7%), 29% out of the country, 
61% out of the district, and 10% out of the village. Before tracing, 442 patients had 
been officially transferred out of the SMART programme, meaning that they were given 
a referral document to continue ART at another health facility out of the district. It was 
found through tracing that additional 26 patients had obtained such a transfer 
document, but were not recorded accordingly as transferred. After tracing, a total of 
5.6% (468) patients were officially transferred out. Tracing revealed that 235 patients 
lost to follow-up had moved away. Adding the “silent” transfers to the official transfers 
resulted in a proportion of 8.3% (703) patients who left the programme due to 
migration. 
At the time of tracing, only 29 (3.7%) lost patients (22 in Bikita and 7 in Zaka) were still 
alive. The following reasons for stopping ART were reported (n=29, multiple answers 
possible): transport costs (16), lack of family support (7), good health (7), disclosure 
issues (5), illness (4), religion (4), travel / migration (4), treatment costs (3), and lack of 
support by the employer (1). At study closure, 14/29 (48%) had restarted ART. In 35 
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(4.4%) cases, the traced patient was not known by the community, in most cases due 
to a wrong address given to the health facility.  
Figure 6-3: Flowchart of tracing outcomes 
 
 
ART=antiretroviral treatment; LFU=lost to follow-up 
6.2.4 Programme outcomes before and after tracing 
Table 6-3 and figure 6-4 compare the programme outcomes before and after tracing. 
Tracing revealed that due to documentation errors, the proportion of retained patients 
was slightly higher in reality than according to the medical records: total retention was 
78.8% before and 79.6% after tracing. Retention at 12 months was 83.4% before and 
84.7% after tracing. After ascertaining the true status of the lost patients, death became 
the major reason for attrition from ART: before tracing, 590 (7.4%) patients were 
reported dead, 1102 (13.8%) were classified lost to follow-up. Tracing revealed that 
1080 (13.6%) patients had died and 547 (6.9%) remained lost to follow-up, partly 
because they moved away without reporting. Tracing increased the proportion of 
deaths at 12 months by 80% from 6.4% to 11.5%, and at 36 months by 111% from 9% 
to 19%. Before tracing, programme attrition was attributed to 38% and 51% deaths at 
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12 and 36 months. After tracing, the proportion of deaths was 75% and 76% at the 
same time points.   
         69 
 
Table 6-3: Programme outcomes before and after tracing (January 2005 – June 2012) 
 Before tracing   After tracing  
 total 12 months 36 months  total 12 months 36 months 
Enrolled gross 8425 6431 2203  8425 6431 2203 
Transferred out 442 201 119  468 215 122 
Enrolled net 7983 (100) 6230 (100) 2084 (100)  7957 (100) 6216 (100) 2081 (100) 
Dead (%) 590 (7.4) 396 (6.4) 270 (13.0)  1080 (13.6) 716 (11.5) 392 (18.8) 
Lost to follow-up (%) 1102 (13.8) 639 (10.3) 263 (12.6)  547 (6.9) 237 (3.8) 124 (6.0) 
Retained (%) 6291 (78.8) 5195 (83.4) 1551 (74.4)  6330 (79.6) 5263 (84.7) 1565 (75.2) 
 
Figure 6-4: Reasons for attrition before and after tracing  
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6.2.5 Cohort analysis 
I conducted a cohort analysis between annual ART enrolment groups to explore 
retention trends over calendar time. Table 6-4 shows selected characteristics of the 
seven annual cohorts. The analysis shows that the patient volume grew exponentially. 
In 2005 and 2006 low patient numbers were enrolled, most of them in Zaka. Between 
2007 and 2011, the size of the cohorts increased six-fold. 59% of all patients were 
enrolled in 2010 and 2011. Besides the massive growth of the annual cohorts in 
numbers, the table shows that over time, the cohorts became younger and the 
programme managed to initiate patients at an earlier stage of the disease; the median 
CD4 cell count at baseline increased steadily from 55 in 2006 to 178 in 2011.  
Table 6-4:  Selected baseline characteristics of patients by year of first visit (annual 
cohort) 
Year of  
ART start 
Patients 
enrolled 
(%) 
% Zaka % Female 
sex 
Median age 
in years 
CD4 baseline 
n median 
2005 108 (1.3) 97 72 41 5 116 
2006 182 (2.2) 98 64 39 31 55 
2007 485 (5.8) 38 69 39 292 78 
2008 832 (9.9) 32 68 40 340 107 
2009 1359 (16.1) 38 67 39 1119 121 
2010 2194 (26.0) 47 70 38 1986 151 
2011 2806 (33.3) 54 69 38 2433 178 
 
Table 6-5 and figure 6-5 show that retention generally improved over calendar time; 
with the 2005 and 2009 cohorts being outliers. Retention at 6 months suggests that the 
positive trend since 2009 is continuing.  
Table 6-5: Retention rates by annual cohorts at different time points 
Annual 
cohort 
Patients  
enrolled 
Retention rate at time points after enrolment 
6 m 12 m 24 m 36 m 48 m 60 m 72 m 
2005 108 90.7% 86.0% 81.0% 79.0% 73.7% 71.6% 67.4% 
2006 182 84.3% 76.7% 71.3% 67.1% 62.7% 58.9% 
 
2007 485 85.4% 82.6% 78.5% 75.2% 74.1% 
  
2008 832 87.1% 83.0% 78.2% 76.4% 
   
2009 1359 84.9% 81.1% 77.4% 
    
2010 2194 88.8% 85.0% 
     
2011 2806 90.1% 
      
m=months 
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Figure 6-5: Retention rates of seven annual cohorts in Zaka and Bikita over time 
 
ART=antiretroviral treatment 
6.2.6 Treatment interruption  
As noted in section 6.1.5, a patient was defined as retained if he or she was alive and 
on ART at the time of database closure (30 June 2012). Yet, retained at a certain point 
in time does not imply that the patient was consistently adherent to ART appointments. 
Table 6-6 shows that irrespective of their ART duration, 28.3% of the retained ART 
patients missed their ART visit appointment at least once for more than 7 days, 
suggesting that they may have had a treatment interruption. The median (IQR) duration 
of each patient’s longest treatment interruption was 32 (20-60) days. 89.4% of the 
interrupters returned to care within 90 days after the missed appointment, thus before 
they were recognized as losses. 10.6% returned to the ART programme after being 
classified lost to follow-up.  
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Table 6-6:  Retained ART patients who had at least one treatment interruption of more 
than 7 days 
 Zaka  Bikita  Total  
Median (IQR) days 42 (22-64) 30 (19-58) 32 (20-60) 
8-29 days (%) 259 (36.7) 506 (47.1) 765 (43.0) 
30-59 days (%) 215 (30.5) 334 (31.1) 549 (30.8) 
60-89 days (%) 136 (19.3) 141 (13.1) 277 (15.6) 
>90 days (%) 95 (13.5) 94 (8.7) 189 (10.6) 
Total 705 (100) 1075 (100) 1780 (100) 
Total interrupters/retained (%) 705/3105 (22.7) 1075/3186 (33.7) 1780/6291 (28.3) 
IQR=interquartile range 
In summary, a total of 3407/7983 (42.7%) enrolled patients discontinued ART. Of those 
who discontinued, 1627/3407 (47.8%) died or became lost to follow-up and never came 
back, whilst 1780/3407 (52.2%) patients restarted after interruption.   
6.2.7 Retention and deaths at different time points corrected after tracing 
Corrected after tracing, programme attrition was characterised by a high proportion of 
deaths and losses within the first 12 months of treatment: table 6-7 and figure 6-6 show 
the proportions of retained, dead and lost patients at different points in time. 12 months 
after treatment start, 84.7% of the enrolled patients were alive and on ART. The 
retention proportion decreased over time: at 24, 36, 48 and 60 months, 78.3%, 75.2%, 
71.5% and 69.5% were alive and on ART. The proportion of deaths was 11.5% at 12 
months, climbing to 16.1%, 18.8% and 21.9% at 24, 36 and 48 months. The analysis 
also shows that the proportion of programme attrition caused by death versus losses 
did not change much between 12 months (75%) and 60 months (70%).  This result 
indicates that even though early mortality prevailed, death remained a problem 
throughout follow-up time.  
 
Table 6-7: Programme outcomes at different time points, corrected after tracing 
 Enrolled Transferred out 
Retained 
(%RTt) 
Dead (%Dt) LFU (%LFUt) 
Total 8425 468 6330 (79.6) 1080 (13.6) 547 (6.9) 
at 12 months 6431 215 5263 (84.7) 716 (11.5) 237 (3.8) 
at 24 months 3987 206 2960 (78.3) 608 (16.1) 213 (5.6) 
at 36 months 2203 122 1565 (75.2) 392 (18.8) 124 (6.0) 
at 48 months 1102 82 729 (71.5) 223 (21.9) 68 (6.7) 
at 60 months 539 47 342 (69.5) 105 (21.3) 45 (9.1) 
D=dead; LFU=lost to follow-up; RT=retained 
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Figure 6-6: Retention and reasons for attrition by time after ART start 
 
The shape of the Kaplan-Meier curves in figure 6-7 express the sharp decline of the 
survival probability during the first 12 months. Based on uncorrected data, the 
probability of survival was 0.94 at 1 year, declining to 0.89 at 5 years. Data corrected 
for loss to follow-up show a sharper decline during the first few months of treatment, 
describing a survival probability of 0.90 at 1 year, declining to 0.82 at 5 years.  
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Figure 6-7: Kaplan-Meier survival estimates before and after tracing 
 
6.2.8 Characteristics of deaths 
Based on corrected data after tracing, I determined associations between patient 
characteristics at baseline and the outcomes death and loss to follow-up, using 
unadjusted risk ratios at 24 months, as shown in the tables 6-8 and 6-9. The risk for 
death at 24 months was considerably higher for men than women (RR 1.71), whilst 
there was no relevant association between male sex and loss to follow-up (RR 1.17). In 
contrast, age was associated stronger with loss to follow-up than with death: the risk for 
loss to follow-up was four times higher in the age group 18-24 than in the age group 
>45 (RR 0.24). Young age was also associated with death, but to a much weaker 
extent (RR 0.82 for the age group >45). Unsurprisingly, patients starting ART in WHO 
stage IV (RR 5.65) were much more likely to die than patients starting in WHO stage I 
(referent group), II (RR 1.33) and III (RR 2.75). Similarly, the risk of death was almost 
three times higher in patients with a CD4 below 50 than in patients with a CD4 cell 
count between 100 and 200 (RR 0.39). Interestingly, the death risk in patients who 
were on tuberculosis treatment at ART start was largely the same (RR 1.06) as in 
patients who were not on tuberculosis treatment. Unsurprisingly, death was 25 times 
more likely to occur when the patient had his last visit at the hospital, as compared to a 
health centre (RR 0.04). 
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Table 6-8: Characteristics of patients lost to follow-up and deaths and risk ratios for death at 24 months, corrected after tracing 
  Retained Lost to follow-up Deaths  RR 95% CI 
Sex n (row %) 2960 78.3% 213 5.6% 608 16.1% 
  
Female 2081 81.4% 142 5.6% 334 13.1% 1.00 
 
Male 879 71.8% 71 5.8% 274 22.4% 1.71 1.48-1.98 
Age group n 2960 78.3% 213 5.6% 608 16.1% 
  
18-24 87 69.6% 16 12.8% 22 17.6% 1.00 
 
25-34 748 74.3% 76 7.5% 183 18.2% 1.03 0.69-1.54 
35-44 1150 78.4% 83 5.7% 233 15.9% 0.90 0.61-1.34 
>45 975 82.4% 38 3.2% 170 14.4% 0.82 0.55-1.22 
WHO stage n 2960 78.3% 213 5.6% 608 16.1% 
  
1 152 88.9% 9 5.3% 10 5.8% 1.00 
 
2 459 87.1% 27 5.1% 41 7.8% 1.33 0.68-2.60 
3 2125 78.1% 158 5.8% 437 16.1% 2.75 1.50-5.04 
4 224 61.7% 19 5.2% 120 33.1% 5.65 3.04-10.50 
CD4 baseline n 2033 80.2% 131 5.2% 372 14.7% 
  
1-49 354 70.2% 30 6.0% 120 23.8% 1.00 
 
50-99 434 78.3% 25 4.5% 95 17.1% 0.72 0.57-0.92 
100-200 836 85.9% 47 4.8% 90 9.2% 0.39 0.30-0.50 
>200 409 81.0% 29 5.7% 67 13.3% 0.56 0.42-0.73 
Tuberculosis 
diagnosis at ART 
start 
n  2960 78.3% 213 5.6% 608 16.1% 
  
no 2123 78.5% 154 5.7% 427 15.8% 1.00 
 
yes 837 77.7% 59 5.5% 181 16.8% 1.06 0.91-1.25 
Health facility type n 2953 82.4% 181 5.1% 450 12.6% 
  
Hospital 1832 74.7% 177 7.2% 443 18.1% 1.00 
 
RHC 1121 99.0% 4 0.4% 7 0.6% 0.03 0.02-0.07 
Site n 2960 78.3% 213 5.6% 608 16.1% 
  
Zaka 1309 78.3% 98 5.9% 264 15.8% 1.00 
 
Bikita 1651 78.2% 115 5.5% 344 16.3% 1.03 0.89-1.20 
Haemoglobin n 1943 79.1% 122 5.0% 390 15.9% 
  
<12 g/dl 1352 76.5% 96 5.4% 319 18.1% 1.00  
>12 g/dl 591 85.9% 26 3.8% 71 10.3% 0.57 0.45-0.73 
ART=antiretroviral treatment; CI=confidence interval; RR=risk ratio; WHO=World Health Organization
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Table 6-9:  Risk ratios for loss to follow-up at 24 months among those not known to have died, corrected after tracing 
  retained   lost to follow-up  RR 95% CI   
sex n (row %) 2960 93.3% 213 6.7% 
  
Female 2081 93.6% 142 6.4% 1.00 
 
Male 879 92.5% 71 7.5% 1.17  0.89-1.54  
age group n 2960 93.3% 213 6.7% 
  
18-24 87 84.5% 16 15.5% 1.00 
 
25-34 748 90.8% 76 9.2% 0.59  0.36-0.98  
35-44 1150 93.3% 83 6.7% 0.43  0.26-0.71  
>45 975 96.2% 38 3.8% 0.24  0.14-0.42  
WHO stage n 2960 93.3% 213 6.7% 
  
1 152 94.4% 9 5.6% 1.00 
 
2 459 94.4% 27 5.6% 0.99  0.48-2.01  
3 2125 93.1% 158 6.9% 1.24  0.64-2.38 
4 224 92.2% 19 7.8% 1.40  0.65-3.01 
CD4 baseline n 2033 93.9% 131 6.1% 
  
1-49 354 92.2% 30 7.8% 1.00 
 
50-99 434 94.6% 25 5.4% 0.70  0.42-1.16  
100-200 836 94.7% 47 5.3% 0.68  0.44-1.06  
>200 409 93.4% 29 6.6% 0.85  0.52-1.38  
tuberculosis 
diagnosis at 
ART start 
n  2960 93.3% 213 6.7% 
  
no 2123 93.2% 154 6.8% 1.00 
 
yes 837 93.4% 59 6.6% 0.97  0.73-1.30  
health facility 
type 
n 2953 94.2% 181 5.8% 
  
Hospital 1832 91.2% 177 8.8% 1.00 
 
RHC 1121 99.6% 4 0.4% 0.04  0.02-0.11  
site n 2960 93.3% 213 6.7% 
  
Zaka 1309 93.0% 98 7.0% 1.00 
 
Bikita 1651 93.5% 115 6.5% 0.93  0.72-1.21  
haemoglobin n 1943 94.1% 122 5.9% 
  
<12 g/dl 1352 93.4% 96 6.6% 1.00 
 
>12 g/dl 591 95.8% 26 4.2% 0.64  0.42-0.97  
ART=antiretroviral treatment; CI=confidence interval; RR=risk ratio; WHO=World Health Organisation
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As indicated in section 6.2.6., programme attrition was most severe during the first 12 
months of ART. In effect, the analysis of corrected data revealed a median time 
between ART start and death of 104 (IQR 36-244) days for the entire study population. 
676/1054 (64.1%) deaths occurred during the first 6 months after treatment start. There 
was a notable difference between the sites: in Zaka, the median duration from initiation 
to death was 135 days, in Bikita 83 days.  
6.2.9 Characteristics of unreported deaths 
The proportion of deaths among patients classified lost to follow-up was 44.5% 
(490/1102), as compared to 7.9% (590/7471) among patients who were not lost to 
follow-up, resulting in a relative risk of death in losses to follow-up of 5.6 (95% CI: 5.1-
6.2). As unreported deaths appeared as an important determinant of programme 
attrition in Zaka and Bikita, the question is raised: who were these lost patients whose 
death was not reported? Table 6-10 compares the characteristics of the patients whose 
death was reported (n=590) with the patients whose death was not reported (n=490). 
Patients whose death was not reported were on ART for a shorter period of time (28 
days) than patients whose death was reported (43 days). Female deaths versus male 
(RR 1.26), deaths in Zaka district versus Bikita (RR 1.32), and deaths after the first 
ART visit (RR 1.13) were more likely to be unreported than deaths after more than one 
ART visit. Deaths were also more likely to remain unreported in patients who died after 
a treatment interruption (RR 1.61) than without having interrupted ART, interruption 
again defined as having missed an appointment for more than 7 days.   
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Table 6-10: Comparison between reported deaths and unreported deaths 
  
 
 
total deaths reported 
deaths  
(before 
tracing) 
 % unreported 
deaths  
(after LFU 
tracing) 
 % risk ratio 
(95% CI) 
total  1080 590 54.6 490 45.4 
 
median age (IQR) 38 (33-47) 39 (34-47)   37 (32-46)   
 
median bsl CD4 (IQR) 82 (36-171) 87 (37-174)   76 (34-171)   
 
duration on ART (IQR) 39 (0-155) 43 (0-205)   28 (0-101)   
 
males 460 278 60.4 182 39.6 1 
females 620 312 50.3 308 49.7 1.26 (1.09-1.44) 
no TB diagn at 1
st
 visit  807 435 53.9 372 46.1 1 
TB diagn at 1
st
 visit 273 155 56.8 118 43.2 0.94 (0.80-1.10) 
Bikita district 582 352 60.5 230 39.5 1 
Zaka district 498 238 47.8 260 52.2 1.32 (1.16-1.51) 
death after >1 ART visit 780 438 56.2 342 43.8 1 
death after first ART visit 300 152 50.7 148 49.3 1.13 (0.98-1.29) 
death without interrupt. 572 370 64.7 202 35.3 1 
death after interruption 508 220 43.3 288 56.7 1.61 (1.40-1.84) 
ART=antiretroviral treatment; CI=confidence interval; LFU=lost to follow-up; RR=risk ratio; TB 
diagn=tuberculosis diagnosis; bsl=baseline 
6.2.10 Time between the missed appointment and death 
From the ART programme point of view, the time between the missed appointment 
date and the date of death matters. Figure 6-8 shows that 574/1055 (54.4%) deaths 
occurred before the next appointment, whereas 481/1055 (45.6%) deaths occurred 
after the patients had missed an appointment. The analysis shows that there was a 
time window that would have allowed the health system to trace the missed patient. 
However, as figure 6-8 shows, it is a narrow time window; 321/481 (67%) died as 
interrupters (90 days after missing the appointment), 224/481 (47%) within 30 days. 
Besides death on ART and death after interruption, a third category of deaths, the 
remaining 160/1055 (15.2%), occurred more than 90 days after the missed 
appointment, which is equal to the loss to follow-up threshold.  
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Figure 6-8: Number of patients by time between missed appointment and death 
 
ART= antiretroviral treatment 
 
6.3 Discussion of the quantitative findings 
6.3.1 High retention on ART in spite of a socio-economic crisis 
The national ART programme of Zimbabwe achieved excellent retention outcomes in 
the districts of Zaka and Bikita. The retention rate of 75% at 36 months indicates that 
these two districts were performing in the upper range of ART programmes in sub-
Saharan Africa. In comparison, large retention studies reported between 64% (Cornell, 
2010) in a South African government programme and 72% (Fox, 2010). in a systematic 
review of research supported ART programmes across 39 African countries. The 
achievements of the Zimbabwean ART programme are remarkable not only in the 
context of a general economic crisis and a poorly resourced health system. It is more 
than noteworthy that people were retained on ART even during the humanitarian 
hardship in 2008 and 2009, when the economy suffered hyperinflation, large parts of 
the health, water and transport infrastructure temporarily broke down, and when Zaka 
and Bikita were hit by a severe cholera outbreak. 
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According to the WHO Early Warning Indicator (EWI) for HIV drug resistance “retention 
in care” (WHO, 2012), the cohorts 2006, 2007, 2008 and 2009 were on “amber” (below 
the 85% retention threshold at 12 months). The EWI for the cohorts 2010 and 2011 
indicated “green” (for above 85%). Whilst retention improved in general over calendar 
time since the ART programme was launched, there are two exceptions: The 2005 
cohort had outstandingly high retention proportions at any time point, starting with 86% 
at one year to 67.4% at six years. Most probably, this was due to the fact that there 
were many health workers amongst the first 108 patients who were enrolled in 2005. 
Health workers represent a patient group that has immediate access to drugs, 
diagnostics, information and other services that enhance adherence and retention. The 
second outlier was the 2009 cohort: the 12-months retention dropped temporarily from 
83% in the 2008 cohort to 81% in the 2009 cohort, before climbing to 85% in the 2010 
cohort. As discussed above, this effect – at a small size though – might have been due 
to the humanitarian crisis in 2009.  
I argue that three factors have contributed to improved retention over calendar time: 
Early initiation: It is most likely that earlier ART initiation contributed to improved 
retention: the median CD4 cell count at enrolment increased steadily from 55 in the 
2006 cohort to 178 in the 2011 cohort. As low CD4 cell counts clearly increased the 
death risk in this study, earlier ART initiation obviously led to improved retention.  
Socio-economic recovery: After the crisis in 2008 and 2009, the socio-economic and 
humanitarian recovery might have contributed to improved ART outcomes. Since 2010, 
people had money in their pockets; fuel, water and electricity were available; and the 
cholera outbreak was under control. Consequently, the annual number of ART 
initiations has steeply increased since 2009 (from 1359 to 2806 in 2011), and the 6-
month retention proportion has improved (from 85% in 2009 to 90% in 2011).  
Decentralisation of ART follow-up: Even though it was not a specific research 
question, this study confirms evidence from other studies, such as Fatti (2010) and 
Long (2011), suggesting that decentralisation of ART provision contributes to improved 
retention. By 30 June 2012, 31% of all patients in the SMART programme had their last 
consultation at health centre level. The risk for death was 25 times higher in patients 
who had their last visit at a hospital, if compared to patients who had their last visit at a 
health centre. Obviously, this result is strongly influenced by the fact that clinical 
stability was a criterion for decentralization.  
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6.3.2 Tracing reveals high mortality on ART  
A previous study conducted by the IeDEA collaboration Southern Africa reported 
approximately the same proportions of retention, loss to follow-up and deaths for Zaka 
and Bikita as our study did before tracing: at three years, Wandeler (2012) found 75% 
patients retained (this study 74%), 16% lost to follow-up (this study 13%) and 9% dead 
(this study 13%) without correcting data for mortality among patients lost to follow-up.  
Based on corrected data after tracing, our study revealed that 62% of the patients who 
were initially classified lost to follow-up had died, and 30% had moved away without 
reporting it to the health facility. After tracing, the proportion of deaths contributing to 
attrition doubled. Underestimated mortality on ART is well-known. It has been mainly 
attributed to early deaths. Based on mortality data after active tracing, Brinkhof (2009) 
and Egger (2011) developed a mathematical model to calculate mortality estimates 
adjusted for loss to follow-up. Wandeler (2012) applied these models to the mortality 
data they found in Zaka and Bikita. The modelling resulted in an estimated mortality 
increase at 12-months from 6% to 11%, which matches very well with the corrected 
data ascertained through tracing by this study (6.4% mortality increasing to 11.5% at 
12 months). Whilst the model provided accurate estimates of corrected 12 months 
mortality, our study added long-term retention observations. With a median time of 461 
days between the missed appointment and the day of tracing, SMART ascertained the 
status of patients long after the patients were lost to follow-up. This study showed that 
late deaths (after 6 months) on ART are even more underestimated than early deaths. 
Our findings showed that the status “lost to follow-up” is an administrative category, 
comprising unreported deaths and unreported transfers. As the risk of death is 5.6 
times higher in patients classified as lost than in the rest of the ART cohort, to enhance 
retention on ART, programmes should investigate and address their unreported 
deaths. Risk factors for unreported deaths have implications for ART programmes 
since sustainable patient tracing interventions should target the most vulnerable 
patients.  
After death, unreported “silent” transfers of patients to another health facility were the 
second reason for losses to follow-up. The SMART tracing pilot showed that a 
considerable proportion of mobile patients did not obtain a transfer letter when moving 
away, and might therefore face obstacles to stay on ART without interruption. Ensuring 
proper transfers of patients to another ART programme would not only assist the 
patient, but reduce programme attrition. In Zaka and Bikita, transfer letters could only 
be issued by the two hospitals, but not by ART follow-up sites. It appears that 
decentralized patients were reluctant to travel to the hospital to obtain a transfer letter. 
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An electronic patient data system, containing the national patient identification 
numbers, would contribute to a reduction of losses to follow-up, allowing patients to 
access ART at any point in the system whilst travelling. ART sites should also provide 
patients with an extra supply of ART drugs to cover for missed appointments.  
6.3.3 Decentralised tracing 
Tracing in the SMART programme was conducted at health centre level by 
professional health workers (nursing personnel and environmental health technicians) 
and by community health workers. The study results suggest that tracing by 
professional health workers works well if there are monetary incentives, such as the 
US$3 per traced patient in the early stage of the SMART tracing programme. Adding 
the costs for utilising motorbikes, tracing by professional health workers might not be 
afforable in the long run. Moreover, considering the severe shortage of professional 
health workforce in Zimbabwe, home tracing by professionals does not appear an 
effective allocation of scarce human resources. Phone tracing, which was not 
performed by the SMART programme, might be a cost-effective alternative worth 
considering. When payments for tracing were dropped, the professional health workers’ 
tracing efforts decreased remarkably, and the workload was taken over to a large 
extent by voluntary community health workers, in particular by the CHASA, thus adding 
valuable extra lower-skilled workforce to the SMART programme.  
The programme managed to trace 86% of the suspected losses. The high tracing 
coverage was due to the fact that tracing was conducted in a decentralized system. 
Centrally-organised tracing programmes have found it difficult to locate lost patients. 
Weigel (2011) reported tracing coverage of only 40% from a large ART programme in 
Malawi, explaining the low response largely by the fact that patient contact information 
was not available to the tracers. Besides the fact that centrally organised tracing is 
costly because it requires designated personnel and motorbikes, this study shows that 
decentralized tracing is feasible and can achieve a high coverage.  
12% of the suspected losses were actually patients who were alive and on ART. 
Inaccurate medical record keeping by the ART nurses contributed to these false losses 
to follow-up simply caused by health workers failing to keep records on ART 
consultations. The study team observed that the reason for erroneous documentation 
in SMART hospitals was attributable to the system. Nurses routinely documented an 
ART visit after the consultation to safe time. Because long queues of patients were 
waiting to be seen, ART nurses often only filled in the medical records in the evening, 
often omitting key data. We perceived a generally careless attitude of health workers 
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on data management. Good quality electronic data was available only thanks to 
extensive quality control and data cleaning efforts by the SMART’s data managers.  
6.3.4 Treatment interruption a neglected threat to long-term retention 
Retention studies tend to overlook the fact that many ART patients temporarily interrupt 
therapy. This study found that treatment interruption was a frequent event in Zaka and 
Bikita. 28% of the ART patients who were considered “retained” by SMART actually 
missed an ART appointment for a median duration of 32 days. This finding compares 
well with other studies. A cohort study in urban South Africa found that 35% ART 
patients missed at least one ART visit for more than 7 days (Brennan, 2010). In their 
systematic review of 70 cohorts worldwide, Kranzer and Ford (2011) found 23% 
interrupters with a median duration of 150 days. However, only 16 studies were from 
sub-Saharan Africa, and the review found heterogeneous definitions of ART 
interruption, ranging from 24 hours to one year. The review revealed a broad range of 
frequency proportions, from 5.8% therapy interruption in a large Swiss cohort to 83.1% 
in a prison cohort in the USA (ibid.). Most recently, a study from urban Uganda showed 
that 11% patients had a treatment interruption of more than 12 months before resuming 
ART (Mills, 2013b).  
As described in section 6.1.5, I defined “treatment interruption” as missing an ART 
appointment for more than seven days under the assumption that the patient has a 
reserve supply for five days only and runs out of drugs from day six after missing an 
appointment. In reality, a treatment gap can occur before the next appointment if the 
patient loses or sells his or her drugs. On the other hand, patients might borrow pills to 
cover for more than five days. Using a threshold of 30 instead of seven days still 
resulted in 16% interrupters among the retained patients. Our findings show that 
unstructured treatment interruption is a problem in SMART, particularly with regard to 
drug resistance development.  
These findings call into question the validity of the WHO early warning indicator 
“retention in care” on ART drug resistance (WHO, 2012) which does not take treatment 
interruption into account. In the light of the findings of this study, the retention indicator 
does not appear as an appropriate measurement for the risk of resistance 
development.  
6.3.5 Risk factors for death 
Contrary to studies correcting mortality based on mathematic modelling, this study 
allowed linking tracing data with patient data, and thus describing the group of all 
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deaths in more detail on the basis of corrected data. This study confirmed available 
evidence that early mortality is highly relevant, since two thirds of the deaths occurred 
within 6 months after therapy initiation – a result which according to recent literature on 
death during ART is most likely to be caused by tuberculosis (Wong, 2012). 
Concerning risk factors for death, this study showed consistent results with previous 
research: male sex, low CD4 cell count, advanced WHO clinical stage and anaemia 
were strongly associated with death, as reported in the systematic review by Gupta 
(2011). However, retention studies, including many of those reviewed by Gupta (ibid.) 
use uncorrected data and therefore tend to report risk factors strongly biased for 
unreported deaths among losses. Compared with the well-known significant 
associations between low CD4 cell count and mortality, loss to follow-up in our study 
was not associated with the patients’ clinical stage at treatment initiation. Other studies, 
such as Boyles (2011) and Charurat (2010), showed that non-death losses were 
associated with a high CD4 cell count. In our study, young age was much more 
strongly associated with loss than with death. These findings underline that loss to 
follow-up largely comprises two entirely different groups of patients: young and healthy 
patients classified lost because they moved out of the programme area and unreported 
death of very sick patients.  
6.3.6 Death a consequence of ART discontinuation 
We showed that only very few patients did directly benefit from patient tracing. 
Because tracing was only initiated 90 days after a missed appointment, only very few 
interrupters were found alive. 62% had already died. Our study revealed that a large 
proportion (45%) of the deaths was hidden and that deaths were more likely to remain 
unreported if they occurred after missing a scheduled appointment than before. 
Interventions to reduce mortality on ART might need to consider the time of death in 
relation to the missed appointment. Deaths in the SMART programme can be 
distinguished into three groups; death on ART, death after interruption, and death after 
loss to follow-up, as shown in figure 6-8. 
Death on ART  
More than half of the deaths (54%) occurred before the next scheduled appointment, 
whilst the patients theoretically still had ART drugs. Most likely, these patients were 
very sick, which might have been the reason why they stopped ART. Treatment might 
have been initiated in spite of a severe opportunistic infection, or the health worker 
might have missed life-threatening signs and symptoms. Previous studies have clearly 
shown that delayed ART initiation is the major reason for these deaths (Lawn, 2008). In 
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spite of the recommendation by the WHO and the MOHCW to initiate patients earlier, 
the median CD4 cell count at baseline in the SMART programme was still as low as 
180 in 2012. Besides earlier initiation, the literature suggests that preventing this group 
of deaths requires timely diagnosis and treatment of tuberculosis and a careful, 
decentralised clinical monitoring of ART patients during the first six months of 
treatment.   
Death after interruption  
The second group, accounting for almost one third of all deaths (30%) died within the 
first 90 days after missing an appointment and – most likely – running out of ART 
drugs. Taking into consideration that patients who discontinue ART can die for reasons 
not related to HIV/AIDS, it appears plausible that many deaths could have been 
prevented through an ART restart. Due to the fact that patients were traced only 90 
days after missing the appointment, there was no chance that SMART could have 
prevented these deaths through tracing. The analysis shows that there was a time 
window that would have allowed the health system to trace the missed patients, 
particularly those with a low CD4 cell count, and to bring them back to care before their 
condition further deteriorated. However, for half of this group, the time window for 
tracing would have been extremely narrow, since half of this group died within 30 days.  
Death after loss to follow-up 
The third and smallest group (15%) of deaths were patients who died after being lost to 
follow-up, meaning that they missed their appointment – and were without drugs – for 
more than 90 days. It can be assumed that many patients in this group died as a 
consequence of stopping ART. Other than HIV related causes might have contribute to 
the deterioration of these patients’ condition that finally led to their death. In addition to 
their critical health condition, reasons rooted in the social, economic and cultural 
environment of these patients could have made them miss their scheduled ART 
appointment and prevented them from returning back to care.  
6.3.7 Strengths and weaknesses 
The aim of the quantitative study component was to set the scene for the qualitative 
research, and to raise questions to be addressed through interviews and focus group 
discussions. The available good quality electronic data sets allowed a broader analysis 
than initially planned. A particular strength was the availability of tracing data that was 
merged with patient and visit level data. Many retention studies are strongly biased by 
unreported deaths classified as lost. Mathematical modelling can correct mortality 
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rates, but it does not provide a better understanding of death on ART. A strength of our 
study was the temporal analysis of corrected data, marked by the time points last visit, 
missed appointment, tracing date, date of loss to follow-up, and date of death. Our 
study can be considered fairly generalizable in the context of rural Zimbabwe, since the 
NGO support was moderate. The electronic database was probably the most 
sophisticated intervention of SMART, and it is the good quality data generated by this 
system which is not available in many other rural districts of the country. 
There were limitations in this study component. As the priority of the study was initially 
given to the qualitative component, I was not trained in advanced statistical analysis. 
This led to a certain lack of depth in the analysis of the data. This methodological 
constraint limited the validity of the quantitative results, as non-adjusted risk ratios did 
not allow testing the degree to which confounding was affecting the observed 
associations. For example, it remains unresolved to which extent factors that were 
related to the differences between Zaka and Bikita influenced the associations found 
between patient characteristics and retention outcomes. The settings in terms of the 
health care system, the ART programme, and the distances were very similar in both 
districts. The study results suggest that there were slight differences with regard to the 
SMART interventions and the cohorts: Bikita launched ART services two years after 
Zaka, and decentralisation of ART follow-up also progressed slower in Bikita (35% in 
Zaka versus 27% in Bikita attended their last visit at a decentralised site). Zaka (19.3%) 
enrolled fewer patients during the years of crisis (2008-09) than Bikita (32.3%). 
Furthermore, patients from Zaka initiated ART at a later stage of the disease than 
patients from Bikita, as indicated by a median CD4 cell count at baseline of 137 in Zaka 
versus 157 in Bikita. As for the tracing intervention, formal health care workers were 
more frequently involved in tracing in Bikita (74%) than in Zaka (53%). The findings 
also revealed that treatment interruptions among retained ART patients were more 
frequent in Bikita (33.7%) than in Zaka (22.7%), whilst the median treatment gap was 
shorter in Bikita (30 days) than in Zaka (42 days). In spite of some minor differences 
between Zaka and Bikita, the retention outcomes were almost identical between the 
two sites. To what extent the site differences influenced retention outcomes could have 
determined by means of multivariate statistics. With regard to the main quantitative and 
qualitative findings of the present study, however, I consider the site differences of 
minor relevance. 
 
Our quantitative data suggested that treatment interruption was a relatively frequent 
event, occurring in every fourth retained patient. It appeared that ART restart after 
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interruption critically impacted long-term retention. Hence, the key issue to be explored 
in the qualitative study component was to better understand why patient did or did not 
return to the ART programme after temporarily stopping therapy.   
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7 Understanding ART interruption and restart: 
qualitative findings 
 
7.1 Conceptual framework 
The present study is based on the theoretical assumption that everything that humans 
do – such as perceiving, feeling, thinking, interpreting and acting – is social practice in 
a sense that it is both influenced by structure, the context where individual action is 
embedded, and agency, the capacity of human subjects to act, take choices, and to 
change their environment (Ortner, 2006). This theoretical approach, Practice Theory, 
rejects any deterministic theory that explains social action either as a consequence of 
entirely individual attitudes and beliefs or as determined by economic, cultural or 
ecologic structures and power relations. 
Influenced by health psychology, theories of individual health behaviour focus on 
cognitive factors, such as information, knowledge, attitudes, motivations and beliefs. In 
this theory tradition, health behaviour is the outcome of an individual’s perceptions and 
expectations, as suggested by the Health Belief Model (Nutbeam, 2013). The Social 
Ecological Model, also focusing on individual behaviour, argues that health behaviour 
is shaped by “health-enabling social environments” rather than a function of individual 
beliefs (Skovdal, 2011b). The two models imply different approaches to health 
promotion. Whilst cognitive theories promote changes of the individual’s knowledge 
and attitudes – for example through information, education and communication 
methods – the sociological models suggest community-based interventions to increase 
social cohesion and collective self-determination (ibid.).  
Whereas behaviourist and sociological models suggest that people can improve their 
health primarily through behaviour change, Marxist and feminist theories emphasise 
that social life is determined by unequal power relationships in the wider society (Ulin, 
2005). In these theory traditions, changes in the lives of people require transformation 
of the social, cultural and economic environment. These theories suggest that societies 
are fundamentally shaped by power relationships, for example between men and 
women, rural and urban, or labour workers and property owners. Rather than 
promoting changes in individual behaviour, health interventions informed by Marxist 
and feminist approaches attempt to change broader policies and systems affecting the 
health of disadvantaged groups. This theory tradition was critiqued as “constraint-
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based” (Ortner, 2006), tending to neglect the ability of individuals and communities to 
improve their health by transforming their immediate environment.  
Studies on medication adherence often use a behaviourist approach to explore factors 
that influence the patient’s “motivation” for pill taking. To gain a better understanding 
why patients interrupt and restart life-long ART in the setting of rural Zimbabwe, this 
study required a broader conceptual framework than behaviourist or structuralist 
models offer. 
In the conceptual framework of Practice Theory, social practice is influenced by the 
individual through “human agency” and by the larger environment through “social 
structure” (Ortner, 2006). The approach suggests that agency and structure are related 
to each other by the fact that individuals shape the world in which they live and are at 
the same time guided in their action by their cultural, social and economic environment 
(ibid.). Agency is a key concept of Practice Theory. It refers to the individual’s capacity 
to act, to take decisions and to make choices (ibid.). Closely linked with social practice 
is the concept of social capital, defined as the individual’s “resources embedded in a 
social structure which are accessed and/or mobilized in purposive actions” (Lin, 1999). 
This concept suggests that the quality and quantity of an individual’s social 
relationships and networks influence the outcomes of his or her actions. Social ties 
facilitate access to information, exert influence, represent the individual’s social 
credentials, and reinforce his or her social identity (ibid.). The notion “capital” 
underlines the individual’s aim to invest in social relationships with expected returns. 
Individuals engage in social networking through investments as diverse as care, loans, 
marriage, or participation in community activities. The concept suggests that individuals 
engage in social networks because they expect future gains. 
Translated into the field of ART retention, people living with HIV are “practicing” ART 
retention, as illustrated in figure 7-1. Through agency that is driven by the patient’s 
individual needs and desires (white arrows), and constrained by their environment and 
the health system (black arrows), the patient may or may not be motivated and able to 
adhere to life-long ART. 
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Figure 7-1: Conceptual framework of the study 
 
 
 
The chosen conceptual framework had a number of implications for the design and the 
methodology of our study. Firstly, it encouraged a mixed-methods approach including 
qualitative methods to explore and understand retention as social practice. Secondly, 
since the framework suggested that retention is “practiced” between agency and 
structure, the study explored the social microcosm of people on ART. Rather than 
aiming at interviewing a broad variety of individual cases throughout the two districts, 
data were collected in limited geographical clusters, with a particular focus on the local 
health care system and the patients’ social networks. Thirdly, the interviews and focus 
group discussions were held not only with patients lost or retained on ART, but also 
with members of their family, household and community as well as with their health 
workers. Fourthly, the conceptual framework informed the topic guides for interviews 
and focus group discussions in such a way that it covered a broad range of issues 
related with retention at the level of the individual, the health system and the patient’s 
immediate social, economic and cultural environment. 
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7.2 Methodology 
7.2.1 Cluster sampling strategy  
With the aim to explore patient retention in the context of selected local health facilities 
and social networks, I limited the study area geographically to four clusters: the 
surroundings of the two district hospitals and a cluster of health centres in each district. 
Figure 7-2 maps out the selected health facilities and study participants. The cluster in 
district A (population 35,000) included three health centres 30-50 kilometres from the 
district hospital; district B (population 50,000) included four health centres, 20-60 
kilometres from the hospital. The selection criteria for the health centre clusters were 
purposive and logistic: the clusters had to be at least 20 kilometres from the hospital so 
that transportation and decentralisation were potentially relevant themes; enough ART 
patients to allow identification of the required number of ART interrupters; and 
accessible by vehicle within a three-hour drive to allow the interviewers getting there 
and back within a day.  
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Figure 7-2: Mapping of health facilities and study participants 
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7.2.2 Data collection methods 
To better understand the reasons why ART patients discontinue their therapy and 
under what circumstances they return to the programme, I applied a triangulation 
approach, choosing three methods of qualitative social science, namely in-depth 
interviews, focus group discussions, and participant observation (Green and 
Thorogood, 2009). In my understanding of triangulation, this approach does not aim at 
validating the “truth” of the patient’s story in the sense of a positivist perspective of 
health research (Ulin et al., 2005). Distinct from geographical navigation, triangulation 
in qualitative social science aims at a deeper and more holistic understanding of the 
research subject. In this study, different data collection techniques provided data – 
namely perceptions and interpretations – from different angles on the very same 
research question; ART treatment interruption. To reconstruct and understand the 
individual stories of the therapy interrupters, I interviewed not only the patient himself, 
but also his or her relatives and health worker on how they perceived and interpreted 
the patient’s decisions to stop and restart ART. Sometimes, the accounts were 
contradictory, and sometimes the stories remained inconsistent. It was striking to 
recognize that different actors suggested different interpretations of the situation. 
Besides triangulation of data, even more importantly, triangulation of the three methods 
enriched the overall picture on how ART interruption and restart is perceived at 
different levels, such as the individual, the community, and the health system. In-depth 
interviews were conducted to capture detailed first-hand information and explanations 
from a personal point of view. I conducted focus group discussions to complement the 
interviewees’ personal perspectives. Data from focus group discussions provided – 
sometimes conflicting, sometimes commonly accepted – insights into community 
opinions and attitudes on why patients interrupt ART.  Participant observation, finally, 
was conducted to “read between the lines”, and to better understand the meaning of 
the respondents’ information in the local context and in the setting of the health facility.  
a) In-depth interviews:  
In-depth, open-ended interviews with patients were the principal data collection method 
with the aim of reconstructing case stories of patients who interrupted ART. In addition, 
we held one or more interviews with partners and relatives in the social and health care 
environment of the patients to contextualise the case.  
Inclusion criteria for the patient cases were  
- an interruption of ART for at least 90 days, either at the time of the interview or in 
the past; 
 94 
 
- age over 18; 
- residing in the catchment area of one of the selected health facilities; 
- inclusion of both sexes, different age groups and residents of both districts. 
We interviewed 44 participants in the following four groups: 
- 16 ART patients who interrupted therapy – the “cases”; 
- relatives of the cases; 
- health workers (9 nurses and 1 professional counsellor) of the cases; 
- CHASA who knew the cases. 
We recruited the patient cases through purposive and snowballing sampling, pursuing 
two main strategies. Firstly, we identified patients purposively among those found alive 
by a tracer through the on-going SMART patient tracing intervention. Secondly, ART 
nurses and other ART staff at the included hospitals and health centres, including 
community health workers, were asked through snowballing if they knew retained 
patients who once interrupted ART. Out of the sixteen cases included in the study, five 
were found through tracing, eleven through health worker contacts. 
We also used purposive sampling to recruit health workers. With the aim to collect data 
from professional as well as lay health workers, we asked ART nurses and CHASA at 
every health facility to participate in the study. We included the participants on the 
basis of their availability during our field visits. To recruit partners or relatives, we used 
opportunistic sampling. At the end of the interview, we asked the patients whether they 
would allow us to interview a close relative or their ART treatment partner. In nine out 
of sixteen cases, we successfully recruited partners or relatives. 
We explained the purpose of the study to all candidates, gave them a participant 
information sheet, and asked them for written consent (see the forms in appendix 5). 
All candidates agreed to take part in the study. We held and audio-recorded all 
interviews in Shona language. In interviews I conducted myself, I was assisted by a 
translator (see section 7.2.5 on roles). We used different interview topic guides for 
patients, relatives and health workers (see appendix 6). The 10 topics in the guide for 
patients and relatives were: the patient’s health now; experience and perception of 
ART and ART interruption; retention and adherence; being HIV-positive; role of the 
health facility; role of family and kin; role of support groups; partnership and gender 
relations; knowledge and cultural concepts; and patient tracing. The topic guide for 
health workers included 8 topics: personal background; ART programme in general; 
ART patients (including the known cases); retention and adherence; support groups; 
CHASA; cultural concepts; and tracing. 
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b) Focus group discussions 
We held eight focus group discussions with 78 participants (48 female), of whom 71 
were on ART and 8 were health workers (table 7-1). Three focus group discussions 
were held in district A and five in district B, as shown in figure 7-2.  
Table 7-1: Participants of the focus group discussions 
 type of participants number of participants number on ART median age 
  total female male   
FGD 1 support group members 11 8 3 8 52 
FGD 2 women age < 25 years 5 5 0 5 23 
FGD 3 men > 24 years 13 0 13 13 54 
FGD 4 women > 24 years 11 11 0 11 43 
FGD 5 health workers (tracers) 8 4 4 5 41 
FGD 6 support group members 9 7 2 9 47 
FGD 7 women mixed age 9 9 0 9 37 
FGD 8 support group members 12 4 8 11 45 
 Total 78 48 30 71 43 
FGD=focus group discussion; ART= antiretroviral treatment 
There were three types of focus groups: ART patients (4 groups), support group 
members (3), and health workers (1). We formed the groups and recruited the 
participants through snowballing during field-work in the selected study areas. We 
chose members of support groups of people living with HIV due to their strong 
representation in the two districts, and based on the fact that health workers 
considered the groups as an important link and platform between the health care 
system and the community. Candidates for group discussions were also informed 
about the study and asked for written consent. One candidate opted out after receiving 
the information. Focus group discussions were held in the Shona language and audio-
recorded, moderated by one or two trained Zimbabwean facilitators. Topic guides are 
shown in appendix 6.  
c) Participant observation 
During two months of field-work at the included health facilities we engaged in informal 
interactions and documented our observations in field notes and memos. The study 
team and I engaged in numerous informal conversations with health workers and 
patients, particularly at the ART clinics of the two district hospitals, where the 
researchers were based during field-work. The ART clinics were suitable settings for 
observing health worker-patient interactions and everyday life in the clinic. Informal 
chats were held with patients and their relatives in the waiting area, and with health 
workers and supportive personnel in the administration units. Health centres served as 
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meeting points for community health workers and support groups, where we benefitted 
from informal encounters.  
7.2.3 Data analysis 
We transcribed and translated all interviews and focus group discussions into English. 
To assure good quality of the transcriptions, we gave the audio files and transcription 
documents to a third person for checking of the translation. Her comments were 
discussed with the transcribers. The study team undertook preliminary content analysis 
of selected interviews in the course of field-work. We discussed the emerging themes 
as well as the individual cases. Towards the end of the field-work, the interviewers 
gave a presentation to the health workers of the included health facilities on the 
tentative study findings.  
After completion of the field-work, I imported the transcripts of the interviews and group 
discussions and the field notes from participant observation into NVivo 9 for data 
analysis. I found Framework Analysis to be the most appropriate method for analysing 
the qualitative data, because it was developed explicitly to generate findings for public 
health practice and to inform policy makers on developing and steering health 
interventions (Green and Thorogood, 2009). The framework matrix provided a useful 
grid to display and summarize the patient case stories as well as the key themes.   
To familiarize myself with the data, I listened to the audio-files and read the transcripts 
and other written data sources. During familiarisation, I investigated the qualitative data 
for themes and coded the text accordingly. I used the emerging coding scheme to 
index all qualitative data. After discussing the coding scheme with my academic 
supervisor, I established the analytic framework. The analytic framework included eight 
thematic categories with a number of related codes each. Moving from description to 
analysis, I reconstructed the sixteen case stories using the available sources from 
different interview participants (see section 7.3 for selected case narratives and 
appendix 7 for the rest of the case narratives). From the analytic framework, I identified 
key themes and compared them across the sixteen cases and the focus group 
discussions. I then cross-tabulated the key themes with all utilised codes in NVivo 9 to 
identify frequent links made by the participants between themes. The results of this 
descriptive analysis are presented in section 7.4. I mapped out the key themes related 
to ART interruption and restart and the strength of the links so that patterns could 
become visible. I established the framework matrix using the sixteen cases as rows 
and the identified themes as columns (table 7-4). I filled each cell of the matrix with a 
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summary of the respective data. Finally, I interpreted the entire qualitative data on the 
basis of the maps and the matrix.  
7.2.4 Roles 
Five study team members were involved in the qualitative study component as 
interviewers (Sibonginkosi Dunjana, SD, and Stephen Buzuzi, SB), translators 
(Sibonginkosi Dunjana and Lillian Chemhere, LC), community mobilisers (Lillian 
Chemhere and Mugove Gonese, MG). LC and MG, who work for the local NGO 
Batanai HIV/AIDS Support Organisation (BHASO), assisted me in recruiting the study 
participants and communicating with community members for participant observation. I 
conducted 25 interviews myself, assisted by either SD or LC as translator. SD, who is a 
trained interviewer with a Master of Social Science, conducted 19 interviews on her 
own in Shona. I facilitated the focus group discussion with the patient tracers, assisted 
and translated by SD. The other seven focus group discussions were facilitated in 
Shona by SB, SD and LC. All transcripts were checked for translation quality by an 
external translator. At the end of the field work, a workshop was held with the study 
team, where cases and emerging themes were discussed. I analysed the qualitative 
data after completing field work on my own in NVivo 9.  
 
7.3 Interrupting ART: Case characteristics and narratives 
The qualitative component of our study is built around the stories of sixteen patients 
who discontinued ART. Three narratives are presented in this section, the rest of the 
stories can be found in appendix 7. The following is a brief introduction of the 16 cases 
(all names are pseudonyms), their detailed characteristics are shown in table 7-2. 
Batsirai, the abandoned young mother: interrupted ART to hide her HIV status from 
her new husband, was later abandoned by her in-laws, became severely ill, and never 
restarted treatment until her death a few months after the interview. 
Chido, the primary school teacher: interrupted ART whilst on travel, was denied 
down-referral upon return to care, felt maltreated by the hospital nurse for being a 
“defaulter”, and restarted after 5 months thanks to a close relationship with a health 
centre nurse. 
Chikonzi, the former prisoner: was on ART in prison, interrupted treatment after 
being released, felt blamed as a “defaulter” by hospital staff and claimed long distance 
to the hospital the main reason for staying away from ART. 
 98 
 
Edzai, the brave widow: mother of two children whom she had to leave with her 
parents’ when she married again, stopped ART to hide her HIV status to her new 
husband, but was determined to restart even at the cost of a divorce. 
Ega, the old man with the beautiful garden: stopped ART after being encouraged to 
do so by the Apostolic Church leader, felt ashamed for having “defaulted”, and 
restarted ART after falling ill thanks to the support of his wife and the nurse in-charge.  
Fungisai, the woman who saw flames: initiated ART during an episode of mental 
disorder, was never fully adherent and was successfully restarted thanks to her brother 
who is the nurse in-charge at the local health centre. 
Jayaguru, the wealthy farmer: famous in the district for his tomato plantation, 
discontinued ART during extended travel, felt ashamed for having “defaulted” and 
therefore stayed away from the hospital until a CHASA encouraged him to return to 
care. 
Jekuche, the religious teacher: well-known and highly educated Headmaster of a 
secondary school, stopped ART after an announcement of the Apostolic Church leader 
to abstain from medication, fell ill and was compelled to restart treatment by his wife. 
Linda, the widow with the stick: was left by her husband after testing HIV-positive, 
stopped ART after getting involved with a religious community, became disabled after 
suffering a stroke, and was then taken home by her sister who helped her restart ART.  
Maidei, the mother who stopped drinking beer: illiterate widow and mother of five 
children, considered herself a former alcoholic, stopped ART drugs after completing 
tuberculosis treatment, married Chikonzi, stopped drinking and restarted ART during 
pregnancy with her latest child. 
Meso, the maltreated orphan: probably vertically infected with HIV, lost both parents 
in early childhood, married early to escape from abusive custody at brother’s family, 
stopped ART to hide HIV status in marriage, lost husband and baby whilst still a 
teenager, fell ill and died a few months after the interview without having ever found a 
caring environment. 
Nashe, the labour migrant: was on ART whilst working in South Africa, discontinued 
treatment when returning home to wife and baby, stayed away from ART due to lack of 
income, distance to care, and feelings of shame for having “defaulted”. 
Pfuma, the illiterate mother: living in extreme poverty in a remote homestead, 
husband working in South Africa without supporting his family, discontinued ART after 
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having missed a follow-up consultation and been sent back to hospital for re-start, 
stayed away from treatment due to long travel distances causing high transport and 
lodging costs. 
Runako, the teenage orphan: probably vertically infected with HIV, kept asking 
herself “why me?” during adolescence, stopped ART secretly, restarted after falling ill, 
thanks to caring aunt who worked and lived at hospital. 
Simbisai, the rebel orphan: probably vertically infected with HIV, insisted on moving 
from grandmother’s rural home to Harare at the age of seventeen, discontinued ART in 
town where she lived with her sister who influenced her to abandon biomedicine and 
accept spiritual healing instead; returned to her grandmother’s after falling ill, but 
stayed away from ART until traced by a CHASA.  
Tomupeishe, the wealthy housewife: wife of a wealthy teacher who is also on ART, 
both discontinued ART after missing their follow-up consultation due to prolonged 
travel; a one-week delay turned into seven-month treatment interruption because the 
couple felt ashamed and guilty for having “defaulted”. 
Interrupting a life-saving medical treatment is an expression of social practice with far-
reaching and potentially fatal consequences. Emerging as an irrational choice at a first 
glance, interrupting ART might become a meaningful act in the light of the whole 
narrative. Exploring case stories allows a deeper understanding of the interplay 
between the individual illness and treatment history with the structural determinants in 
a given context. The following are the narratives of Chido, Edzai and Jekuche.  
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Table 7-2: Characteristics of the sixteen study participants who discontinued ART 
name sex, age 
socio-economic  
status 
marital status 
Time on ART before 
interruption 
Time between interruption and restart 
Batsirai f, 22 low divorced A few months stopped a year ago, no restart 
Chido f, 36 medium widow 2 years 5 months 
Chikonzi m, 35 low married (to Maidei) one year stopped > 1 year ago, no restart 
Edzai f, 32 low  married > 2 years stopped 6 months ago, no restart 
Ega m, 74 medium married four years 3 months 
Fungisai f, 35 medium divorced 2-3 months 6 months 
Jayaguru m, 57 medium married 2 years 6 months 
Jekuche m, 57 high  married 4 years 6 months 
Linda f, 48 medium divorced a few months more than 1 year 
Maidei f, 36 low married (to Chikonzi) six months 2 years 
Meso f, 20 low widow 2 years 12 months 
Nashe m, 38 low married 1 year stopped 2 years ago, no restart 
Pfuma f, 26 low  married 2 weeks stopped 7 months ago, no restart 
Runako f, 18 low unmarried < 1 year 1 year 
Simbisai f, 18 low  unmarried > 2 years 12 months 
Tomupeishe f, 36 high  married 2 years 7 months 
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Chido: “They don’t deny your drugs, but they just give you small supplies” 
Chido was a mother of three children. Her husband died, and the 9-year-old boy was 
HIV-positive and on ART. It worried Chido that she had not yet managed to tell him that 
he was HIV-positive. As a primary school teacher, she had a regular income, yet she 
was using most of her salary to support relatives, and there was not much money 
remaining at the end of the month. It was nurse Chenai at the local health centre who 
diagnosed Chido’s HIV status. Since then, the two women had kept a warm 
relationship, as the nurse expressed in the following quote: 
She knew I was never going to tell anyone so that is why we clicked. (#) I know her 
history, I understand her. [interview with Chenai, nurse] 
Chido had been on ART for two years when she travelled to Harare. At that time, life 
was rough in Zimbabwe; hyperinflation devalued the cash in Chido’s pocket, fuel 
became short, and public transport collapsed. Chido was not able to return to her home 
as planned. Without a referral letter from the hospital, Chido was not able to access 
HIV care at the public ART clinic in Harare. Stuck in the country’s capital city for a 
couple of weeks, she ran out of drugs, and an interruption of a few weeks turned into a 
serious crisis for Chido. She finally returned home to her ART clinic at the hospital with 
a treatment gap of a month. As a “defaulter”, she was given a two-week drug supply 
only instead of the routine two- or three-months. Yet, the economic crisis did not allow 
Chido to spend US$24 for transport there and back every two weeks, so she stayed 
away from ART for another 4 months. When her stomach started troubling her she felt 
desperate because of her son who also needed ART. She felt guilty and, eventually, 
went to nurse Chenai to ask for help. At that time, nurse Chenai’s health centre had 
become a decentralized ART site. Many ART patients comfortably collected their drugs 
locally. Yet, as a "defaulter" who had not been on ART for long enough, Chido did not 
qualify to be decentralized. She felt bitter about what she perceived a punishment by 
the nurse at the hospital, and about how she was treated: 
They don’t want people to default, so when you do that they punish you by giving you 
small supplies like two weeks or one month while others are getting supplies for three 
months. They don’t deny your drugs but they just give you small supplies so that you 
have to come again and again. (#) If only they could use polite words even if one 
defaults, because there are certain words that you cannot use when talking to people. 
Even other staff members know that he is rough. When patients are not behaving they 
say we will call him to come and deal with you or close down this place. He sometimes 
send people out of the consultation room and says l will serve you later if you just have 
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a small misunderstanding in answering his questions.  I was once offended when I had 
my child and they said those with children come this side. l went there but was not 
given the food package others were being given because they said I am a teacher. I 
have heard some saying there is a bus fare fund for children but l am afraid to ask the 
nurse because he is scary.  [interview with Chido, ART patient] 
Chido was re-initiated on ART only after an intervention of nurse Chenai through the 
hospital’s sister in-charge. Chido has fully recovered since and never missed a pill or 
an appointment again.  
 
Edzai: “This is my way, even if it means divorce” 
We interviewed Edzai in a counselling room at the local health centre. It would have 
been impossible to visit her at home because her husband did not know that she was 
HIV-positive. Edzai was 34 years old and had a very poor socio-economic background; 
she dropped out of school early, not used to write nor read and not able to recall the 
year when she started ART. She had no income and stayed many walking hours away 
from the main road in her husband’s homestead where they lived from subsistence 
farming. At the interview, she looked wasted and her voice sounded feeble. Edzai had 
two boys aged 13 and 6 years from her previous marriage. After her first husband’s 
death, Edzai and her children returned to her parental home where they lived until 
Edzai remarried. After re-marrying, she moved to her new husband’s home and left her 
children behind. The older son was taken by the family of her first husband. The 
younger remained with her parents. Edzai was on ART, she used to collect the drugs 
for herself and for her son. She said she had always taken her drugs when she lived 
with her parents. But she feared that her new husband would want a divorce if she told 
him that she was HIV-positive. She hid the drugs outside the house for a while, but 
soon stopped taking them. She thought that her husband was HIV-positive too, 
because his former wife died and four children all died. Before they married, she 
suggested they could test for HIV together. But he refused saying he would only get 
tested when he fell ill. Edzai did not have anybody to whom she could talk about her 
desperate and burdening situation. She could not even turn to her parents, who have 
been supportive to her, as she explained in the following interview section:  
Interviewer: So how do you plan to deal with your husband and your ARVs? 
Edzai: I wish he could agree that we get tested together. I had planned to just come 
and take drugs and show him that this is what I have done.  
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Interviewer: Why are you having such thoughts?  
Edzai: I fear that if I continue not taking ARVs sooner or later I will fall sick and I won’t 
know where to start from if that happens. (#) 
Interviewer: Does your family know that you stopped ART and what do they say about 
that? 
Edzai: To be frank they don’t know that I am no longer taking my ARVs and they 
wouldn’t be happy that I stopped taking drugs. (#) It is difficult because I should have 
told my parents that I stopped but it’s not an easy thing to do. Sometimes I would come 
here at the clinic prepared to restart ART, prepared to take whatever comes, this is my 
way, even if it means divorce.  
A couple of months before the interview, health centre nurse Chamunorwa realized that 
Edzai was overdue and sent a village health worker to trace her at her home. She was 
found ill and the tracer encouraged her to resume treatment. She came to the health 
centre and was diagnosed with herpes zoster and pneumonia. The nurse said he 
treated her and advised her to urgently re-initiate ART. Edzai kept refusing. At the time 
of the interview, six months had elapsed since Edzai stopped ART. Her health had 
deteriorated and the fact that she was hiding her HIV status both to her husband and to 
her family members disconnected her from any social and psychological support. 
Edzai’s refusal to restart ART in spite of her ill-health and in spite of feeling guilty in 
front of her family underscores the power of HIV stigma in marriage, representing both 
a cause and a consequence of the colossal gender inequality in Zimbabwe’s society.   
 
Jekuche: “They restarted me and I explained to them I had learnt my lesson.” 
Jekuche was a 57 years old and a secondary school headmaster. He had been 
married for nine years and had six children from two marriages. Jekuche’s first wife left 
him when he married his current wife because she did not want to live in a polygamous 
marriage. In 2007 Jekuche became seriously ill, with diarrhoea and stomach pain. He 
“tried everything to get healed” [quoting Jekuche] but it did not help. Eventually, his wife 
encouraged him to test for HIV. He tested positive and initiated ART. His wife tested 
negative. Three years later, during one of her pregnancies, Jekuche’s wife tested 
again, but she was now HIV-positive.  
Jekuche was deeply religious. He and his wife were members of different Christian 
churches before they joined the African Apostolic Church in 2009. At a public ceremony 
of the church in June 2011, an Apostolic leader encouraged HIV-positive church 
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members to stay away from hospitals and to stop ART, as he explains in the following 
interview section: 
 It was at a church function when we were misinformed. We were told that we have all 
been healed. And I accepted that and I went home, including my wife. After some time 
(#) I started feeling ill. Shaking and what and what. Then in January, it got worse, I 
started experiencing real shake-ups and a mild stroke. And I had wounds in the back 
which were serious and deep. So I had to come to the hospital. Then when I came to 
the hospital, they restarted me and I explained to them I had learnt my lesson, I will 
never ever drop these things again, for whatever reason. Now even our church leader 
explained that no, hospital was made by God, so people are healed by God (#).  
Jekuche was a wealthy and well educated Zimbabwean. As headmaster of the 
secondary school, he was a locally well-known and respected personality. He had been 
on ART for four years and he knew that ART saved his life. And yet, the announcement 
of the religious leader made him stop ART. Jekuche said he restarted ART after 
changing his mind. However, his wife underlined that he did not want to return to care 
as long as the church did not withdraw the announcement. It was her who ultimately 
convinced him that “he would die and leave me alone yet we have a lot of children” 
[interview with Jekuche’s wife] and took him to the hospital. Jekuche explained that 
after he restarted, the church reconciled spiritual healing with biomedicine by stating 
that hospitals were made by God. Jekuche enthusiastically defended his church, 
underlining that it was a misinformed leader who made the announcement without 
consulting his superiors: 
A lot of people died. And a lot of people are ill right now because of this problem. Now 
after this announcement was made, the church leader, he made the public 
announcement that people should go back to the hospital. Because this is wrong. 
Hospitals were made by God to assist people. This announcement was wrong. It was 
misplaced. It meant to kill people. And to make people stay away from the church. 
[interview with Jekuche, ART patient] 
At the time of the interview, the SMART programme considered Chido and Jekuche as 
retained patients, whilst Edzai was classified lost to follow-up. The cases of Chido and 
Jekuche show that retention does not indicate persistent adherence to ART drugs and 
appointments. They both had treatment interruptions of several months before 
restarting ART. The same was the case with eight other cases. Edzai, like four other 
cases, has been away from ART for many months without returning to care. Whilst 
Edzai and two others (Nashe and Chikonzi) restarted ART after the interview, Batsirai 
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and Meso did not manage to return to care, and died a few months after our encounter. 
The narrative analysis of the cases suggests that understanding the determinants of 
long-term retention requires an investigation of two critical passages in the treatment 
career of an ART patient: firstly, the reasons why patients interrupt treatment, and 
secondly, under what circumstances patients return to care or turn a temporary ART 
interruption into a prolonged and potentially fatal therapy discontinuation. 
 
 
7.4 Analytical framework 
This section describes the analytical framework I generated from the qualitative data. 
The content analysis of the qualitative data resulted in 51 thematic codes which I 
organised in 8 categories as shown in table 7-3.  
Table 7-3: The analytic framework 
Thematic category Code (number of coding references) 
Extended family 
 
marriage & partnership (69) / family and kinship (68) / children (26) / in-laws 
(11) / adolescents (9) / care-giver (8) 
Health and ill-health illness (48) / feeling healthy (26) / tuberculosis (21) / mental illness (7) 
Health care system health workers (43) / distance (28)/ hospital admission (5) / treatment costs (2) / 
referral (1)  
ART programme 
 
ART interruption (91) / tracing (54) / CHASA (49) / drug adherence (44) / HIV 
test (34) / ART restart (30) / ART initiation (27) / decentralization (24) / 
appointment keeping (12) / counselling (8) 
Biomedicine 
 
CD4 cell count (23) / vertical HIV transmission (15) / CTX prophylaxis (12) / HIV 
transmission (3) / drug regimen (2) 
Livelihood income (12) / migration and travel (18) / employer (3) / food and nutrition (8) 
Community resources support group (51) / churches (35) / community (21) / traditional healing (10) / 
witchcraft (6) 
Processes 
 
reasons (73) / disclosure (53) / treatment support (52) / perceptions (33) / death 
(17) / stigma (14) / behaviour (12) / conflict (8) / fear (7) / confidentiality (6) / 
violence (2)  
 
 
I analysed in which thematic context the participants of the interviews and focus group 
discussions talked about the coded themes. The weight of the relationships between 
the thematic codes, measured as number of text references coded at both themes, is 
indicated in brackets in table 7-3.  
The following is a brief description of the eight thematic categories. 
Extended family: ART patients, as people living with HIV, consider the extended 
family the social domain with the strongest influence on their lives. The extended family 
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includes the marriage at the core, linking the partners’ descent groups, and thus 
forming the larger kinship network of the ART patient. The data showed that the 
relationships between the patient and his or her extended family strongly determined 
key aspects of the patient’s therapy career, such as disclosure of the HIV status, 
treatment support, and therapy interruption.  
 
Health and ill-health: Patients talked about health and ill-health both as a cause and 
consequence of failed retention. The data showed that interruption and restart of ART 
often occurred in the context of an illness episode, often tuberculosis, and that 
churches appear to have an influence on illness experience.  
 
Health care system: The health care system was frequently raised as an influential 
domain for retention by study participants. The data suggest that health workers had a 
strong influence on treatment careers, particularly their behaviour and the perceptions 
of both the patients and the health workers on their relationship.  
 
ART programme: Figure 7-3 shows the themes and their weight that emerged in 
relation with treatment interruption and restart, the two critical stages in the participants’ 
ART careers. The data shows that the patient – health worker relationship, illness, the 
influence of churches, and family and kinship networks were the most dominant 
themes related to ART interruption and restart.  
 
Biomedicine: CD4 cell count and pre-ART co-trimoxazole prophylaxis were two 
biomedical themes frequently mentioned by the study participants. 
 
Livelihood: The data suggest that socio-economic factors had an influence on the 
course of ART, particularly related to labour mobility and migration. 
 
Community resources: Looking at the community as potential facilitator or barrier to 
ART retention, churches and HIV/AIDS support groups and CHASA came up as 
frequently linked themes.  
 
Processes: This set of codes included frequently emerging themes explaining social or 
psychological processes in relation with the participants’ treatment experiences. These 
themes added insightful qualitative characteristics to the above raised themes.  
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As shown in figure 7-3, the five thematic codes that were most frequently linked with 
ART interruption were health workers, illness, churches, CHASA, and migration and 
travel. Thematic codes most commonly linked to ART restart were illness, family and 
kinship, health workers, tracing, and support.  
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Figure 7-3: Frequency of codes linked to interruption of ART and restart of ART, 
measured as number of concurrent coding references.   
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7.5 Reasons for treatment interruption 
The narrative analysis of the sixteen cases (see appendix 7) and the thematic analysis 
of the entire qualitative dataset resulted in four main reasons why patients interrupted 
ART, as shown in figure 7-4: 
Failed initiation: Patients were enrolled in the ART programme and received the initial 
ART drug supply, but were not able to adhere to the drug regimen from the start. The 
dominant causes for failed initiation were mental confusion, adolescence and illiteracy, 
as was the case with Fungisai, Maidei, Pfuma and Runako. 
Stigma in marriage: Female patients discontinued ART to hide their HIV status from 
their new partner and his family, as it was the case with Batsirai, Edzai and Meso. 
Mobility: Patients interrupted ART because they ran out of drugs during prolonged 
travel or due to migration and a failed transfer from one ART clinic to another, such as 
Chido, Jayaguru, Simbisai, Pfuma and Tomupeishe. 
Religious authorities: Confronted with two conflicting healing paradigms, patients 
chose to follow religious in preference to biomedical authorities, as Ega, Jekuche and 
Linda did. 
Figure 7-4: Reasons for ART interruption 
 
 
 
7.5.1 Failed initiation 
The SMART programme considered a patient as initiated on therapy if he or she 
attended his or her first ART consultation. At this first ART visit, the patient received his 
or her first ART drug supply which usually lasted for two weeks. Whilst these patients 
on the grounds of their formal programme enrolment contributed to programme 
attrition, in reality, their therapy initiation failed. The cases of Fungisai, Maidei, Pfuma 
and Runako suggest that the main causes of failed initiation were a lack of treatment 
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literacy and adherence support in combination with psychological and mental 
challenges at the point in their lives when they were eligible for ART. Fungisai was 
mentally confused when she was initiated treatment, as she expresses in this quote: 
I came back from South Africa very ill. I came to the clinic and I couldn’t even eat so I 
survived through drips. I went to the hospital and was initiated on ART. (#) But I 
confused the drugs and when I went to the ART clinic and explained everything to the 
nurse (#), then she gave me my second supply. I took it home and suddenly I started 
seeing the flames of fire turning blue. I went mad and from that time I interrupted ART. 
[interview with Fungisai, ART patient] 
Maidei could hardly write and read, and she lacked adherence support and knowledge 
of the different drug regimens for CTX prophylaxis, prevention of mother-to-child 
transmission, ART, and tuberculosis treatment. She initiated ART during a course of 
tuberculosis treatment, but stopped the ART drugs after completing the tuberculosis 
treatment, as she felt healthy and started drinking: 
It was the devil. I wasn’t thinking clearly, I used to drink beer by then and taking ARVs 
together with beer would make me feel a burning sensation in my chest so I decided to 
stop the ARVs. I was later taught at the clinic that ARVs and beer don’t get along so 
when on ARVs one should stop drinking beer. [interview with Maidei, ART patient] 
Runako was a teenager when she was prescribed ART. As a teenage HIV orphan 
living with her aunt, Runako did not accept her HIV status. She could not accept that 
among her siblings she was the only one who was HIV-positive. In denial about her 
status and pained by the question “why me?” Runako’s initial ART initiation failed. Like 
Meso and Simbisai, the other orphans who participated in the study, Runako was most 
probably vertically infected. In an environment where people living with HIV were still 
blamed for their sexual behaviour, HIV-positive adolescents in their fragile life stage 
were particularly vulnerable and exposed to the stigma of HIV. Encounters with HIV-
positive peers helped Runako to understand that becoming HIV-positive was not her 
fault, and it helped her to return and adhere to ART, as the following quote suggests:  
I would tell them that we are not the one who looked for the virus, it just came to us and 
it was not our fault. So we just have to keep taking drugs because that is how we keep 
alive. [interview with Runako, 19, ART patient] 
Pfuma’s ART initiation failed because she arrived a day too late at the ART clinic for 
her first follow-up consultation, and was therefore sent to the district hospital for review 
where she never went. In contrast to Fungisai, Maidei and Runako, Pfuma was well 
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aware of the importance of ART and willing to initiate therapy. But Pfuma, with a CD4 
cell count of 150, was not aware of the procedures of the ART programme and about 
her patient rights. Being illiterate, living alone as second woman with her small children 
in a polygamous marriage, Pfuma lived in extreme poverty and in long distance from 
health facilities. Initiating ART was the end of a prolonged referral odyssey she 
undertook between her local health centre where she was tested HIV-positive, the 
nearest ART site where she attended pre-ART sessions and initiated treatment, and 
the hospital where she was referred to for re-initiation. Pfuma, who had already 
travelled far and frequently to access HIV care, was not able to raise money for another 
transfer, and she gave up.  
7.5.2 Stigma in marriage 
The fear of being rejected by the husband and the in-laws was a dominant reason why 
women concealed their HIV status, hid their drugs, delayed initiation or abandoned 
ART. The stigma of HIV in partnerships and marriage and its impact on ART retention 
was a frequently debated subject in the focus group discussions, as the following 
quotes show: 
I know of a girl who stopped ART because she had found a boyfriend who wanted to 
marry her. She went to live in Harare with the boyfriend and later developed some 
cancer on her face. She came back and went to the hospital but it was too late and she 
died shortly after. [participant of focus group discussion with support group members] 
I didn’t tell my husband that I had been tested, and I kept my ARVs in the granary and 
would sneak to the granary when it was time to take them. I had to lie to my husband 
that there is a sick relative at my maiden home so I could find an excuse to go home 
and tell my mother. My mother was supportive and she comforted me. Each time I get 
an ART appointment I had to lie to my husband that I am visiting relatives. [participant 
of focus group discussion with support group members] 
Hiding their HIV status from their fiancé or new husband was an overwhelming reason 
for ART interruption in almost all female ART patient cases. Batsirai stopped ART 
because she feared her husband’s and his family's reaction. When she became ill, she 
started feeling rejected by her in-laws, as she explains in the following quote: 
He was perverted by his parents, they interfered. They said to him you are keeping a 
sick person what for? And he left me. [interview with Batsirai, ART patient interrupting 
treatment] 
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Meso found herself in the same dilemma as Edzai who was portrayed in section 7.3 ; 
concealing her HIV status to the fiancé and at the same time hiding from her own 
family the fact that she stopped ART: 
Meso: I feared that I they (my brothers and aunts) would ask me why I stopped. I was 
afraid they would be mad at me. 
Interviewer: why do so many women stop ART because of marriage? 
Meso: In fear that if he discovers he will dump you if he knows about your status. In my 
case, my brothers were discouraging me from getting married, saying you are HIV-
positive and no one will ever marry you. [interview with Meso, ART patient] 
Maidei, Linda and Pfuma had also been hiding their HIV status from their husbands, 
but had not yet started ART. Maidei’s husband died before she started treatment. After 
his death and the death of one of their children, her former in-laws publicly accused her 
at the child’s funeral of being responsible for their deaths. Linda’s husband left her after 
she tested HIV-positive. And Pfuma felt discouraged by her husband to test for HIV 
when he was still with her.  
The perspective of the cited female cases though was challenged by some male FGD 
participants and by nurses. They claim that men have the right to know their future 
wives’ HIV status, as the following quote shows:  
For instance marrying someone from outside the district means that people marry with 
little knowledge about each other. As such, people marry HIV-positive people who did 
not disclose their status to their partners and who would have defaulted ART. It 
happened recently that someone married someone thinking that she was a young girl 
yet she was even a widow. Only later when she went to the hospital and she was 
asked to bring her husband for counselling the man found out. [interview with an ART 
nurse] 
7.5.3 Mobility 
"Searching for greener pastures" is a common saying in Zimbabwe if someone moves 
away from home to look for a job. For people on ART, to stay away from home can 
become a threat. Mobility was a reason vigorously debated in interviews and focus 
group discussions why people interrupted ART, either due to unexpectedly extended 
travel or as a result of relocation due to employment or family reasons. In the following 
quote, CHASA Damien was asked what he thought was the major reason for ART 
interruption: 
 113 
 
The greatest reason is that people go away to look for greener pastures (#). There is a 
person who, after being initiated on ART and recovering, migrated to South Africa and 
phoned me saying that he was sick again.  I also have a passport and I go out to 
Botswana but before travelling, I talk to my nurse and ask for more supply than the 
usual amount and return before it is finished. So some people don’t do that prior to 
travelling. [interview with Damien, CHASA] 
In contrast to the reasons of failed initiation and stigma in marriage, patients who 
interrupted ART due to mobility would have been willing to continue ART. They 
dropped out of HIV care simply because they physically left the programme area.  
Mobility was a notable pattern in the SMART programme and probably the most 
common reason why patients interrupted ART. Seven out of the sixteen cases 
interrupted ART due to mobility. Jayaguru, Chido and Tomupeishe missed their 
scheduled ART visit to due to an unexpectedly prolonged travel; Nashe, Chikonzi and 
Simbisai interrupted ART because they moved away from their ART programme. 
Jayaguru left his farm for a temporary job in town and ran out of drugs before returning 
home for his next ART follow-up consultation: 
When I went to Bulawayo I had supply enough for a month and I thought I would be 
back before it ran out, unfortunately it didn’t turn out that way. (...) I didn’t talk to 
anybody about it but I kept pondering about this, fearing that anything could happen to 
me because of stopping ART. [interview with Jayaguru, ART patient) 
Chido went to Harare where she failed to obtain her drugs from another ART clinic, as 
shown in her narrative in section 7.3.  
Tomupeishe and her husband attended a funeral in town and stayed longer than 
planned: 
It so happened that we were due for ARVs supply while we were still there and so we 
missed our appointments. [interview with Tomupeishe, ART patient] 
Simbisai stopped ART when she left her grandmother's home and moved to her sister 
in town. 
I left my drugs behind and I was not taking anything when I was there. I then fell sick 
again and came back already sick. [interview with Simbisai, ART patient] 
After being released from prison, Chikonzi moved to his wife’s place. Even though he 
was formally referred to the ART clinic, obtaining his medical records and a transfer 
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letter from the prison, he did not manage to continue ART. In the following quote, 
Chikonzi gives a number of reasons for having interrupted:  
When I came out of the prison they gave me a letter that I took to this hospital together 
with my cards. I was taking my drugs properly and I was staying at my wife’s place at 
that time. I defaulted because these drugs require that someone gets enough food, yet 
I did not have enough. I also didn’t manage to go for my supply appointments because 
of transport money to go there and lack of adequate food to eat and be strong enough 
to walk. So I defaulted. [interview with Chikonzi, ART patient interrupting treatment] 
Nashe started treatment when he was employed on a farm in South Africa. The 
employer supported Nashe to get treatment and ART was easily accessible. Life 
became difficult for Nashe when he returned to Zimbabwe: 
What happened is that I used to work so l could collect my tablets but when l stopped 
working and came back home l couldn’t afford the bus fare to go and collect drugs in 
the hospital. I only had it for one month and for the next appointment l walked and it 
made my leg to swell such that it was extending to the upper part (pointing to the lap). 
The swelling was serious for 2 to 3 weeks and l told my wife that with this kind of 
swelling l will no longer be able to continue walking to the hospital to collect drugs. So 
when those drugs finished I stopped. My wife is fit so she walks to the hospital to 
collect hers. [interview with Nashe, ART patient interrupting treatment] 
Lack of money for transport or having no access to an ART clinic were the two 
dominant reasons given by patients who discontinued ART due to mobility. Some 
health workers and CHASA expressed their doubts about these explanations. The 
underlying reason, they argue, was the patients’ failure to disclose their status in their 
new environment, as CHASA Shorai said in the following quote:   
There is nothing bad about looking for a job, but if one gets the job then they should 
disclose their status to the employer. Some default because they go out of the district 
to look for jobs and when they find the job, they don’t disclose their status (...).Some fail 
to come because when they arrive there they get new lovers and don’t disclose their 
status so they fail to constantly come back for their drugs. I think it’s not about 
challenges in sourcing bus fare to come back for supply but it’s about lack of disclosure 
such that it becomes difficult to keep requesting for off-days to come for ART 
appointments. [interview with Shorai, CHASA] 
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In the case of Chikonzi and Nashe, shame about being HIV-positive and not being able 
to earn their family’s livelihood after returning home made them feel aggressive 
(Chikonzi) or depressed (Nashe). 
7.5.4 Religious authorities 
In Bikita and Zaka, like in other areas of Zimbabwe, certain church communities 
promoted spiritual healing and discouraged church members to abstain from 
biomedical health services, such as giving birth in health facilities or ART. Religious 
authorities temporarily prevailed over biomedical authorities in the treatment careers of 
Jekuche (see his story in 7.3), Ega, Simbisai and Linda. Similarly to Jekuche, Ega 
followed the announcement of an Apostolic Church leader and abandoned ART. In 
Simbisai’s case, it was her sister with whom she lived as care-giver, who paid for a 
church leader who came to sprinkle water at their home to spiritually heal Simbisai. 
Similarly, when Linda was taken care of by a religious community after suffering a 
stroke, she was discouraged to stay away from ART by her mentor. Other patients also 
observed the strong influence by some church communities on the health-seeking 
behaviour of people living with HIV. There was a time when Jayaguru and his wife were 
also confronted with discriminatory announcements of their religious leaders. The 
threats of the religious leader made Jayaguru's wife hid her status and collected her 
drugs at a different health centre away from the local area: 
Sometimes they discourage us from taking drugs (...). At one time they said those who 
take drugs will be ordered to take off the garment. At that time I used to visit a clinic 
that’s down that side so that I wouldn’t be seen by those who know me. But it’s now 
allowed to take drugs (#), they fear bad publicity, that they will be treated like the other 
apostolic sect (#) that prohibits people from going to hospitals. [interview with 
Jayaguru's wife, patient on CTX prophylaxis] 
Tomupeishe and her husband are also deeply religious and members of an Apostolic 
Church. Yet, stopping ART for religious reasons has never been an option for them, as 
Tomupeishe's husband said: 
Yes I also heard about those churches and some don’t allow people to drink Coca Cola 
because it is black, but our pastor says people should take ARVs because God gave 
those who made ART drugs the knowledge (...) so that they save his people. The 
prophet tells us that the same God is the God whom you are following, and one day he 
may remove the disease but meanwhile he gave them knowledge. [interview with 
Tomupeishe's husband, teacher, on ART] 
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CHASA Shorai gave a plausible explanation why some church leaders managed to 
change the attitudes and practices of some ART patients: 
When people become fit they think they are completely healed and at that stage their 
attitudes are easily changed by religious people who preach about divine healing and 
discourage the use of ART. People from those churches tell people that they are 
healed completely and if they continue taking ARVs they will saturate their bodies with 
the drug and it will eventually kill them. (interview with Shorai, CHASA) 
The same pattern was reported by nurse Sekaye. She said that churches are the main 
reason why patients stop ART in her region: 
Their church discourages them from taking drugs and they believe that their leader is 
the prophet sent by the Lord.  Some church leaders want to test their powers to see if 
they actually heal people and they tell people that they are healed and so the patients 
stop taking their medication. [interview with nurse Sekaye, nurse] 
CHASA Hupenyu reported that patients who are not members of support groups were 
particularly susceptible to misleading notions promoted by some religious authorities, 
as the popular claim that “Christian water” cures HIV: 
Those who are not in support groups are the ones who tell us stories like I was given 
water by a prophet so I am not taking pills anymore, so we just leave them like that as 
there is nothing else you can say to them. [interview with Hupenyu, CHASA, on ART] 
I showed in this section that failed initiation, stigma in marriage, mobility and influence 
by religious authorities were major reasons why patients interrupted ART. At the time of 
our interviews, eleven out of sixteen patients who had interrupted ART had already 
restarted. The fundamental question to better understand long-term retention that 
remains to be explored is why some patients restart ART after interruption, and others 
do not. 
 
7.6 Facilitators and barriers for ART restart after interruption  
The narrative and thematic analysis of the qualitative data revealed that after missing a 
follow-up appointment, patients found themselves in a critical passage of their 
treatment career – a time window of medical and social vulnerability.  
Facilitators and barriers for ART restart were identified in three domains: 
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Health status: Good health at the time of ART interruption was a resource patients 
mobilized to return to care after interrupting ART, illness was a major barrier.  
Social capital: Patients with family and kinship networks supporting disclosure and 
treatment found it easier to restart ART than socially-excluded patients. 
Health system: The relationship with health workers and the geographical and social 
proximity of the nearest ART clinic were key facilitators for ART restart. Distance and 
the stigma of defaulting were major barriers. 
A combination of facilitators and barriers in the three mentioned domains determine the 
outcome of the interruption episode, which is either a therapy restart or, ultimately, 
death, as shown in figure 7-5. 
Figure 7-5:  Reasons for therapy interruption and facilitators and barriers to restart on 
the continuum of ART 
 
 
7.6.1 Health status 
The patient’s health status after treatment interruption influenced their subsequent re-
entry into care in either a positive or a negative way. On the one hand, some healthy 
patients did not see an urgent reason to restart ART whilst a deteriorating condition of 
the patient alerted the partner or family members to encourage and assist him or her to 
return to care. Illness, on the other hand, was often a reason why patients lost the 
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strength to restart ART, especially if they lacked partner and family support, as I will 
show in secion 7.6.2. 
The quantitative results showed that there was a narrow time window for restart after 
ART interruption. Though, the time window was wide enough for the study participants; 
most of them had returned to ART. Of the cases in this study, six patients were 
severely ill at the time of restarting ART, and five were deteriorating. Severe illness 
after ART interruption was a contributing factor why Fungisai, Jekuche, Linda, Meso, 
Runako and Simbisai returned to ART after 6 to 18 months. After ART restart, five of 
them recovered, including Linda who has lived with a disability since. These cases 
demonstrate that the patients found their way back to care only when it was urgently 
needed. For one of them, though, it was too late: Meso restarted ART and recovered 
from tuberculosis, but her health remained fragile, and she died a few months after the 
interview. Chido, Ega, Jayaguru, Maidei and Tomupeishe also returned to ART more 
than three months after therapy interruption, but, in contrast to the group mentioned 
above, they considered themselves only moderately ill. Among the patients who had 
not restarted ART at the time of the interview, Batsirai was severely ill, Edzai, Nashe 
and Pfuma moderately, and Chikonzi was feeling healthy.  
Interrupting ART hugely increased the patients’ medical vulnerability, defined as 
susceptibility to illness. With very few exceptions, the patients’ health status gradually 
deteriorated. Some patients restarted ART before getting seriously ill, but most 
returned to care only when they started suffering severe illness. The described cases 
show that there is usually a time window of several months between ART interruption 
and potential restart. There were other factors than health and illness facilitating or 
hindering ART restart – factors to be explored in the next sections. 
7.6.2 Social capital 
ART interruption did not only increase the medical, but also the social vulnerability of 
people living with HIV. The study participants described ART overwhelmingly as an 
escape from social exclusion, provided they were able and willing to disclose their HIV 
status to their immediate social environment. Thanks to regaining physical and 
psychological strength, they were able to resume responsibility for the livelihood of their 
families and to participate in economic and social activities. In the described patient 
cases, disengagement from ART often contributed to a gradual social disengagement. 
As their health started deteriorating, the gains of ART were inverted not only medically, 
but also socially. In the absence of economic resources and social security schemes, 
social capital, defined as investment in social relations with expected returns (Lin, 
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1999), emerged as a critical facilitator for ART restart. After treatment interruption and 
with gradually deteriorating health, marriage as well as family and kinship networks 
became the patients’ essential source of social capital.  
Marriage: facilitator for men, barrier for women 
The cases of Edzai, Batsirai, Meso and Pfuma demonstrated not only the stigma of HIV 
in marriage (see section 7.5.2), but showed also the potentially harmful impact of the 
in-laws on a married women’s course of ART. The following quote of CHASA Anotida 
who is an ART patient herself shows the influence of in-laws, even if the partner is 
willing to accept his wife’s HIV status: 
My husband was supportive but the family members were not. They seemed 
understanding and accommodating to me but behind my back they said things such as 
‘how can we live with someone who is sick’ and by then they didn’t even know my 
status. So when they got to know about my status they confronted my husband and 
told him that it was impossible to continue living with me, what if I infected him too? But 
because l had given my husband enough information about the disease, he was not 
swayed by what they said. But I was troubled thinking about my fate especially losing 
him and finding a new partner again. (#). [interview with CHASA Anotida, ART patient] 
Fear of losing the new partner was identified as a reason why women hide their HIV 
status and stop ART. Whilst failed disclosure in marriage remained a restart barrier for 
women, marriage was identified as a facilitator for ART restart in concordant 
partnerships, especially for men: Ega, Jayaguru, and Jekuche were supported by their 
HIV-positive partners who played a key role, urging them to return to treatment.  
Rural family and kinship networks as safety net 
Family and kinship networks were the paramount safety net and facilitator for ART 
retention and restart. Family members were key facilitators for ART restart in the cases 
of Ega (wife and son), Jayaguru (brothers), Fungisai (brother), Linda (sister) and 
Simbisai (grandmother). Linda’s case demonstrated the importance of the family back 
home in the rural village as a safety net for female patients who left their homes for 
marriage. Linda and her sister had always been very close to each other. They grew up 
in a family of 16 children in the countryside. Whilst her sister married in the village, 
Linda married in Harare. Her husband left her when she tested HIV-positive, and 
Linda’s life changed abruptly. She was first taken care of by a church community, 
where things became even worse. Her sister saved her life when she took her to her 
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rural home after Linda had stopped ART and suffered from a stroke, as her sister 
explains in the following interview section:      
I thought she was taking pills when she went for some prayers but the church had told 
her to stop taking pills (#). When she had the stroke they called me because it was 
difficult; she couldn’t go to the toilet or bath alone, she messed herself, I had to go and 
wash and she messed herself again. She then resumed ART and she got better but 
she still has stroke. (#)Today, I am always on the look-out, to check if she takes her 
pills at 8 am, if she leaves her sadza, I heat it and give her. If there is no sadza we 
make porridge and she eats then takes her pills. If I am there everything is ok. 
[interview with Linda’s sister] 
Support groups: access to social and economic capital for privileged patients 
Family and kinship networks were clearly the most powerful source of social capital for 
ART patients, especially for women whose partners and in-laws condemned and 
excluded them for their HIV status. Outside family and kinship networks, ART patients 
reported few supportive social relationships. Church communities, for example, 
appeared as important platform for spiritual support. ART patients, however, did not 
consider religious communities supportive to adherence.  
For many people living with HIV in Zaka and Bikita, support and self-help groups were 
a principal source of social capital beyond family and kinship networks. Support groups 
provided access to a variety of benefits, such as NGO-funded income-generating 
activities, loans and HIV counselling and testing campaigns. In the rural setting of the 
SMART programme, support groups had become a new structure of non-kinship, non-
governmental and non-religious self-organisation. Nurses and CHASAs were often the 
driving forces when new support groups were created. In nurse Tadisa’s experience, 
the public perception of HIV/AIDS had changed dramatically. Before the roll out of 
ART, people were "stigmatizing themselves" [interview with nurse Tadisa], feeling 
embarrassed, and hiding their HIV status. Support groups changed this: 
We have supported our patients to form support groups. They understand each other in 
the villages that each one is responsible for himself, and that nobody has to die from 
AIDS anymore. So they are coming in large numbers, they understand much better. 
Previously, it was confidential, and people did not want to disclose. They just disclosed 
for the purpose of treatment. (#) The nurses at the clinics they know the support 
groups, they report to these people, to the executives of the support groups. So these 
people they know each other, they report back to the clinic.[interview with nurse 
Tadisa] 
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ART patients reported that support groups offered them an escape from social isolation 
and self-stigmatisation. At the same time, joining a support group offered them an 
exceptional opportunity to disclose their status to community members. The following 
quotes demonstrate the importance of support groups in the view of their members: 
We sponsor bus fares to those without money to go for drug collection. We also run 
savings clubs and we loan that money to those who need it and they pay it back with 
interest. [participant of a focus group discussion with support group members] 
I like support groups because there is a lot of knowledge. There are a lot of things that I 
didn’t know. Sometimes I wish I had known certain things before my husband died I 
could have done good things for him. Maybe I was the one who caused him to be 
promiscuous. I learnt a lot of things, including how to be self-sustainable with my family 
not just waiting to be given things by other people. [participant of a focus group 
discussion with support group members] 
We have a slogan in our support group, which we say everyday, “have you juiced”, as if 
it is loading credits on a phone, so that we remind each other on whether people have 
taken medication? Because if you skip your medication when it is supposed to work for 
12 hours, the virus will increase. [interview with CHASA Hupenyu, ART patient] 
Some ART patients were critical about support groups though. They complained about 
community leaders using the support groups to raise money, and then mismanaging 
the finances of the support group.  
For those who were members, support groups were generally highly valuable source of 
social capital and economic benefits. However, medically and socially vulnerable 
patients were rarely members of such support groups. From the ART patient cases, 
Ega and Fungisai were the only patients who were member of a support group. Ega felt 
ashamed vis-à-vis his peers for “having defaulted” therapy, and said he pretended he 
missed ART appointments due to a journey to Mozambique. Fungisai claimed she paid 
a US$2 contribution to an income generating activity but was disappointed by the poor 
results of the project. Other patients knew about support groups but did not trust their 
leadership, such as Jayaguru and Chikonzi, who considered support groups as 
exclusive and closed platforms for credit and savings. Women who would have 
urgently needed adherence support after interrupting ART, claimed they had never 
heard of support groups, such Batsirai, Edzai Linda, Maidei, Pfuma, Runako and Meso.  
Our findings suggest that in the event of a therapy interruption, social capital is a critical 
resource for ART patients to return to HIV care. Medically vulnerable ART interrupters 
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who were embedded in a caring safety net of family and kinship had good chances to 
restart ART. Vulnerable interrupters were largely excluded from community-based 
networks, such as churches or support groups. 
7.6.3 Health system 
The way ART patients were connected to the ART programme crucially influenced their 
chances to restart therapy after interruption. This was particularly the case for patients 
in a deteriorating health state who lacked caring support in their social environment.  
Access to ART follow-up: link to care versus delayed decentralisation  
The "bus fare" was a frequently cited burden for ART patients and their treatment 
partners who lived far away from the ART follow-up site. In Bikita and Zaka, where ART 
was free, transport costs were critical indirect costs of treatment. Households were 
prepared to allocate money for the bus fare to bring a family member to the hospital in 
an emergency. Since ART required regular travel for check-ups and drug collection, 
distance became a threat to retention. To bring the services closer to the patients, the 
SMART programme was in the process of decentralising ART follow-up to health 
centres. ART patients were eligible for decentralised care if they had been stable for at 
least six months. Distance was not a problem for Jayaguru, Jekuche, Meso, Runako 
and Tomupeishe who lived near the district hospital. Physical proximity to the ART 
clinic neither prevented ART interruption nor facilitated prompt ART restart. And yet, in 
the case of Runako, who actually lived with her aunt in a staff house within the hospital 
premises, the immediate access to the ART clinic clearly facilitated her ART restart, 
once she was psychologically ready. The other patients lived 30 to 50 kilometres away 
from the hospital. Transport costs were a major obstacle that clearly prolonged ART 
interruption for some of them. Pfuma was overwhelmed by logistical problems during 
the process of her ART initiation: 
I was initiated in February and I was supposed to go back to the hospital on the second 
of February and it coincided with a funeral in my family and my aunt was critically ill. So 
after attending to these emergencies I came to the hospital and they said it was too late 
so they referred me to health centre. I didn’t have bus fare so I went to ask from my 
sister and she told me she couldn’t help as she had tried her best to help before. We 
were also expecting that my husband would send me some money from South Africa 
but he didn’t. So I am planning that when schools close I will take my children with me 
and drop them off at my parents’ home and proceed to the hospital. It’s troubling me, I 
really want to restart treatment but I don’t have the money. [interview with Pfuma, ART 
patient currently interrupting treatment] 
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Nashe and Chikonzi also claimed that they stayed away from ART because they could 
not afford transport costs to attend ART follow-up consultations at the district hospital. 
Nashe and his wife lived close to a health centre which already provided ART follow-up 
consultations. Transport to the hospital and back cost US$24 per person. Depending 
on which services were available at decentralized sites, patients were required to travel 
to the hospital for pre-ART sessions, CD4 cell count and other lab tests, ART initiation, 
and first follow-up after two weeks - up to 5 consultations within a short period of time. 
As Farai, the Primary Care Counsellor at Nashe’s health facility emphasized, many 
patients made great efforts and walked 30 kilometres to the hospital. In Nashe's case, 
however, the swollen leg and his general health condition did not allow him to walk. 
Nurse Chenai remembered that the situation affected more patients before CD4 testing 
was decentralized: 
Many people opted in to test HIV. We discovered a lot of problems because we could 
test people if they were positive they did not go to the hospital. Most of these people 
were in stage 3 or 4. They did not have bus fare and they walked very long distances 
for CD4 registration and counting and also for HIV lessons. After the HIV tests we did 
post-test counselling then we would tell them to go to the hospital but these people did 
not come back because they walked long distances and eventually, some of them died. 
[interview with nurse Chenai] 
Chikonzi's story, whether it is true or not, also tells a story about an ART patient 
struggling to adhere to appointments: 
I went there on the 10th of February and was told to come back on the 6th of March, 
when l got there they said I was late and didn’t consider the walking distance from 
where I was coming from.  They gave me another appointment on the 27th of April, that 
time I had money and so I boarded a mini-bus, but it had a breakdown on the way. But 
still I didn’t arrive there very late, they would have assisted me but they didn’t, I was 
given another date. [interview with Chikonzi, ART patient] 
It is noteworthy, however, that Nashe’s and Chikonzi’s wives who were both on ART 
managed to adhere to the appointments, sometimes walking the 30 kilometres to the 
hospital with a baby on their back. Edzai who was medically (deteriorating health) and 
socially (hiding status from husband) highly vulnerable, lived 50 kilometres from the 
hospital and 20 kilometres from the main road, but did not mention the distance as a 
reason why she did not restart ART. Neither did Linda, who returned to care in spite of 
a large distance from her home to the hospital, and her walking impairment. 
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Maidei and Batsirai were linked to the ART programme through the prevention of 
mother-to-child transmission programme, but with different outcomes. Maidei restarted 
ART for her own health through this programme when she was pregnant. Maidei lived 
near an ART providing health centre, but was not eligible to be decentralized. Maidei 
kept walking to the hospital, but complained:  
I collect at the hospital and my next appointment is 14 June. We have however 
suffered a lot because it’s too far and we have to walk. When we leave this place just 
before 7am we arrive at around 4pm and sleep there and I go there alone mostly 
because my husband would be out searching for menial jobs. [interview with Maidei, 
ART patient] 
Patient – health worker relationship: personal relationship versus shame of 
“defaulting“ 
Tomupeishe and her husband were both on ART. They were wealthy, well educated, 
and member of a church that encouraged members to adhere to ART. The couple had 
three healthy children, and, as her husband said, a “bright future ahead of us”. As the 
couple lived in a house close to the district hospital, they had immediate access to ART 
– and still interrupted ART for seven months. What had happened? Tomupeishe and 
her husband had been travelling and returned to their home place a week after their 
scheduled ART appointment. Out of fear of being "shouted at" [interview with 
Tomupeishe, ART patient], they did not approach the ART clinic to explain their 
situation. Instead, and despite their knowledge about the consequences of ART 
discontinuation for their health, they stayed away from the ART clinic for many months.  
Feelings of shame and guilt after interrupting ART emerged as a frequent pattern 
throughout the interviews and focus group discussions. Even though health workers 
generally acknowledged genuine access barriers, there were strong and judgemental 
perceptions among some individual health workers about patients who missed their 
ART appointment. Missing an ART appointment was socially inacceptable. 
Health worker Farai, who was on ART himself, had strong doubts about Nashe’s 
reasons for not re-initiating ART. He argued that retention on ART required a good 
attitude; patients like Nashe “defaulted” because they lacked a sense of responsibility 
for their own lives and those of their families: 
In fact, many people do not default because of the distance. Some people don’t tell the 
truth, as far as we observe here. Because you find that there are chaps who are quite 
strong, physically fit, but who do not go for ART initiation. (#) I told you that I am a 
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widow, I am a single parent with three children. So if I do not go for treatment, and I 
cannot work, then the children will suffer. So it is one of the things, if you are concerned 
about your family, you have to make an effort and go for treatment. But if you are 
negligent, you don’t even care about your children# [interview with health worker 
Farai, ART patient] 
Nurse Robert emphasised that retention was a matter of knowledge and attitude, 
“defaulting” in turn a matter of lacking knowledge and having the wrong attitude, as this 
section shows: 
Some default because of lacking knowledge about how ART works so this should be 
stressed on pre-ART sessions and health workers should be knowledgeable and also 
be capacitated on educating patients during pre-ART lessons. [interview with nurse 
Robert] 
The stigma of “defaulting” was a frequently perceived and stated barrier to ART restart 
among the study participants. Besides the above presented case of Tomupeishe and 
her husband, Chido, Chikonzi, Jayaguru and Nashe talked about feelings of shame 
and anger in relation with their status as “defaulters”. As a "defaulter" who had not 
been on ART for long enough, Chido did not qualify for decentralized ART. She felt 
bitter about what she perceived a “punishment” by the nurse, and about how she was 
treated. Chido’s report of the insensitive behaviour of one particular nurse at hospital B, 
as portrayed in section 7.3, was not an isolated account. During participatory 
observation at the ART clinic of hospital B, we witnessed the particular nurse by-
passing the triage desk, talking in an unprofessional way to waiting patients, and 
picking selected patients from the queue. Other ART nurses felt uneasy about his 
behaviour, and the nurse-in-charge was aware of the problem: 
Tadisa: Yes. It is happening. I encountered about five who were given one-month 
supply. It was from the same nurse. They were punished because they had (laughing) 
skipped some days before coming, so they were told ‘I am going to give you one 
month, in the next month you come’.  
Interviewer: Like a policeman? 
Tadisa: Ya, like a policeman. So I encountered these patients. And they were from one 
nurse. So I told this nurse you are causing a lot of congestion in the clinic and you are 
causing actually the withdrawing of patients from taking their drugs if you punish them 
this way. [interview with nurse Tadisa] 
Jayaguru interrupted ART because he ran out of drugs whilst working on a farm 200 
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kilometres away from home. Having missed his follow-up appointment, he feared 
returning to the hospital: 
When I returned I feared going back to the hospital in fear that I could be shouted at. 
(#) I had never heard of anything that could have happened to anyone who missed an 
appointment but I knew that when I was initiated l was told that I am not supposed to 
default so I felt guilty of doing that. I even had thoughts of going and starting afresh 
from blood tests as if I was a beginner. [interview with Jayaguru, ART patient] 
Whether real experience or perceived fear, the stigma of “defaulting” showed that the 
quality of the patient-health worker relationship was an important determinant of 
adherence and retention on ART. In contrast to the quoted cases, the stories of Ega, 
Fungisai, Meso and Runako showed that a continuous, close and trusting relationship 
can facilitate ART restart. Fungisai’s brother worked as an ART nurse at the local 
health centre where he facilitated decentralized ART restart for his sister. Meso and 
Runako were familiar with ART nurses who were good friends of their late mothers. 
Even for Chido, who claimed that the offensive behaviour of an ART nurse contributed 
to her prolonged ART interruption, it was eventually thanks to her close relationship 
with nurse Chenai that she restarted therapy. 
Tracing: safety net versus confidentiality 
Nine out of the sixteen portrayed ART interrupters were visited at their homes by 
community health workers through the SMART tracing programme: the other patients 
were not aware of the programme. In the cases of Jayaguru, Meso and Simbisai, 
tracing facilitated their return to HIV care. 
Jayaguru was considered lost to follow-up when the hospital sent CHASA Kutenda to 
trace him. Jayaguru expressed how grateful he was that Kutenda encouraged him to 
return to HIV care before he fell ill:  
My guilty conscience made me think I would be questioned and even when the CHASA 
came to call me I thought I was going to be put under interrogation but we had a nice 
discussion and I was reinitiated. [interview with Jayaguru, ART patient] 
Batsirai, Chikonzi, Edzai, Nashe and Pfuma were traced by CHASAs during the 
present research project and recruited to participate in the study. Pfuma said on tracing 
that “having someone to talk to in such situations would be very helpful”. They all 
restarted ART after the tracing intervention and the study interview, except Batsirai 
whose condition deteriorated further until her death a few months after the interview.  
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Tracing of patients who discontinued ART was generally perceived as a useful and 
acceptable intervention, as the following quotes illustrate: 
Participant 1: I was once followed up when I had stopped ART... 
FGD facilitator: Is it right or bad to be followed up? 
Participant 1: It is good. You might have problems or even just decide to stop due to 
circumstances or facing other problems. Those who follow up may give you advice. 
Participant 2: It’s good because they know what would have caused us to miss our 
appointment and would provide help if they can. 
Participant 3: Tracing is a good activity because even in the bible there was Noah who 
advised people about the coming flood and that they should prepare for that. So it’s 
good to inform one another and to remind each other. Someone who reminds you and 
talks to you are good because they are concerned about your life, they love you. 
 [Focus group discussion with young female ART patients] 
 
There were, however, some study participants who do not think health workers should 
trace them at their homes. In the case of Edzai, for example, the village health worker 
approached her husband who did not know that Edzai was HIV-positive and enrolled 
on the ART programme. Confidentiality was a delicate issue and potential concern 
related to tracing, as the following study participant expresses: 
At times they do not even know where I stay then they get lost and walk around asking 
people. [participant of a focus group discussion with male ART patients] 
Tracers reported various cases of ART patients whom they successfully encouraged to 
return to care.  
When we trace them and get the reasons why they defaulted, we then give them 
correct information. For example, someone defaulted because they did not like the 
feeling of hunger that they felt after taking the tablets. Tracing helps as CHASAs give 
them information about how they can cope when they do not have adequate food 
supplies. Another example is that of a person who defaulted because he had been told 
in their church that he has been healed and is free from HIV, when we traced him and 
learnt that, we quickly gave the person the right information and convinced him to 
restart ART until he agreed. [participant of a focus group discussion with ART patient 
tracers] 
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Tracers also reported that their activity helps understand the reasons why patients 
interrupt treatment: 
Through tracing, we learnt about a lot of causes for defaulting.  We learnt that people 
default due to religious beliefs and this is very common around this place. [participant 
of a focus group discussion with ART patient tracers] 
Tracers also reported that they found many patients who were identified as suspected 
interrupters but in reality never stopped ART. Documentation errors at the ART clinics 
were the major reason for these cases that were misclassified as lost to follow-up. 
Some patients complained about being classified as “defaulters” without having missed 
an appointment, as the following quote shows: 
We started tracing of lost to follow ups last year and we have found it an effective way 
of learning exactly what’s happening to those suspected defaulters. Sometimes when 
we get there we discover that the patient is adherent and it was just an issue of flawed 
documentation. So tracing creates a platform for the correction of mistakes within the 
system. Sometimes you get to know that the patient died. (#) [interview with CHASA 
Shorai] 
The documentation process is flawed: some people are documented as defaulters yet 
they are retained patients. So when we follow up such people we realise that it does 
not go down well with them, as we would be unnecessarily bothering them. [participant 
of a focus group discussion with ART patient tracers] 
Hence, tracing was identified as useful intervention to improve the ART programme: 
Tracing and doing follow-ups has helped the hospital to know the actual people who 
are still on ART and excluding those who are deceased. This has helped them enrol 
more cases. (#) Tracing is good because it helps the hospital update its patient 
records and realise faults in the system. [participant of a focus group discussion with 
ART patient tracers] 
Tracers emphasised that following-up patients only after 90 days was far too late: 
Tracing should start maybe within 5 days to 7 days so as to save lives. If tracing starts 
after 7 days of defaulting, it might take the tracer 3 days before finding the patient and 
another week to convince them to restart ART and by then the person would have 
defaulted for over a month, so time should be of essence, trace them early and get 
them back on ART before they default for longer. [participant of a focus group 
discussion with ART patient tracers] 
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Who should be the tracers had been a controversial discussion between the SMART 
programme and the health authorities. During the pilot, all health worker cadres 
including trained and supervised community health workers were at the ART nurses’ 
disposition to trace patients lost to follow-up at their homes. ART patients generally 
welcomed any tracer who was supportive and who protected their confidentiality. 
Based on the CHASAs’ individual conduct and his or her relationship to the patients, 
participants from different focus groups in different areas had different experiences and 
views of the CHASAs as tracers, as the following quotes show:  
FGD facilitator: Who do you think is the best cadre to do tracing? 
Participant 1: I think it should be the CHASA because the CHASA has got an 
understanding of such issues and can talk about these issues better than anyone else. 
Participant 2: I think it should be a CHASA because they were specifically trained for 
that. They know exactly how they were trained regarding that job and they probably 
have better knowledge in these approach issues even better than nurses themselves. 
Participant 3: CHASAs are better placed because some can even approach you and 
talk about such confidential issues in public but the CHASA was trained on that.  
[Participants of a FGD with male and female support group members] 
Another focus group of support group members also preferred CHASA as tracers, but 
were critical about confidentiality breaching behaviours they experienced in their area: 
Participant 1: The CHASA is ok if he is a decent person because they know better 
about HIV issues and every CHASA is HIV-positive so he is the right person to visit and 
talk to such people. 
Participant 2: There is a problem with CHASAs because they can’t keep people’s 
issues confidential. It goes to an extent where they offer counselling using a patient’s 
name as an example. 
Participant 3: CHASAs should be given lessons on keeping confidentiality because no 
one would want to go to the hospital and the next thing they hear people talking about 
the drugs they are taking having been told by the CHASA. 
[Participants of a FGD with male and female support group members] 
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7.7 Discussion: medical and social vulnerability after treatment 
interruption 
There is a variety of reasons why patients interrupted ART. Long-term retention on 
ART was essentially influenced by their ability to return to care after a temporary 
treatment gap. In this section, I will discuss the qualitative study findings and compare 
it with other studies. The implication of the results will be presented as well as the 
strengths and weaknesses of this study component.  Table 7-4 shows the framework 
matrix – a tool for qualitative data analysis introduced in section 7.2.3 – that gives an 
overview on the sixteen cases and the identified reasons for ART interruption and 
restart.  
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Table 7-4: Framework matrix on reasons for ART interruption and facilitators and barriers to ART restart in sixteen cases 
THEMES 
 
 
 
CASES 
Reasons for 
ART 
interruption 
Facilitators for and barriers to restart after interruption 
ART status Health status during 
ART interruption 
Social capital 
marriage 
family and kinship networks 
support groups 
Health system 
access to ART follow-up 
patient-health worker relationship 
patient tracing 
Batsirai, f, 22 stigma in 
marriage 
stopped 1 
year ago, no 
restart 
(died few 
months after 
interview) 
severely ill with TB; on 
CTX prophylaxis 
Facilitators: mother her only support, but at a 
late stage only 
Barriers: husband left her when she fell ill after 
stopping ART; lived with in-law family who 
rejected her 
 
Facilitators: CHASA traced her and brought her 
back to care temporarily 
Barriers: distance to ART clinic; rigid down-
referral policy at hospital;  
  
Chido, f, 36 mobility restarted 5 
months after 
ART 
interruption 
healthy, feeling ill after 
4 months (diarrhoea) 
Barriers: competing interests, family members 
expecting monetary support from her since she 
is employed 
 
Facilitators: restart thanks to personal 
relationship with local nurse who intervened at 
hospital asking for down-referral 
Barriers: collecting drugs at hospital, 40 
kilometres away, in spite of local health centre 
being ART follow-up site (rigid down-referral 
policy); felt “punished” after having “defaulted” 
due to travel by getting small ART drug 
supplies only, causing frequent travel to 
hospital, ultimately causing repeated ART stop 
Chikonzi, m, 35 mobility stopped  
more than 1 
year ago, no 
restart 
healthy but depressed 
according to his wife; 
previous TB; on CTX 
prophylaxis 
Facilitators: married with Maidei who is 
supportive 
Barriers: no supportive family or kin in the 
district; no community networks, considers 
support groups as closed savings and credit 
groups 
Facilitators: traced by a CHASA 
Barriers: transport costs to the hospital prevent 
him from re-initiating ART; rigid down-referral 
policy at hospital; felt blamed to be a “defaulter” 
by a hospital ART nurse, complained about 
favouritism at ART clinic 
Edzai, f, 32 stigma in 
marriage 
stopped 7 
months ago, 
no restart 
deteriorating health 
since ART interruption; 
pneumonia; suffered 
herpes zoster; on CTX 
prophylaxis 
Facilitators: her parents and sibling are 
supportive and look after her child, but they do 
not know she stopped ART 
Barriers: husband does not know her status 
and does not want to test HIV himself 
Facilitators: traced by a community health 
worker 
Barriers: resides 20 kilometres from health 
centre and 50 kilometres from hospital, cannot 
afford transport 
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Ega, m, 74 religious 
authorities 
restart 3 
months after 
ART 
interruption 
feeling weak, stopped 
working in his garden 
Facilitators: supportive wife (herself on CTX) 
and son; embedded in religious community, 
supported by other ART patients in religious 
community; support group member (despite 
“leadership problem”) 
Barriers: feels neglected by relatives 
Facilitators: good relationship with health 
worker at hospital who convinced him to restart 
Barriers: 30 kilometres distance not a problem 
due to relative wealth 
  
Fungisai, f, 35 failed 
initiation  
restarted 6 
months after 
failed ART 
initiation 
mental illness episode, 
suspected HIV 
encephalitis 
Facilitators: restart thanks to supportive brother 
(who is a nurse at the local health centre); 
member of support group, which she considers 
an income-generation project 
Barriers: widow living with her mother who did 
not provide adequate treatment support  
Facilitators: lives near a local ART initiation 
pilot site; direct link to health centre and ART 
programme through her brother 
Barriers: 30 kilometres distance to hospital not 
a problem due to local health centre a pilot 
treatment initiation site 
Jayaguru, m, 57 mobility restarted 6 
months after 
ART 
interruption 
healthy Facilitators: supportive wife (on CTX 
prophylaxis); supportive brothers; member of 
religious community 
Barriers: Member of Apostolic Church which 
discouraged members from biomedicine 
 
Facilitators: lives in short distance to hospital; 
CHASA traced him and brought him back to 
ART 
Barriers: felt ashamed about having missed 
follow-up appointment, feared to be blamed as 
“defaulter”   
Jekuche, m, 57 religion  restarted 6 
months after 
ART 
interruption 
became severely ill 4 
months after 
interruption: rash, 
wounds, fever, “shake-
ups” and “mild stroke” 
(Jekuche) 
Facilitators: supportive wife (on CTX) who 
persuaded him to restart ART after getting ill 
Barriers: member of religious community; 
sceptical about support group due to 
leadership issues 
Facilitators: lives near hospital A, no physical 
access barriers; restart after tracing by CHASA 
who he was acquainted with 
  
Linda, f, 48 religious 
authorities 
restarted 
more than 1 
year after 
ART 
interruption 
physically disabled due 
to a stroke after 
interrupting ART 
Facilitators: strongly supportive sister who 
made her restart ART; a network of people with 
whom she made business and whom she 
supported in the past; 
Barriers: religious community discouraging her 
from ART 
Facilitators: - 
Barriers: disability; distance to hospital, local 
health centre not yet a decentralized ART site 
 
Maidei, f, 36 failed 
initiation 
restarted 2 
years after 
failed 
initiation 
felt healthy after 
completing TB 
treatment; alcohol 
Facilitators: husband Chikonzi supportive after 
release from prison 
Barriers: no support from relatives, in-laws of 
former husband blaming her for death of him 
and the 8-year old child  
Facilitators: returned to care through PMTCT 
during latest pregnancy 
Barriers: distance to hospital, delayed 
decentralisation   
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Meso, f, 20 stigma in 
marriage 
restarted 12 
months after 
ART 
interruption 
(died few 
months after 
the 
interview) 
wasted and severely ill 
with TB 
Facilitators: her late mother had close relation 
to ART nurse at hospital; supportive aunt 
desperate to take her and care for her 
Barriers: recent loss of husband and baby; lost 
parents, lived with brother’s family, keeping her 
as labour force, not giving care and support to 
her 
Facilitators: access to ART follow-up; lived near 
hospital; personal relationship to ART nurse 
Barriers: appears not having received adequate 
care at hospital 
 
Nashe, m, 38 mobility stopped 2 
years ago, 
no restart 
 
deteriorating health 
since interruption; 
diarrhoea and swollen 
leg; on CTX 
prophylaxis 
Facilitators: supportive wife who is on ART 
Barriers:lived in emigration (South Africa) 
before illness, has, seems therefore socially 
isolated in Zimbabwe; not member of support 
group 
Facilitators: gets CTX at local health centre; 
restart after tracing / study 
Barriers: hospital 50 kilometres away; rigid 
down-referral policy at hospital; fear to be 
blamed for “defaulting 
Pfuma, f, 26 failed 
initiation 
ART 
initiation 
failed 7 
months ago, 
no restart 
feels healthy; CD4 of 
151; on CTX 
prophylaxis  
Facilitators: sister, paternal aunt and aunt’s 
daughter are supportive 
Barriers: polygamous marriage with husband in 
South Africa, discourages her from ART 
 
Facilitators: traced by CHASA 
Barriers: very long distance to initiation clinic 
(hospital); long walking distance and no 
transport means from home to ART follow-up 
site 
Runako, f, 18 failed 
initiation 
restarted 1 
year after 
failed 
initiation 
admitted at hospital 
after getting ill 
Facilitators: lived with paternal aunt who was 
close to mother; knows some other adolescent 
ART patients, meets them informally at hospital 
Barriers: orphaned; adolescence   
Facilitators: resided in hospital compound with 
aunt who worked at hospital; immediate access 
to ART clinic thanks to good contacts to nurses 
 
Simbisai, f, 18 mobility  restarted 12 
months after 
ART 
interruption 
 
wasted and severely ill 
with TB 
Facilitators: lived with grandmother who took 
her home from Harare and brought her to 
hospital 
Barriers: mother died, father (on ART) not 
supportive; sister discouraged her from ART on 
religious grounds 
Facilitators: lived near ART initiation pilot site 
Barriers: prompt tuberculosis treatment at 
hospital A after return from Harare, but failed 
referral from tuberculosis programme to ART 
programme; restart of ART at health centre 
after tracing by a CHASA  
Tomupeishe, f, 36 mobility restarted 7 
months after 
ART 
interruption 
good health Facilitators: supportive husband who was on 
ART, decided together to restart ART before 
getting ill as they were before starting ART 
 
Facilitators: lived near hospital 
Barriers: felt ashamed for having missed follow-
up appointment, had experienced insults by a 
nurse in the past, feared to be blamed as 
“defaulter”  
ART=antiretroviral treatment; TB=tuberculosis; CHASA=Community HIV/AIDS Support Agent; CTX=co-trimoxazole; 
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7.7.1 ART interruption despite strong motivation to remain in care 
There is a broad range of reasons why patients interrupt ART, some of them strongly 
connected with the local context such as the limited drug supply given to ART patients 
by a particular health facility, others rooted in more general issues, such as gender 
relationships in Zimbabwe. We found four main reasons for ART interruption. First, 
many ART patients dropped out at an early stage of therapy. Strictly, they should not 
be considered interrupters since they never really initiated ART. Mental and 
psychological conditions as well as losses during referral were underlying reasons for 
failed ART initiation. A second reason for ART interruption was women who stopped 
taking drugs to hide their HIV status from their new partner or husband and his family. 
This phenomenon revealed a deep gender conflict in the studied communities: women 
complained that men commonly refuse HIV testing before marriage, whilst men blamed 
women for hiding that they are HIV-positive. In the context of extreme poverty, 
marriage was for many women an imperative for social and economic survival. It 
appears that for many women, striving for social survival in everyday life prevailed over 
their longer-term desire for good health. Our findings on the impact of gender conflicts 
on ART confirm research from Zimbabwe and other sub-Saharan countries (Skovdal, 
2011a). Mobility was a third and probably the most frequent reason for ART interruption 
– a relevant aspect of retention which has rarely been studied by qualitative research. 
As the Zimbabwean ART programme is a fragmented system of individual and often 
different hospital and district ART programmes, prolonged travel and migration often 
led to treatment gaps due to failed referrals, short drug supply or missed appointments. 
Fourth, some patients stopped ART as they found themselves caught between 
religious and biomedical authorities. In contrast to other studies, traditional African 
medicine and “witchcraft” did not emerge as a contradictory health system to 
biomedicine. Some Apostolic Churches were much more powerful and radical in 
promoting magic and spiritual healing in opposition to ART. Whilst there is a rich 
literature of qualitative research on the potentially conflicting cultural models of 
traditional and biomedical healing, the impact of the growing evangelicalism across 
sub-Saharan Africa on ART retention has not been studied. 
In their qualitative study on ART interruption, Ware (2013) distinguished between 
intentional and non-intentional ART interruption. Related to the findings of this study, 
stopping ART due to failed initiation, HIV stigma in marriage and religious authorities 
would be considered intentional, whilst stopping ART due to migration or travel would 
be non-intentional. The authors argued that patients who unintentionally stop ART due 
to logistical or financial reasons usually return to care after a temporary interruption 
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thanks to their “willingness” and “motivation” (ibid.). Our study does not support the 
concepts of “intention” and “willingness” with regard to adherence and retention. The 
patients who missed their ART appointment due to prolonged travel or unexpected 
incidents stayed off ART for a longer period. Our study rather supports the findings of 
the systematic review of Merten (2010), arguing that patients are highly motivated to 
adhere to ART, yet struggling to balance competing moral, social and medical interests 
and demands in their social lives than losing will and intent to stay healthy. Temporary 
ART gap turned into prolonged disengagement for other reasons than those causing 
the treatment interruption.  
The two above cited influential studies by Merten (2010) and Ware (2013) focused on 
individual and social determinants influencing adherence and retention, largely ignoring 
reasons engrained in the health system and ART programme itself. Other qualitative 
studies, such as the monographs by Nguyen (2010) and by Mattes (2011) provided rich 
and critical insights into inclusion and exclusion mechanisms of ART programmes; their 
findings though were limited due to quality issues.  
7.7.2 Safety nets after interruption key for long-term retention 
Whilst there is a large literature on reasons for ART interruption, our study adds new 
insights on what happens after patients drop out of the ART programme. Preventing 
attrition from ART thus is less a matter of getting lost than of getting found. Patients 
who interrupt ART enter into a time window of medical and social vulnerability with 
unknown outcome. Figure 7-6 shows a flow chart summarizing the patient’s scenarios 
and choices after treatment interruption which either lead to ART restart and retention 
or to prolonged therapy discontinuation and attrition.  
ART interrupters have three potential safety nets that can prevent them from 
permanent disengagement: their own health, their social capital, and the health system. 
From a Practice Theory point of view, the function of these safety nets is to help the 
patient regain agency: his or her capacity to take action, as for example to return to the 
ART programme.  
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Figure 7-6: Flow chart on facilitators of and barriers to ART restart after interruption 
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7.7.3 Kinship networks: a key source of social capital 
Patients whose health status deteriorated had good chances of resuming ART if they 
possessed sufficient social capital through marriage, family and kinship networks. 
Descent was the primary supportive relationship. Lack of social capital in these primary 
networks, however, increased the patient’s social vulnerability, defined as susceptibility 
to social harm and exclusion (Allotey, 2012), bearing high risks of attrition from ART. 
This was predominantly the case for female ART patients who stopped ART to hide 
their HIV status from their partners and in-laws. Even if they disclosed their status, they 
often lacked family support as long as they stay with their partner and in-laws. Their 
(rural) parental home was a critical safety net for HIV-positive women who separated 
from their partners.  
Our findings on the paramount importance of kinship for long-term adherence and 
retention confirm insights from other studies, investigating extended family as a source 
of social capital in Zimbabwe. The studies of Parsons (2012) and Zagheni (2011) 
explored how kinship networks cope with the immense number of orphans due to 
HIV/AIDS deaths in Zimbabwean society. The authors argued that paternal aunts and 
uncles as natural care-takers were not able to absorb the mounting number of orphans 
in Zimbabwe. In the course of the HIV epidemic, grandmothers, adolescent siblings, 
those often in urban or semi-urban settings, and maternal aunts and uncles became 
involved in care of orphaned children. Parsons (2012) stressed that in the framework of 
Zimbabwean’s patrilineal kinship system, the mother’s kin, especially her brother, play 
a key role in the event of a mother’s death. Zimbabweans imply a strong affective and 
spiritual bond with their mother’s brother, which is often explained with the power of the 
dead mother’s spirit (ibid.). For this reason, Zimbabweans consider all female maternal 
relatives of mother’s generation mai (mother). Thus, in the case of a child whose 
mother dies, the two complementary concepts of patrilineal kinship on the one hand 
and the power of the maternal spirit lead from the child’s point of view to a separation, 
and thus to a potential competing influence between baba (the principle of descent) 
and mai (the principle of the spirit) and their respective extended families. Parsons 
(2012) illustrates this notion of “competition” by telling the story of an orphaned girl. The 
father’s family decided that the girl would live with her mother’s relatives as long as she 
remains unmarried. The author showed that that care – in a sense of “loving 
motherhood” – was delegated to the maternal relatives. When the time of marriage 
came, the patrilineal kinship claimed her back. In the Zimbabwean society, bride price 
payment is a prevailing regulation of customary marriage. Marriages of female kin thus 
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represent a potential source of income compensating the extended family’s loss of her 
productive and reproductive working capacity (ibid.).  
The Zimbabwean kinship structure has not only absorbed the tremendous need for 
orphan care. Our study showed that it also serves as a supportive safety net for ART 
patients in need of care and assistance, particularly in the event of a personal crisis, 
such as after a treatment interruption. The case stories presented in this study 
demonstrate that marriage, family and kinship are powerful structures of inclusion and 
exclusion.  
In the last ten years, the concept of social capital has gained the attention of policy 
makers (Scott 2011). OECD (2001) and World Bank (2002) explored the potential 
impacts and benefits of social capital for social and economic development. In the 
public health domain, the social capital approach has been used in a variety of study 
topics, including ART. Ware (2009) showed the importance of social capital for long 
term ART adherence. The authors argued that obligations, responsibility and 
reciprocity within social networks were the driving factors why patients in sub-Saharan 
Africa make tremendous efforts to adhere to ART. Our findings support the importance 
of social capital for adherence and retention, however largely limited to family and 
kinship. Whilst community resources represent an important resource for ART patients 
to adhere to ART drugs and appointments, we found that vulnerable ART interrupters 
who are most in need are not supported by the community. Socially-vulnerable ART 
interrupters are rarely members of HIV/AIDS support groups. In fact, the missing link to 
a support group makes them socially vulnerable. Support groups, frequently found in 
the study area, were a way of collective self-determination among ART patients with 
social capital. Support groups were strongly connoted with an identity creating 
discourse of social inclusion and exclusion, both by members and non-members. 
Members tend to blame non-members for being in denial about their HIV status, whilst 
non-members often consider support groups as exclusive clubs.  
7.7.4 The need for a supportive health system 
ART interrupters in a deteriorating health condition who lacked supportive partner, 
family and kinship relationships were at high risk to permanent disengagement from 
ART, especially if they were confronted by barriers in the health system. Intricate re-
initiation procedures not responding to their needs were a main reason why ART 
interrupters delayed therapy restart. Our case studies showed that vulnerable patients 
who were most in need of support did not have the resources and confidence to 
embark on a renewed initiation process simply because they could not afford it or did 
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not have the physical strength for multiple visits to the district hospital. These findings 
confirm the existing literature on ART client satisfaction and retention obstacles from 
Zimbabwe that identified long waiting times, high visit frequencies, and unpredictable 
clinical pathways major issues affecting ART patients (Campbell, 2011a). 
In addition to the system barriers, ART interrupters often felt ashamed and guilty for 
having “defaulted”. Many patients reported they were blamed and offended by health 
workers for missing their ART appointment; others feared hostile reactions when 
returning to the same ART clinic where they “defaulted”. The notion of “defaulting ART” 
had a strongly accusatory connotation. It had been used in tuberculosis programmes 
with a stigmatizing association for many years, and it appears that its condemnatory 
meaning has been taken over in the ART programme. ART patients started 
complaining not only about the negative perception, but also about offensive behaviour 
of health workers in relation to missed appointments. Patients internalised the stigma of 
“defaulting” to such an extent that they did not dare return to the clinic. It appears that 
the source of the stigma of “defaulting” was the health system itself. The existing 
qualitative evidence on health system related determinants suggests that besides 
decentralised ART provision, the patient-health worker relationship is key to adherence 
and retention throughout sub-Saharan Africa, as Kagee (2012), Dahab (2011) and 
Gusdal (2009) reported from South Africa, Agnarson (2010) and Mattes (2011) from 
Tanzania, Sanjobo (2008) from Zambia, and Campbell (2011a) from Zimbabwe. There 
is, however, further research needed to understand the human resources challenges of 
chronic care integrated in primary health care systems. Innovative interventions are 
required to strengthen trusting and continuous patient-health worker relationships in 
ART.  
On the other hand, our findings suggest that ART interrupters have good chances of 
returning to care if the health system provides conditions where the patients can regain 
agency. Three facilitating approaches appear particularly relevant: first, decentralised 
ART initiation and follow-up makes restart easier. Physical proximity to the ART site 
obviously reduces the patient’s financial burden to the household. Decentralised 
preparation, initiation and follow-up of ART also allow the patient to locally reconcile 
competing interests within family, kinship and community, potentially supported by the 
familiar health facility, the community health workers or a support group. Our study 
showed that concealment of ART is not an option in the setting of rural Zimbabwe. 
Socially-vulnerable patients, such as newly married women, require a locally-
accessible supportive safety network. The local primary health care facility is an ideal 
gateway not only for “one-stop” primary health services including ART, but also for 
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information sharing, peer education and social networking. Integration of ART into 
primary health care would require full decentralisation of ART.  
Trusting patient-health worker relationships are critical for ART restart. Instead of 
blaming patients for missing their appointment, health workers can assess the patient’s 
social vulnerability and structural adherence barriers. Again, health workers in the local 
health facility might be in a better position to understand the reasons why the patient 
interrupted ART, and propose potential ways to resume treatment. A trusting patient-
health worker relationship is particularly important in the event of a crisis, such as a 
treatment interruption. Health facilities should therefore put the quality and continuity of 
this relationship in the centre of the ART programme.  
Community-based adherence support should be targeted to reach medically- and 
socially-vulnerable ART interrupters who do not have family and kinship networks. 
Patients who need it most are usually not part of community support groups. 
Community-based tracing is highly accepted and demanded both by professional 
health workers and patients. However, the study results suggest that community-based 
tracing should be, firstly, initiated at an early stage after a missed appointment, and 
secondly, targeted to patients considered medically and socially vulnerable. It appears 
that patient tracing is most feasible, efficient and effective in a decentralized ART 
programme. Local health facilities are in a better position to identify interrupters than 
hospitals because they oversee fewer patients and because the health personnel and 
community workers often know them personally. Interrupters can be promptly and 
easily identified provided the facility uses an appointment system; tracing can be 
organised through existing working relationships between professional health staff and 
mobile community health workers on bicycles.  
7.7.5 Strengths and weaknesses 
Most qualitative studies on ART retention have explored reasons for therapy 
interruption. The major strength of this study was its focus on patients who restarted 
ART after interruption. Our focus on patients who interrupted ART allowed 
documentation of lived experience of therapy disruption. The approach to reconstruct 
case stories contributed to a better understanding of failed retention in the context of 
the treatment career and the immediate social environment of the patient. The team-
work with Zimbabwean researchers and translators allowed me to get insights into 
cultural concepts around HIV and ART. The interviews with patients and relatives and 
the focus group discussions were conducted in Shona, and the English transcripts 
were discussed with the translator and with a third Shona-speaking person who was in 
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charge of checking the quality of the transcript. Geographical clustering and combing 
methods and techniques were an additional strength of the study. Rather than 
sampling individual cases in a large geographical area, the focus on four study sites 
allowed a deeper familiarisation by the study team with the local environment, the 
social networks and the everyday lives of patients and health workers in the health 
facilities. Interviewing not only the patient, but one or two close relatives allowed 
reconstructing the narrative on the basis of perceptions from different angles. 
Interviews, focus group discussions and participant observation were conducted at the 
same four geographically-limited study areas. Hence, the study team members were 
able to link accounts collected across the three methods with each other, and to frame 
individual statements in the local context. The perceptions of partners and relatives 
added valuable insights into contextual circumstances under which the interrupter 
cases managed or failed to restart ART. Focus group discussions and participant 
observation served to validate and critically discuss themes and concepts that emerged 
from the cases.  
There were inconsistent or even conflicting responses related to some cases and 
themes. For example, good health was in some cases a barrier to and in other cases a 
facilitator for ART restart after interruption. Support groups were considered 
instrumental for some patients and inaccessible for others. Treatment interruption was 
an issue of attitude and moral failure in the view of some health workers, and a 
consequence of poverty for others. Interviews bear the major weakness of self-
reporting. I did not aim at reconstructing an “objective truth” to why exactly the patients 
interrupted and restarted ART. Putting the participants’ responses in the context of their 
own history of ART or role in the ART programme often helped resolving 
inconsistencies. In the case of Nashe, for example, there were a number of parallel 
narratives as to why he did not return to ART after coming back from South Africa. His 
nurse suspected an issue with his family in-law, his counsellor found he had a 
negligent attitude on life, his wife said he was depressed, and he himself claimed he 
did not want to spend his family’s money for transport to the hospital. Interviews do not 
reveal how things are in the real world, but they reflect how people talk and think about 
things. I tried to resolve inconsistent responses by reconstructing the history and the 
context that might have influenced the participants’ perception of ART interruption and 
restart. Nashe’s health seeking behaviour was clearly shaped by his migration history 
and the feelings of shame and guilt related to his failure as bread winner. His 
counsellor’s view on Nashe’s “irresponsible behaviour”, on the other hand, reflected a 
general pattern of some health workers judgemental views on patients who did not 
adhere to their instructions.  
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There are a number of limitations to the qualitative study findings. Given the restricted 
geographical area of the study, the generalizability of the study is limited. The specific 
social and economic circumstances in rural Zimbabwe and the characteristics of the 
health system and ART programme in Zaka and Bikita do not allow the transfer of the 
findings to other settings. It would have been advantageous to choose a comparative 
design, for example by selecting two distinct districts. Comparing qualitative data from 
the two neighbouring districts Zaka and Bikita under the same ART programme did not 
provide any relevant insights. Furthermore, the patient cases were analysed in 
retrospect. As lived experience is critical to better understand ART restart after 
interruption, it would have been beneficial to undertake a prospective qualitative study. 
Patients were only interviewed once. In a prospective design, the five interrupters who 
had stopped ART at the time of the interview could have been followed-up for a certain 
period and interviewed several times. On the one hand, this might have deepened 
insights; on the other hand, this approach would have raised ethical concerns if no 
action had been taken to help those whose disengagement from care posed a threat to 
their health. In a number of cases, it was thanks to the intervention of the study team 
that the participant resumed ART. In two cases, I learnt that the participants died a few 
months after the interview. Whilst following-up these cases, I might have had to assist 
the participant to access life-saving hospital care.  
I conducted large parts of the data analysis on my own after returning to Europe. Whilst 
coding was partly done in collaboration with study team members, the analytical 
framework was not established by multiple researchers. Involvement of other 
researcher in the analysis might have strengthened the credibility of the study findings.    
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8 Discussion and conclusions 
I chose a mixed-methods study design to explore the magnitude and the underlying 
reasons of ART programme attrition in a rural setting in Zimbabwe. This final chapter 
presents a discussion of the integrated qualitative and quantitative findings (8.1) and of 
the strengths and weaknesses of the study (8.2). The thesis ends with a reflective 
commentary (section 8.3) and with recommendations on programming and research 
(section 8.4). 
 
8.1 Discussion of main findings 
A synthesis of the quantitative and qualitative research resulted in three overall study 
findings that are presented in this section: firstly, ART re-engagement after interruption 
is a key to long-term retention; secondly, early tracing of vulnerable interrupters could 
reduce mortality on ART; and thirdly, retention has improved over calendar time, 
possibly thanks to earlier therapy initiation and to decentralisation of ART provision. 
The mixed-methods integration matrix below (table 8-1) shows how the findings of the 
quantitative and qualitative components were integrated in the course of data analysis: 
results of each component were translated into questions to be explored by the 
complementary component, as indicated by the arrows. 
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Table 8-1: Mixed-methods integration matrix 
Quantitative findings Emerging questions for complementary 
investigation 
Qualitative findings 
75% retention 3 years after ART 
initiation 
What were the reasons for good 
retention? 
 strong motivation to adhere to drugs and appointments 
district ART programme supported by NGO project (SMART) 
12-months retention increased from 
77% (2006 cohort) to 85% (2010 
cohort) 
median CD4 baseline increased from 
55 (2006 cohort) to 151 (2010 cohort) 
Besides the fact that patients 
initiate ART earlier, what were 
the reasons for improved 
retention over time? 
 SMART gradually strengthened supportive interventions at 
health facility level (decentralised ART provision) and 
community level (CHASA programme and tracing) 
86% tracing coverage 
62% traced by professional health 
workers, 38% by community health 
workers 
median time between missed 
appointment and tracing 461 days 
How was tracing performed by 
SMART and perceived by the 
involved parties? How did 
monetary incentive influence 
tracing performance?  
 tracing feasible and well accepted by patients and health 
workers 
time of tracing perceived too late 
high numbers of patients traced by professional health 
workers on motorbike when tracing was incentivised  
community health workers took over tracing on bicycles after 
monetary incentives were ceased 
17% LFU incorrect due to 
documentation errors 
What are the causes and 
consequences of erroneous 
losses? 
 high patient workload, chaotic organisation and management 
failures at hospital level caused missing and erroneous 
recording by ART nurses 
tracers blamed by misclassified ART patients for suspecting 
them to be “defaulters” 
62% LFU found to be dead; only 4% 
found alive  
mortality 1.8 times higher than officially 
reported 
64% early mortality (during first 6 
months of ART)  
baseline characteristics: 73% WHO 
stage III or IV, median CD4 of 149; 
19.5% on tuberculosis treatment 
How do patients and health 
workers perceive and explain 
death on ART?  
What was the role of health 
status in interruption and restart? 
 health workers and patients perceived death as a result of late 
testing and ART initiation 
tracers perceived death as a consequence of non-adherence 
and ART interruption  
deteriorating health after interruption perceived as a dominant 
reason why patients restarted ART, wives and family playing a 
facilitating role 
tuberculosis perceived a major obstacle for retention 
local health centres know their patients and are better 
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informed about event of and reasons for losses or deaths than 
hospitals 
30% moved away without reporting 
transfer moved 
Why do people not obtain an 
official transfer letter? 
 local health centres not issuing transfer letters 
patients reluctant to attend hospital consultation to obtain 
transfer letters 
national ART programme not harmonized 
54% deaths before, 46% after last 
scheduled appointment 
47% of deaths after interruption 
occurred within 30 days 
 How large is the 
time window for 
tracing between 
missing an ART 
appointment and 
death? 
patients’ health deteriorated after treatment interruption 
patient tracing for ART restart was well accepted by health 
workers and patients 
43% patients interrupted ART for more 
than 7 days at least once 
 How common are 
treatment 
interruptions? 
main reasons for treatment interruption: women hiding their 
HIV status to their partners, religious authorities discouraging 
patients from ART, and missing an ART appointment due to 
travel 
early interruptions occurred due to failed initiation, caused by 
illness, including mental and psychological conditions 
52% interrupters resumed ART 
(median interruption of 32 days), 48% 
did not 
 What proportion 
of interrupters 
restarted ART 
and what is the 
average length of 
interruption?  
temporary ART interruption turned into prolonged 
disengagement from ART due to lack of safety net in social 
environment and disconnection from health system, caused by 
high transport costs and negative attitudes by health workers 
on “defaulting” 
restart after interruption was facilitated by family and kinship 
networks and a supportive health system, such as good 
patient-health worker relationship, local access to ART, and 
physical tracing 
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8.1.1 Return after interruption key for improved retention 
More than one out of four retained patients had a treatment gap of at least seven days. 
Given the frequent incidence of temporary ART interruption in the SMART programme, 
the question to understand long-term retention is not just why patients interrupt, but, 
even more importantly, under what circumstances they restart ART.  
Stopping ART cannot be interpreted as a lack of adherence motivation. Our qualitative 
findings rather suggest that patients are confronted with social and cultural conflicts in 
their immediate family, kinship and community environment which are so powerful that 
they are prepared to put their health and, ultimately, their lives at risk. Two main 
reasons for therapy interruption were women hiding their HIV status from their partners, 
and religious authorities discouraging patients from taking ART. ART interruption 
appeared as a symptom of deep gender conflict and the influence of the Apostolic 
Church in Zimbabwean society. Patients also interrupted ART because they missed an 
ART appointment due to unexpectedly prolonged travel or due to migrating away from 
the ART initiation site. Like all Zimbabweans, ART patients are mobile. 8% of all 
enrolled SMART patients moved away from where they initiated therapy, many of them 
without a formal transfer to another clinic and thus classified as losses to follow-up. In 
what appears to be a fragmented national ART programme with weak links between 
ART sites, moving from one site to the other bears the risk of treatment interruption. 
Our case studies show that in a new social environment, patients can have great 
difficulties to undergo a new process of disclosing their HIV status. If the health system 
does not facilitate a smooth transfer from one site to another, the patient can fail to 
reconnect to the ART programme. A harmonized information system would not only 
reduce the proportion of silent transfers, but could ultimately contribute to improved 
retention. Providing patients with a reserve supply of ART drugs for an extra month 
would be another measure to prevent treatment interruptions.   
ART restart after interruption has been a neglected phenomenon in previous retention 
studies. With a temporary therapy interruption, ART patients enter a period of 
vulnerability. According to our quantitative data, around half of the interrupters returned 
to care after a median interruption of 32 days, whilst the other half permanently 
disengaged from ART. In the setting of our study, as an ART interrupter, the patient’s 
capacity to determine his or her treatment career is constrained by numerous factors in 
the patient’s environment. Merten (2010) characterised ART adherence as the 
outcome of the patient’s permanent evaluation of beneficial versus harmful effects of 
adhering to ART drugs and appointments, balancing out medical, moral and social 
imperatives in his or her environment. After therapy interruption, this struggle is 
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aggravated and becomes existential. Temporary interruption became prolonged 
disengagement from ART predominantly if patients became ill and lacked a safety net 
in marriage, family or kinship. In rural sub-Saharan Africa, family and kinship networks 
are the paramount safety network, substituting non-existent governmental social 
welfare and security, as pointed out by sociological and anthropological studies, such 
as Zagheni (2011) and Parsons (2012) on kinship resources for orphan care in 
Zimbabwe and Mattes (2011) and Nguyen (2007) on the conflicting value to the 
individual between biomedicine and a kinship-based social organisation. Besides the 
lack of social capital, ART interrupters remained disconnected from the health system 
for two main reasons rooted in the health system itself: firstly, distances were too long 
and opportunity costs for transport too high to undergo the ART re-initiation procedures 
at the district hospital; and secondly, ART interrupters did not return to the ART clinic 
because they feared being blamed as “defaulters” by health workers. Shame about 
“defaulting” caused by negative attitudes of health workers about patients who did not 
adhere to ART appointments was a strong and frequent pattern of conflict between 
patients and health workers.  
Having a partner, female sex, older age and less than 6 months ART interruption were 
identified as factors associated with ART restart in studies from Uganda (Mills, 2013) 
and South Africa (Kranzer, 2010). We found three major facilitators for ART restart 
after interruption: access to ART at the local health facility; a trusting and stable 
patient-health worker relationship; and early physical tracing after missing an 
appointment. Given the fact that therapy gaps are inevitable, a better understanding of 
the facilitators of and barriers to ART restart will be crucial to improve retention.  
8.1.2 Mortality on ART: the need for early tracing 
Two thirds of the patients who dropped out of the SMART programme were classified 
as losses to follow-up, their treatment outcome remaining unknown. Only after tracing 
the lost patients at their homes, SMART found that death was the major reason for 
programme attrition. Tracing revealed that deaths were 1.8 times more frequent than 
initially reported by the programme, accounting for 76% of all patients who had 
dropped out of the programme after three years. 45% of all deaths were unreported, 
their causes unknown. The magnitude of hidden deaths raised the question who these 
patients were and under what circumstances they died. Comparing unreported with 
reported deaths showed that patients whose death was not reported were on ART for a 
shorter period of time and were more likely to be female. Of note, deaths were more 
likely to remain hidden if they occurred after the patient had missed his or her ART 
appointment. Half of the deaths occurred before the patient missed his or her ART 
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appointment. Whilst these deaths occurred as the patient was theoretically still in 
possession of ART drugs, the other half of deaths occurred after missing an ART 
appointment. This temporal aspect of death on ART has not been investigated by 
programmes and research so far, probably due to the fact that the date of unreported 
deaths usually remains unknown, unless ART data is matched with death register data. 
Both our quantitative and qualitative findings suggest that early tracing of vulnerable 
ART interrupters could improve retention. Yet, tracing after the 90 days threshold is too 
late: half of the deaths after interruption occurred within 30 days. The SMART tracing 
intervention, therefore, did not improve retention: only 4% of the lost patients were 
found alive; four of them participated as cases in the qualitative study component. 
Professional and community health workers considered tracing of losses after 90 days 
as ineffective and frustrating. 
The qualitative study findings suggest that early tracing of vulnerable ART interrupters 
could reduce mortality and, thus, attrition from ART. Research on ART patient tracing 
in Malawi (Tweya, 2010) and Kenya (Thomson, 2011) and from a systematic review 
(McMahon, 2013) showed a high proportion of patients restarting ART after tracing and 
an overall improvement of retention in ART programmes with tracing compared to 
programmes without tracing. However, the cited programmes were substantially 
supported by NGOs and research projects, and their outcomes thus not necessarily 
transferable to resource-poor public ART programmes. As physical tracing of ART 
interrupters is a potentially costly undertaking, ART programmes need to target tracing 
to medically and socially vulnerable patients. The fact that most of the deaths after ART 
interruption were not reported to the health facility suggests that social isolation and 
disconnection from the health system might have played a role why these patients did 
not restart ART. A lack of partner and family support is clearly a key warning indicator 
for attrition after interruption.   
Our qualitative results suggest that local health centre nurses know their patients better 
than hospital nurses, and are better and earlier informed about losses or deaths. 
Physical tracing was a successful intervention of SMART to improve the accuracy of 
assignment of ART outcomes and to update the electronic patient database. The 
present study showed that tracing is feasible and can be implemented at relatively low 
cost. The qualitative research also showed that physical tracing is well accepted both 
by patients and health workers, as long as the tracers are trained and supervised by 
the local health centre nurse, and that the patient’s confidentiality is protected. The 
qualitative enquiry found that early tracing is most feasible in a decentralised setting 
where health workers and patients knew each other and patient numbers allowed to 
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quickly identify interrupters on the basis of a well-kept appointment book. As shown in 
the systematic review by Wouters (2012), lay community health providers have 
contributed to increased coverage of ART programmes, adding extra human resources 
to overwhelmed health systems. Recent large-size observational studies such as Lamb 
(2012) and Fatti (2012) confirmed earlier findings of a cluster-randomized trial from 
Uganda that showed substantial retention gains in programmes with community-based 
adherence support (Chang, 2010). Our study showed that actors who are familiar with 
their local community, like the CHASA, can incorporate physical tracing of ART 
interrupters into their broader sensitization and adherence support activities.  
Whilst tracing could potentially provide a safety net for vulnerable interrupters, it also 
serves to improved quality of patient data management and programme monitoring. 
Our study revealed that 17% of patients who were classified lost to follow-up in the 
medical records were not genuinely losses. Participant observation at the two hospitals 
in Zaka and Bikita showed that high patient workload, chaotic organisation of patient 
flow and medical records, as well as failures in human resources management in the 
ART departments, caused missing and erroneous recording by ART nurses led to 
misclassification of retained patients as lost to follow-up. Nonetheless, the SMART 
electronic patient database contributed to substantial data quality improvements, since 
SMART data clerks continually verified whether medical records were consistent and 
complete before capturing the data electronically. ART nurses confirmed that the 
tracing intervention was a major data cleaning and updating exercise. The findings on 
medical record keeping confirm earlier research on electronic medical record systems. 
Like most national ART programmes in sub-Saharan Africa, ART records are kept in 
paper-based systems. NGO projects like SMART introduced their own electronic 
system which has led to what Forster (2008) called “antiretroviral database anarchy”, 
lacking data uniformity and standardized ART outcome categories. As the authors 
found in their review, electronic ART databases contribute to reduced losses to follow-
up, especially if they are accompanied by patient tracing and checking of death registry 
data.  
8.1.3 Improving retention over time 
With 75% of the enrolled ART patients retained at 36 months, the SMART partnership 
achieved better outcomes than similar programmes in Zimbabwe and in the region, 
such as for example a large government ART programme in South Africa, reporting a 
36-month retention proportion of 64% (Cornell, 2010b). In the existing retention 
literature, there is no clear trend in retention on ART over recent years. Some studies 
report improving retention (Fox, 2012), other studies report increasing attrition 
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(Mutevedzi, 2013). In the case of SMART, 12-month retention has improved from 77% 
in the 2006 cohort to 85% in the 2010 cohort. The findings suggest two major reasons 
for this trend. Firstly, patients initiated ART earlier over time, as the increase of the 
median CD4 baseline from 55 (2006 cohort) to 151 (2011 cohort) among all enrolled 
patients shows. Secondly, SMART gradually decentralised the supportive interventions 
from hospitals to rural health centre and to the community level. Confirming growing 
evidence from other studies, such as Fatti (2010) and Long (2011), our findings 
suggest that besides the fact that patients initiate ART earlier, decentralisation of ART 
provision has contributed a lot to improved ART outcomes in the SMART programme. 
ART provision at the local health centre can serve as a critical safety net for 
interrupters who lack economic and social capital to restart therapy.  
Earlier qualitative research, such as Nam (2008), Ware (2009) and Merten (2010) 
showed that ART patients in sub-Saharan Africa are highly motivated to adhere to ART 
drugs and appointments. This study confirms that in spite of competing interests and 
high opportunity costs in their immediate social environments, ART patients commonly 
manage to stay on ART or to restart after a temporary interruption. The SMART 
programme demonstrates the resilience of ART patients even during a severe 
economic and humanitarian crisis. Our cohort analysis shows that patients who 
initiated ART in 2009 during political turmoil, hyperinflation, epidemic outbreaks and a 
breakdown of public infrastructure, were only slightly more likely to drop out of care. 
 
8.2 Strengths and limitations 
The methodological strengths and weaknesses of the quantitative and qualitative study 
components were discussed separately in sections 6.3.6 and 7.7.8. In addition, our 
study had a number of strengths and limitations with regard to the overall mixed-
methods approach. 
8.2.1 Strengths 
This research project was one of the rare mixed-methods studies on ART retention in 
sub-Saharan Africa. The literature on quantitative research on retention is vast, and 
there is also a rich body of qualitative literature on adherence to ART, including a 
research project on social capital and HIV/AIDS in Zimbabwe (Campbell, 2011b). Yet, 
as shown in the literature review, we only found one mixed-methods retention study 
from sub-Saharan Africa (Miller, 2010), investigating a relatively small cohort (n=528). 
In our study, we were able to offer more comprehensive insights into ART retention 
than if we had focused on a solely quantitative or qualitative approach. Our cohort was 
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comparatively large (n=8425) and, owing to a cluster sampling strategy and multiple 
interviews concerning single cases, we consider our qualitative data saturated. 
Researching across and between the two methods allowed us to translate results from 
one component into new research questions for the complementary component. We 
explored the quantitative and qualitative data concurrently, allowing integration of the 
findings. As shown in table 8-1, quantitative findings raised new research questions 
that were subsequently explored in the qualitative data analysis. At the same time, 
emerging qualitative findings led to additional quantitative queries that had not been 
foreseen in the study protocol.  
The multidisciplinary composition of the study team was probably the most important 
asset of the mixed-methods approach. Sampling strategy, recruitment of study 
participants and reconstruction of the case stories were discussed between social 
science researchers, programme managers, community facilitators, data officers and 
health workers. At a workshop towards the end of field work, the team members 
presented and discussed their personal analysis and interpretation of the collected 
data. I incorporated my notes on the workshop discussion as valuable extra information 
into the qualitative data set. Even though mainly informally (see limitations below), the 
study team was the driver of the interactions between the qualitative and quantitative 
research components, and eventually, of the integrated findings.  
Another strength of the study was its operational research design. As described in 
chapter 5, SMART supported the existing government ART programme without adding 
parallel ART services. As an operational study embedded into the public ART 
programme, we investigated ART retention under “real world” conditions. The ART 
programme managers had initiated the tracing intervention to address loss to follow-up 
which they considered a growing concern. The three parties – the government ART 
programme, the NGO support project SMART, and the research project – agreed to 
implement the intervention as a learning exercise and defined a strict division of roles: 
SMART developed the tracing scheme and provided the extra funds, the government 
programme implemented the intervention, and the research team observed the process 
and analysed the outcomes of the intervention. Since the programme managers were 
involved in developing the research questions, this study was able to bridge the often 
cited gap between research and practice (Zachariah, 2009). Moreover, the operational 
research approach worked well in this study thanks to a functioning programme 
monitoring scheme. Without the SMART patient data base providing good quality 
cohort data, this study would not have been possible. 
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8.2.2 Limitations 
The study did not exploit the full potential of the mixed-methods approach. As 
O'Cathain (2010) pointed out, mixed-methods studies are often carried out as two 
separate studies. The lack of interaction and conversation between the qualitative and 
quantitative components often limits the additional knowledge that could be generated 
through the combined approach. Integration of the quantitative and qualitative study 
components was not systematically established in the study protocol. During data 
collection in the field, the two study components were not formally interlinked; 
integration was rather performed through informal interactions in the study team, as 
mentioned above. A reason for the lack of formal integration during data collection was 
that we did not collect primary quantitative data. Data collection in the quantitative 
component was largely cleaning, preparing and linking of electronic secondary data 
provided by the SMART programme. Integration was also limited during data analysis 
because I largely analysed the data sets on my own only after returning from field work. 
There are limitations with regard to the generalizability of the study findings. Two faith-
based district hospitals were the backbone of the ART programmes in Zaka and Bikita. 
As explained in chapter 5, faith-based hospitals in Zimbabwe benefit from additional 
resources for infrastructure, equipment and personnel, compared with government 
district hospitals. The ART programme in the study area did not only benefit from 
moderate NGO support through the SMART project, it also benefitted from the long-
standing partnership between the two mission hospitals with foreign health 
organisations and donors, such as SolidarMed, which have regularly provided 
physicians to fill vacant positions. The study findings on retention, loss to follow-up and 
death are therefore not generalizable for the rest of Zimbabwe, but can serve as 
benchmark, since the support has been moderate and SolidarMed, in contrast to other 
NGOs, has supported existing public services and not established its own ART 
services. However, the high proportion of deaths amongst patients classified lost to 
follow-up is with no doubt generalizable to other areas of Zimbabwe and probably to 
other countries in the region, as well as the need for early tracing. A number of locally 
specific factors made patients interrupted ART, for example, the influence of the local 
Apostolic Church or the degree of ART decentralisation in a given district. As 
mentioned before, ART is not a uniform programme in Zimbabwe. The capacities of the 
local health system strongly influence the performance and outcomes of vertical 
programmes, such as ART. Whilst reasons for ART interruption are to large parts 
influenced by the local context, I argue that the main study finding on the medical and 
social vulnerability of ART interrupters, hinting at the need of targeted early tracing, are 
generalizable to other ART programmes in Zimbabwe and the region.  
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8.3 Reflective commentary 
Conducting this study was a balancing act in two ways: between research and 
implementation on the one hand and between the quantitative and qualitative 
paradigms of social science on the other hand. What I experienced as the biggest 
challenge in mixed-methods research was the fact that quantitative and qualitative 
research approaches were not just two different methods, but represent two different 
epistemological paradigms: the positivist and the interpretative paradigm (Ulin, 2005). 
Researching across the methodological boundaries, I occasionally found myself 
“between and betwixt” two positions (a status referred to as being neither here nor 
there in cultural anthropology). Whilst the positivist world view takes the assumption 
that there is an objective truth out there which can be described and analysed by a 
researcher who is independent of his research topic, the interpretative model conceives 
the social world as constructed and interpreted by the observer, who perceives the 
world from his subjective perspective. In the positivist paradigm, the researcher is 
neutral and does not impact on the world he is observing. In the interpretative 
paradigm, the researcher’s presence influences the research process; his or her 
perspective and interest inevitably shapes the research subject and the study findings. 
The world of social science has been polarised between the two approaches to an 
extent that some researchers argue the two paradigms were incompatible (ibid.). In my 
role as Principal Investigator and study team leader, I was not supposed to advocate 
for one of the two world views. During field work, I was wearing the interpretative hat of 
the anthropologist, in meetings with the hospital data clerks and the study statistician, I 
took the role of an epidemiologist. I believe that mixed-methods is a powerful approach 
because it stimulates the researcher to think out of the box and to critically reflect the 
research findings in the light of the two paradigms. Provided there are sufficient 
technical and methodological skills from both approaches in a study team allowing 
good quality quantitative and qualitative research, I would argue that mixed-methods is 
probably the most appropriate design for implementation research, since real world 
interventions require both a clear picture on both the magnitude and a holistic 
understanding of public health problems.    
The question to what extent my own role as previous programme manager “biased” the 
research findings, is problematic. In quantitative research, bias represents a systematic 
error in the measurement, for example in the way data was collected, causing a 
deviation of a measured value from the “true” value, whilst the interpretative paradigm 
rejects the assumption of an objective truth. In the qualitative research process, the 
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subjective patterns of perceiving, thinking and interpreting by the study team members 
obviously influenced the flow and outcomes of the interviews, focus groups discussions 
and participant observation. In qualitative research, the fact that different researchers 
might have come to different results does not necessarily mean that the qualitative 
results are not reliable. As Ulin (2005) suggest, the quality of qualitative research 
should be assessed rather by the “dependability” than “reliability” of the findings. In 
qualitative research, the question is not if the findings but rather if the research 
procedures can be replicated, if the pathway from data collection to analysis and 
interpretation was consistent and transparent, and if interpretations were critically 
discussed between researchers (ibid.) – quality criteria which I consider were met in 
this study.    
Following the interpretative paradigm of social science, I believe that there is no 
“objective truth” in the social world, and that researchers cannot take an “external” view 
on their research subject. I understand that research is always influenced by the 
researcher’s perceptions, values and interpretations. The research interest, the 
theoretical approach, and the choice of methods are always influenced by individual 
preferences, the status, and even by the personal background of the researcher. Many 
journals require the researchers to declare any conflict of interest that might have 
influenced their research findings. Whilst “no conflict of interest” suggests that the 
researcher had an objective view on the topic, I guess the researcher’s scientific 
description, analysis and interpretation of the world was still influenced by his or her 
personal perspective. A critical reflection of my own role in the present study is 
therefore needed to strengthen the credibility and accountability of the research 
findings.  
As mentioned in the introduction, I had been SolidarMed programme manager before 
entering the Doctor of Public Health programme. The commitment to equitable access 
to HIV care was an important value when I contributed to the development of the 
SMART programme. From an early stage of the SMART programme, I advocated for 
decentralised ART provision, task shifting and community participation – such as the 
CHASA programme – which I thought were appropriate strategies to tackle access 
barriers related to high transportation costs and shortage of qualified staff. To what 
extent ART should be provided by nurses instead of doctors and by health centres 
instead of hospitals, and whether or not community health workers should be included 
were issues passionately debated in the SMART programme. Medical doctors and 
government health officials were concerned about the quality of care if ART was 
provided by unskilled personnel and the risk to confidentiality if patient information was 
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shared with non-professionals for the purpose of adherence counselling and tracing. I 
was convinced that the public health and equity gains of decentralised ART provision 
would outweigh the potential losses caused by the absence of medical and laboratory 
treatment monitoring. Yet, advocating for evidence-based programming, I switched 
from implementation to research to investigate if the SMART partnership in Zimbabwe 
was on the right track. 
Practice Theory, as outlined in section 7.1, was the underlying conceptual framework of 
the study, influencing the methodology and analysis of the qualitative study component. 
The study findings confirm that ART retention is influenced by the interplay of “agency” 
and “structure”. Our study shows that ART patients who interrupt their therapy are 
generally highly motivated to return to care. In the event of a treatment interruption, 
when patients become medically and socially vulnerable, structural barriers prevail and 
the patients’ capacity to determine their own action deteriorates. During this critical 
passage of an unstructured therapy interruption, we found family and kinship networks 
to be the key intermediate domain between agency and structure, providing a safety 
net to the patient. Our findings suggest that the most vulnerable patients who would be 
most in need do not benefit from community support. Vulnerable and isolated ART 
interrupters do not have access to HIV/AIDS support groups. This aspect confirms that 
social capital gains require previous investments in social relationships. Yet, being 
socially excluded is exactly what makes ART interrupters vulnerable to prolonged 
therapy discontinuation, for example in the case of women hiding their HIV status to 
their partners and in-laws or migrants living separated from their parental family. As 
descent-based relationships require less social capital investment than community-
based ties, they can be considered the last resort for ART interrupters to regain 
agency, especially as therapy interruption continuous and the patient’s health 
deteriorates. As the patient’s self-determination and resilience decline, he or she 
becomes dependent on structural forces, in our case the health system. Practice theory 
contributed a comprehensive conceptual framework to this study that guided us to 
equally explore individual and structural influences on retention on ART.   
 
8.4 Recommendations for programming and research 
On the basis of the results of this study, the following interventions to improve retention 
are recommended to the Zimbabwean ART programme and NGO support projects, 
such as SMART: 
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1. Decentralise provision of the full package of ART and tuberculosis treatment from 
hospitals to primary health care facilities, including CD4 cell count, pre-ART 
adherence consultations, treatment initiation, and follow-up.  
2. Simplify ART initiation procedures and reduce referrals to prevent early losses.  
3. Prevent early mortality through active screening for tuberculosis prior to ART 
initiation, and through early tracing of patients in an advanced stage of the 
infection, especially during the first six months after initiation. 
4. Roll-out community-based adherence support including early tracing focusing on 
medically- and socially-vulnerable ART patients by well trained, supervised and 
incentivised community health workers to prevent deaths after ART interruption. 
5. Develop the capacities of the health workers at primary health care facilities in such 
a way that they are motivated and skilled to engage in trusting and stable 
relationships with their ART clients, supporting instead of blaming patients in the 
event of a therapy interruption. 
6. Strengthen and harmonize the ART medical record system and simplify transfer 
modalities to allow mobile ART patients to easily access ART drugs at multiple sites 
nation-wide, and to reduce documentation errors leading to false losses to follow-
up. 
Unstructured treatment interruptions have significant public health implications. A better 
understanding of the critical period after ART interruption is required to improve long-
term retention. Further quantitative and qualitative social science research is needed to 
learn more about death on ART, to understand the implications of patients “cycling in 
and out” of ART (Kranzer, 2012), to determine the social indicators of prolonged ART 
interruption, to assess the outcomes of fully decentralised ART provision, and to 
develop cost-effective community-based tracing interventions for medically- and 
socially-vulnerable patients.     
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Appendix 1: Criteria to assess study quality 
For the quantitative studies, I used the following nine quality criteria for critical appraisal 
of observational studies, as proposed by Petticrew and Roberts (2006):  
- description of study participants,  
- similarity of control group and intervention group,  
- description of the intervention,  
- validity and reliability,  
- relevance of the measures,  
- drop-outs in follow-up studies,  
- duration and size of the study,  
- statistical methods,  
- blinding.  
I assessed the qualitative studies using the checklist questions of the licensed Critical 
Appraisal Skills Programme tool (CASP, 2013): 
- Was there a clear statement of the aims of the research? 
- Is a qualitative methodology appropriate? 
- Was the research design appropriate to address the aims of the research? 
- Was the recruitment strategy appropriate to the aim of the research? 
- Was the data collected in a way that addressed the research issue? 
- Has the relationship between the researcher and the participants been adequately 
considered? 
- Have ethical issues been taken into consideration? 
- Was the data analysis sufficiently rigorous? 
- Is there a clear statement of findings? 
- How valuable is the research? 
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Appendix 2: Ethical approval letters 
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OBSERVATIONAL/INTERVENTIONS  
 RESEARCH ETHICS COMMITTEE
 
 
28 March 2012 
 
Thomas Gass 
 
Dear Thomas 
 
Study Title: ART Retention Study Zaka/Bikita: Reasons for non-adherence, 
treatment interruption and loss to follow-up in a decentralized 
antiretroviral treatment program in rural Zimbabwe. A mixed  
methods study 
LSHTM ethics ref: 6140 
Department: Infectious and Tropical Diseases 
  
 
Thank you for your email of 26 March, responding to the Committee’s request for further 
information on the above research and submitting revised documentation. 
 
The further information has been considered on behalf of the Committee by the Chair.  
 
Confirmation of ethical opinion 
 
On behalf of the Committee, I am pleased to confirm a favourable ethical opinion for the above 
research on the basis described in the application form, protocol and supporting documentation 
as revised, subject to the conditions specified below. 
 
Conditions of the favourable opinion 
 
Approval is dependent on local ethical approval having been received, where relevant.   
 
Approved documents 
 
The final list of documents reviewed and approved by the Committee is as follows: 
  
Document    Version    Date      
LSHTM ethics application  n/a    
Protocol V1.0 13/02/12   
Information Sheet V1.0 13/02/12   
Consent form  V1.0 13/02/12   
 
After ethical review 
 
Any subsequent changes to the application must be submitted to the Committee via an E2 
amendment form.    
 
Yours sincerely, 
 
Professor Andrew J Hall 
Chair 
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Appendix 3: SMART patient data base 
(screenshot) 
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Appendix 4: SMART patient tracing form 
 
ART Client Tracing Form (CTF)
1 Type of tracing F □ Field tracing P □ Phone tracing
2 Name / Function patient tracer
3 Date of tracing 
Patient Information
4 Sex M □ Male F □ Female
5 Date of birth
6 Ward / Villlage
7 Date ART started
8 Date of last ART visit
9 Facility name of the last ART visit
10 Last appointment date
11 Nearest rural health clinic
Tracing Results
12 □ Patient found (one answer possible from a to f)
a □ Patient refusing to answ er
b □ Patient w as initiated but never started taking ARVs
c □ Patient is on ART Last visit date: 
d □ Patient is on ART, off icial transfer out Specify site:
e □ Patient is on ART, silent transfer out Specify site:
f □ Patient stopped ART
13 If patient stopped ART, reason(s) for stopping ART (multiple answers possible)
a □ Illness / symptoms Specify:
b □ Transport costs (bus fare, food, etc.)
c □ Treatment costs (lab, drugs, fees)
d □ Religious belief 
e □ Preferring not to disclose HIV status 
f □ Pregnancy / Breast feeding
g □ Doctor's decision (off icial stop)
h □ Belief that ARVs do not w ork
i □ Drugs out of stock
j □ Health w orker behaviour
k □ Household / Family / Partner not supportive 
l □ Employer not supportive
m □ Travel / Migration
n □ Other reason Specify:
14 □ Patient not found
15 Source of information (e.g. Family member, etc.)
16 □ Patient is not know n
17 □ Patient died, specify date of death
18 □ Patient moved aw ay
a □ Out of village Specify w here:
b □ Out of district Specify w here:
c □ Out of the country Specify w here:
19 □ Status reported post tracing Date of  reporting:
20 □ Patient re-started ART Date of  re-start:
21 □ Reported transfer out Date of  transfer out:
22 □ Reported death Date of  death:
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Appendix 5: Participant Information Sheets & 
Informed Consent Forms 
 
London School of Hygiene & Tropical Medicine 
Keppel Street, London, WC1E 7HT, United Kingdom 
 
 
 
 
INFORMATION SHEET FOR HEALTH WORKERS 
STUDY TITLE 
Reasons for non-adherence, treatment interruption and loss to follow-up in a 
decentralized antiretroviral treatment program in rural Zimbabwe. A mixed methods 
study. 
INVESTIGATOR 
Thomas Gass 
INSTITUTION 
London School of Hygiene and Tropical Medicine 
CONTACT 
Email: thomas.gass@lshtm.ac.uk 
 
 
1. INTRODUCTION 
My name is Thomas Gass, I am a researcher of the London School of Hygiene and Tropical Medicine. 
I would like to invite you to participate in my research study. The question of my study is: What are 
the reasons of ART patients in Zaka and Bikita to interrupt or stop the therapy? Before you agree to 
participate, it is important that you read and understand the following explanations on this study. 
This information sheet is to help you decide if you would like to participate. You are entirely free to 
decide whether you would like to take part or not. 
− You should fully understand and be satisfied with the procedures before you agree to take part 
in this study.  
− If you have any questions, do not hesitate to ask me.  
− If you decide to take part in this study, we will ask you to sign this document (consent form) to 
confirm that you understand the study.  
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− It is your right to withdraw from the study at any time and with no explanation.  
 
2. PURPOSE OF THE STUDY 
I am undertaking this study to obtain a scientific degree at the University of London. The results of 
the study will help the hospitals and clinics of Zaka and Bikita to improve the ART program in such a 
way that as many ART patients as possible can be retained on therapy. 
3. LENGTH OF THE STUDY AND NUMBER OF PARTICIPANTS 
My research in Zaka and Bikita district lasts from February until June 2012. The study includes 
interviews with 15 health workers who are involved in the delivery of ART services. I will also 
conduct  interviews with ART patients, conduct group discussions and analyze computerized, 
anonymous data of about 8000 patients at the hospital. 
4. PROCEDURES 
If you agree to take part in this study, I will ask you to sign a consent form to be interviewed. If you 
are willing to take part but unable to be interviewed at this time, we will arrange an appointment at 
a later date.  
In the interview, I would like to ask you about your experiences and opinions regarding 
- your every day activities and workload with ART patients; 
- the strengths and weaknesses how the ART programme is organized; 
- the management of opportunistic infections, including TB; 
- ART initiation and follow-up consultation; 
- the ARV drugs and their effects on the health and wellbeing of patients; 
- side effects of ART; 
- adherence and how patients manage to stay on ART; 
- why some patients do not manage to adhere; 
- ways to improve adherence and retention. 
 
The Interview will be face to face and take between one and two hours. It will take place in a private 
or professional setting of your choice. 
If you are willing, I am going to audio-tape the interview. This will help me remember and verify 
particularly interesting aspects you mentioned during the interview. In addition I will take notes on 
paper. Your name and contact details will not be included on any audiotape or notes, instead a study 
code, unique to you will be used. 
5. CONFIDENTIALITY 
All information obtained during the course of this study, including personal data and research data 
(transcripts and notes) will be kept strictly confidential.  
Your name will not be included on any audiotape or notes, instead a study code, unique to you will 
be used. 
Your name and study number will be kept in a separate notebook which will be stored securely and 
separately from other data. 
In this type of study it is helpful to quote in reports some of the exact things people have said in the 
interview, and we would like your permission do this. 
  173 
Data from this study that may be reported in scientific journals or reports will not include any 
information that identifies you. 
Data will be kept for at least six years after the study is finished for possible checking or further 
analysis. It will then be destroyed. 
6. RISKS OF TAKING PART 
Being involved in this study should not involve any physical, psychological or professional harm for 
you. If there are any questions you do not want to answer, it is ok not to answer them.  
7. BENEFITS OF TAKING PART 
There will be no other direct benefit for you. However, the results of this study will be shared with 
the health authorities, the hospitals and the clinics of Bikita and Zaka district. I will include 
recommendations into my report how the ART could be improved so that all patients can be 
retained on ART. 
8. ETHICAL APPROVAL 
This study was approved by the Medical Research Council of Zimbabwe. Contact: Medical Research 
Council of Zimbabwe. P O Box CY573 Causeway, Harare Zimbabwe Phone: +263-4-791792. 
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MRCZ No. ….................... 
INFORMED CONSENT FORM □□ 
AUTHORIZATION YOU ARE MAKING A DECISION WHETHER TO PARTICIPATE OR NOT IN THIS STUDY. 
ENSURE THAT THE INTERVIEWER HAS APPENDED HIS SIGNATURE ON THIS FORM TO INDICATE THAT 
YOU HAVE READ AND UNDERSTOOD THE INFORMATION PROVIDED ABOVE, HAVE HAD ALL YOUR 
QUESTIONS ANSWERED AND HAVE DECIDED TO PARTICIPATE. 
The date of enrolment in this study, that is today's date, MUST fall between the dates indicated on 
the approval stamp affixed to each page. These dates indicate that this form is valid when you enrol 
in the study but do not reflect how long you may participate in the study. Each page of this Informed 
Consent Form is stamped to indicate the form's validity as approved by the MRCZ. 
I have been informed by the researcher Thomas Gass about the nature, conduct, benefit and risks of 
this study. 
I have read the information sheet concerning this study (or have understood the verbal explanation) 
and I understand what will be required of me and what will happen to me if I take part in it. 
My questions concerning this study have been answered. 
I understand that at any time I may withdraw from this study without giving a reason. 
I agree to take part in this study  Yes □  No □   
I agree the discussion to be audio-recorded  Yes □  No □  
I agree for comments I made to be quoted in the study 
report. My identity will not be revealed.   Yes □  No □  
PARTICIPANT 
Printed Name    Signature    Date 
RESEARCHER 
I confirm that the above participant has been fully informed about the nature, conduct and 
risks of the above study. 
Printed Name    Signature    Date  
  
  175 
 
London School of Hygiene & Tropical Medicine 
Keppel Street, London, WC1E 7HT, United Kingdom 
 
 
INFORMATION SHEET FOR HEALTH WORKERS 
 MRCZ No. …........................... 
 
STUDY TITLE Reasons for non-adherence, treatment interruption and loss to follow-up 
in a decentralized antiretroviral treatment program in rural Zimbabwe. A 
mixed methods study. 
INVESTIGATOR:  Thomas Gass 
INSTITUTION:  London School of Hygiene and Tropical Medicine 
CONTACT  Email: Thomas.gass@lshtm.ac.uk Phone: 077 300 14 77 
 
1. INTRODUCTION 
My name is __________________________________________________. I would like to invite you 
to participate in a research study on antiretroviral treatment. The study is conducted in collaboration 
with the Ministry of Health and Child Welfare. The question of the study is: What are the reasons of 
ART patients in Zaka and Bikita dropping out of the ART program? Before you agree to participate, it 
is important that you read and understand the following explanations on this study. This information 
sheet is to help you decide if you would like to participate. You are entirely free to decide whether 
you would like to take part or not. 
− You should fully understand and be satisfied with the procedures before you agree to take part 
in this study.  
− If you have any questions, do not hesitate to ask me.  
− If you decide to take part in this study, we will ask you to sign this document (consent form) to 
confirm that you understand the study.  
− It is your right to withdraw from the study at any time and with no explanation.  
 
2. PURPOSE OF THE STUDY 
The results of the study will help the hospitals and clinics of Zaka and Bikita to improve the ART 
program in such a way that as many ART patients as possible can be retained on therapy. In addition, 
this research project is part of an educational program Thomas Gass is undertaking at the University 
of London. 
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3. LENGTH OF THE STUDY AND NUMBER OF PARTICIPANTS 
This research project in Zaka and Bikita district will take place in 2012 and last approximately 4 
months. The study includes interviews with approximately 40 ART patients, treatment partners, 
health workers and health officials. We will also conduct group discussions with approximately 50 
ART patients and analyze computerized, anonymous data of approximately 1000 ART patients at the 
hospital. 
4. PROCEDURES 
If you agree to take part in this study, I will ask you to sign a consent form to be interviewed. If you 
are willing to take part but unable to be interviewed at this time, we will arrange an appointment at 
a later date.  
In the interview, I would like to ask you questions about the following topics:  
- Reasons why patients continue or discontinue ART; 
- What helps people to stay on ART , and what makes it difficult to stay on ART, looking at 
things in the family, community and health center; 
- What does the clinic do well that helps people stay on ART, and what it could do better; 
- Enabling and limiting factors of ART retention in the family, community and health facility; 
- Strengths and weaknesses of the ART program regarding retention of patients; 
- Tracing patients who miss their appointments. 
The Interview will be face to face and take between one and two hours. We will agree on a suitable 
place where you feel comfortable to speak freely. 
If you are willing, I am going to audio-tape the interview. This will help me remember and verify 
particularly interesting aspects you mentioned during the interview. In addition, or if you refuse 
audio-taping, I will take notes on paper. Your name and contact details will not be included on any 
audiotape or notes, instead a study code, unique to you will be used. 
5. CONFIDENTIALITY 
All information obtained during the course of this study, including personal data and research data 
(transcripts and notes) will be kept strictly confidential.  
Your name will not be included on any audiotape or notes, instead a study code, unique to you will 
be used. 
Your name and study number will be kept in a separate notebook which will be stored securely and 
separately from other data. In this type of study it is helpful to quote in reports some of the exact 
things people have said in the interview, and we would like your permission do this. Data from this 
study that may be reported in scientific journals or reports will not include any information that 
identifies you. 
Data will be kept for at least five years after the study is finished for possible checking or further 
analysis. It will then be destroyed. 
6. RISKS OF TAKING PART 
Being involved in this study should not involve any physical, psychological or professional harm for 
you. However, if you feel psychologically stressed during the interview, you can withdraw at any 
time. If there are any questions you do not want to answer, it is ok not to answer them.  
  177 
If you are an ART patient, please be assured that your routine care is not affected if you join or do 
not join the study. 
7. BENEFITS OF TAKING PART 
We pay a compensation for the time you spend with us for this interview. If you are an ART patient, 
we can reimburse transport costs for one medical consultation or counseling at any health facility in 
the district. The results of this study will be shared with the health authorities, the hospitals and the 
clinics of Bikita and Zaka district. I will include recommendations into my report how the ART could 
be improved so that more patients can be retained on ART. 
8. ETHICAL APPROVAL 
This study was approved by the Medical Research Council of Zimbabwe. Contact: Medical Research 
Council of Zimbabwe. P O Box CY573 Causeway, Harare Zimbabwe Phone: +263-4-791792. 
You will receive a copy of this information sheet. 
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MRCZ No. ….................... 
INFORMED CONSENT FORM    Participant number □□ 
AUTHORIZATION YOU ARE MAKING A DECISION WHETHER TO PARTICIPATE OR NOT IN THIS STUDY. 
ENSURE THAT THE INTERVIEWER HAS APPENDED HIS SIGNATURE ON THIS FORM TO INDICATE THAT 
YOU HAVE READ AND UNDERSTOOD THE INFORMATION PROVIDED ABOVE, HAVE HAD ALL YOUR 
QUESTIONS ANSWERED AND HAVE DECIDED TO PARTICIPATE. 
The date of enrolment in this study, that is today's date, MUST fall between the dates indicated on 
the approval stamp affixed to each page. These dates indicate that this form is valid when you enrol 
in the study but do not reflect how long you may participate in the study. Each page of this Informed 
Consent Form is stamped to indicate the form's validity as approved by the MRCZ. 
 
I have been informed by the researcher __________________________________ about the nature, 
conduct, benefit and risks of this study. 
I have read the information sheet concerning this study (or have understood the verbal explanation) 
and I understand what will be required of me and what will happen to me if I take part in it. 
My questions concerning this study have been answered. 
I understand that at any time I may withdraw from this study without giving a reason. 
I agree to take part in this study  Yes □  No □  
I agree the discussion to be audio-recorded  Yes □  No □  
I agree for comments I made to be quoted in the study 
report. My identity will not be revealed.   Yes □  No □  
PARTICIPANT 
Printed Name    Signature or Thumb print   Date 
In case of thumb print    Name and Signature of a witness 
RESEARCHER or INTERVIEWER 
I confirm that the above participant has been fully informed about the nature, conduct and risks of 
the above study. 
Printed Name    Signature    Date  
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Appendix 6: Topic Guides     
IDI Participant Number: 
Retention Study Bikita & Zaka 
 
Interview Topic Guide for  
Interrupters 
 
London School of Hygiene & Tropical Medicine 
Department of Clinical Research 
Faculty of Infectious and Tropical Diseases 
London School of Hygiene & Tropical Medicine 
Keppel Street, London WC1E 7HT 
 
Thomas Gass 
thomas.gass@lshtm.ac.uk 
Phone Zimbabwe: 0778 326 217 
Phone Europe: +41 79 681 05 53 
 
  
Name of the interviewer ....................................................................................... 
Tracing number of the participant......................................................................... 
Date of the interview.............................................................................................. 
Start Time.....................................  End Time................................................ 
Location of the interview........................................................................................ 
Date of last ART visit]]]]]]]]]]]]]]]]]]]]]]]]..... 
Period(s) of ART interruption]]]]]]]]]]]]]]]]]]]]]]. 
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A. Introduction, personal information & warm up 
 
− Greet the participant & establish positive rapport 
 
My name is XXX, I am from XXX, I work as an interviewer in this research project. 
 
− Briefly describe the procedure of the interview. 
− Present and explain the Informed Consent Form and get it signed. 
− Start the audio recorder 
− Verify Informed Consent verbally while recording. 
− Inform the participants that they are free not to answer any questions that they are not comfortable with. 
 
To start, please tell me a little about yourself. 
How are you? How is your family? Where were you born?  
What is your education? What is your profession / occupation? 
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B. Interview  
 
Topic Discussion Points Probe Questions 
Health now How is your health condition at present?  
Are you presently under any treatment (biomedical, 
traditional or any other treatment)?  
When did you interrupt ART? 
Why did you interrupt ART? 
 
− To what extent does your health problem affect your 
everyday life and activities? 
− Have you had any health problems during the last 12 
months?  
− Are you currently taking any drugs?  
− Have you recently visited a health facility or a 
traditional healer? 
Experience and 
perception of 
ART and ART 
discontinuation 
What made you start ART? 
How has ART affected / changed your life? 
How did the partner, family, kin, community, employer 
cope with you taking ARVs? 
What do you think does ART to you and your health? 
Have you ever interrupted ART before?  
If yes, for what reasons? 
What made you restart? 
How has discontinuation of ART affected/changed your 
life and your health? 
What do you think happens after discontinuation of 
ART? 
 
− Whom did you involve in decision making? With 
whom did you share your decision to start ART? 
− How many pills per day did you have to take? What 
was the name of the drug? 
− During your ARV treatment, did you seek for other 
treatment? Other drugs? Against which disease?  
− If someone feels ill in your household, what do you do 
for recovery? 
− How do TB treatment and ART interact in your 
experience?  
− Did you experience side effects? What kind of? What 
do you think is the reason for these side effects? 
− How was your health condition when you stopped? 
− Did you involve other people in your decision to stop 
ART? With whom did you discuss? What was there 
advice? 
Retention and Have you ever missed your ART appointment?  − Are there times during the year when you find it 
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adherence Why? Under what circumstances? 
Who is most helpful and supportive to keep you ART 
appointments? 
How do you manage to remember taking your pills 
every day – life long? 
 
 
easier or more difficult to keep going to the ART 
appointments? 
− Are you satisfied with the health workers providing 
ART services? 
− When it comes to ART appointments, what is the role 
of your treatment partner, CHASA, village health 
worker, ART nurse, family members? 
− Do you know other patients who discontinued ART?  
− For what reasons? 
Being HIV 
positive 
How does HIV affect / change your life? 
How has HIV affected your health?  
Did you disclose your status? When? To whom? 
How does the partner, family, kin, community, employer 
cope with you being HIV positive? 
Have you ever experienced harassment or insulting 
based on the fact you are HIV positive or on ART? 
− How was your health condition at that time? 
− Did you share the results with other people? With 
whom? 
− After you received the test result, what advice were 
you given at the health facility? 
− Who else gave you advise what to do next? 
− Do many PLHA suffer TB?  
Role of the 
health facility 
How is the relationship to the health workers at your 
health facility?  
Were they supportive or not? In what way? 
Are you satisfied with the medical service you get? 
If you compare ART provision at hospital (Musiso and 
Silveira) with ART provision at rural health centres, what 
is the difference? 
How could the health facility improve ART service? 
What should be changed in the future? 
 
− Did you discuss / inform your health facility about 
stopping ART? 
− What could the health facility do to support you in a 
better way? 
− Under what circumstances would you stay on 
treatment, return on treatment? 
− Which is the nearest health facility?How far is it? How 
often do you there? How do you travel there?  
− Are you satisfied with their service?  
− Do you have to pay for health services? 
Role of family & 
kin 
 
 
Do your family and kin support you in taking ARVs? 
 
− Who lives in your household? 
− Who brings income home? 
− How is the health of your family members? 
− What do your family and kin members think and 
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believe about ART?  
− Who supports you most? Was there anybody who 
disapproved you are on ART? 
Role of support 
group 
Are you member of a PLHA support group? Why? 
What is your experience with the support group?  
Do you know a CHASA? What do they do? 
 
− Any positive and negative experience with support 
groups? 
− Why are some PLHA member and others they are not 
member? 
− How many people are member of the group?  
− Do you think PLHA groups and CHASA can help 
improve ART and adherence? In which way? 
− Can the CHASA collect the ARV drugs for you? 
− When was your last meeting? What did you discuss? 
− What happens if a member is in trouble? Can you 
remember such a case? 
Partnership and 
gender relations  
How has HIV affected your partnership and marriage? 
How do HIV and ART affect your plans for having 
children? 
− How did your spouse react when you tested HIV 
positive? 
− Do you know the status of your spouse?  
− Does he know your status? 
− What does your spouse think about ART?  
− Since you tested HIV positive, have you had sexual 
intercourse with more than one partners? 
− Do you use contraceptives? What kind? Since when? 
Cultural 
Concepts 
In your village, what do the people know about 
HIV/Aids? What is people's attitude on people with HIV? 
What do you know about how HIV? How is it 
transmitted? What are the most frequent symptoms of 
HIV/Aids? What is the purpose of a CD4 test? Do you 
know side effects?  
 
− What name do people give the disease? What does it 
mean? 
− Has the attitude changed in recent years? How and 
why? 
− What do people think and believe about ARVs? What 
do people think is the effect of ARVs? What do you 
know about ARVs? 
− What do people think and believe about side effects 
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of ARVs? What do you know about it? 
− If someone is sick, is he/she being supported in your 
household/community? Does it happen that sick 
people are left alone? In what cases? 
 
Tracing After missing an ART appointment, have you ever been 
approached by a health worker? Do you know someone 
who has been contacted either by phone or at home? If 
not, how would you feel about this? What would be the 
advantages and disadvantages of such as system? 
What do you know about what happens if an ART 
patient interrupts treatment? How can this best be 
prevented? Do you think tracing would be a good 
solution for the future? Under what circumstances?  
 
- Whom would you accept to approach you if you miss 
an appointment? 
- What do people think about tracing? 
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C. Closing 
 
− Do you want to add or correct something you have told me? 
− Do you have questions? 
− Thank you very much for taking part in this discussion! 
 
 
Field Note (observations & informal conversations) 
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 IDI Participant Number: 
 
 
Retention Study Bikita & Zaka 
 
Interview Topic Guide for  
Health workers 
 
London School of Hygiene & Tropical Medicine 
Department of Clinical Research 
Faculty of Infectious and Tropical Diseases 
London School of Hygiene & Tropical Medicine 
Keppel Street, London WC1E 7HT 
 
Thomas Gass 
thomas.gass@lshtm.ac.uk 
Phone Zimbabwe: 0778 326 217 
Phone Europe: +41 79 681 05 53 
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A. Introduction, personal information & warm up 
 
− Greet the participant & establish positive rapport 
 
My name is XXX, I am from XXX, I work as an interviewer in this research project. 
 
− Briefly describe the procedure of the interview. 
− Present and explain the Informed Consent Form and get it signed. 
− Start the audio recorder 
− Verify Informed Consent verbally while recording. 
− Inform the participants that they are free not to answer any questions that they are not comfortable with. 
 
To start, please tell me a little about yourself. 
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B. Interview  
 
Topic Discussion Points 
1. Background 
1. What is your professional background? 
2. Please describe this health facility and the HIV services of this health facility. 
2. ART programme in 
general 
1. In your experience, what are the strengths and weaknesses of the ART programme in the district. 
2. What is your experience with support and supervision for your HIV services by the DHE? 
3. ART patients 
1. What are your experiences with ART patients at your health facility? 
2. What are the strengths and challenges of decentralization? 
3. How are your patients doing? Do you see side effects? Defaulters? Deaths? 
4. Retention 
1. In your experience, what are the main reasons for deaths on ART and for defaulting on ART? 
2. How could retention be improved in the future? 
5. Support groups 
1. What are your experiences with PLH support groups in the area of your health facility?  
2. How do you collaborate with support groups? 
6. CHASA 1. What are your experiences with the CHASA? 
7. Cultural Concepts 1. In the area, what do the people know about HIV/Aids? What is people's attitude on people with HIV? 
8. Tracing 
1. Are you tracing defaulters? How? Who traces?  
2. Is tracing useful? Why? 
3. Did you manage to bring people back to care after tracing them? 
9. Various 
1. Would you like to add something? 
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C. Closing 
 
− Do you want to add or correct something you have told me? 
− Do you have questions? 
− Thank you very much for taking part in this discussion! 
 
 
Field Notes (observations & informal conversations) 
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Focus Group Discussions 
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Participants (no names) 
 
 Sex  Age Date ART start Ever interrupted ART? Name of health facility at last ART visit 
1      
2      
3      
4      
5      
6      
7      
8      
9      
10      
11      
12      
13      
14      
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A. Introduction, information & warm up 
 
− Greet the participants & establish positive rapport 
 
− My name is XXX, I am from XXX, I work as a facilitator in this research project. This is my assistant XXX. 
He/she takes notes. 
 
− Explain the procedure of the focus group discussion. 
− Present and explain the Informed Consent Form and get it signed by all. 
− Inform the participants that they are free not to answer any questions that they are not comfortable with 
− Start the audio recorder 
− Start with an introduction round. Everybody who wants can tell his / her ART story in a nutshell. 
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B. Focus Group Discussion  
Discussion Topics Discussion Points Probe Questions 
Being HIV positive − How does HIV affect / change your life? 
− How has HIV affected your health?  
− How does the partner, family, kin, community, 
employer cope with you being HIV positive? 
− Have you ever experienced harassment or insulting 
based on the fact you are HIV positive or on ART? 
 
− How was your health condition at that time? 
− Did you share the results with other people? With 
whom? 
− After you received the test result, what advice were 
you given at the health facility? 
− Who else gave you advise what to do next? 
− Do many PLHA suffer TB?  
Treatment − How has ART affected / changed your life? 
− How does the partner, family, kin, community, 
employer cope with you taking ARVs? 
− Did you experience side effects? What kind of? 
What do you think is the reason for these side 
effects? 
− Whom did you involve in decision making? With 
whom did you share your decision to start ART? 
− How many pills per day did you have to take? What 
was the name of the drug? 
− During your ARV treatment, did you seek for other 
treatment? Other drugs? Against which disease?  
− If someone feels ill in your household, what do you do 
for recovery? 
− How do TB treatment and ART interact in your 
experience? 
Retention − Have you ever missed your ART appointment?  
− Why? Under what circumstances? 
− Who is most helpful and supportive to keep you 
ART appointments? 
− How do you manage to remember taking your pills 
every day – life long? 
 
− Are there times during the year when you find it 
easier or more difficult to keep going to the ART 
appointments? 
− Are you satisfied with the health workers providing 
ART services? 
− When it comes to ART appointments, what is the role 
of your treatment partner, CHASA, village health 
worker, ART nurse, family members? 
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 − Do you know other patients who discontinued ART?  
− For what reasons? 
Interruption of ART − Have you ever decided to stop taking ARVs?  
− Why did you decide so? 
− What effect had the ARV interruption on your 
health? On your everyday life?  
− Have you re-started? Do you consider doing so? 
Why? 
− How was your health condition when you stopped? 
− Did you involve other people in your decision to stop 
ART? With whom did you discuss? What was there 
advice? 
 
Role of the health 
facility 
− How is the relationship to the health workers at your 
health facility?  
− Were they supportive or not? In what way? 
− Are you satisfied with the medical service you get? 
− If you compare ART provision at hospital (Musiso 
and Silveira) with ART provision at rural health 
centres, what is the difference? 
− How could the health facility improve ART service? 
What should be changed in the future? 
 
− Did you discuss / inform your health facility about 
stopping ART? 
− What could the health facility do to support you in a 
better way? 
− Under what circumstances would you stay on 
treatment, return on treatment? 
− Which is the nearest health facility?How far is it? How 
often do you there? How do you travel there?  
− Are you satisfied with their service?  
− Do you have to pay for health services? 
Role of family & kin 
 
 
− Do your family and kin support you in taking ARVs? 
 
− Who lives in your household? 
− Who brings income home? 
− How is the health of your family members? 
− What do your family and kin members think and 
believe about ART?  
− Who supports you most? Was there anybody who 
disapproved you are on ART? 
Role of support 
group 
− Are you member of a PLHA support group? Why? 
− What is your experience with the support group?  
− Do you know a CHASA? What do they do? 
− Any positive and negative experience with support 
groups? 
− Why are some PLHA member and others they are not 
member? 
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 − How many people are member of the group?  
− Do you think PLHA groups and CHASA can help 
improve ART and adherence? In which way? 
− Can the CHASA collect the ARV drugs for you? 
− When was your last meeting? What did you discuss? 
− What happens if a member is in trouble? Can you 
remember such a case? 
Cultural Concepts − In your village, what do the people know about 
HIV/Aids? What is people's attitude on people with 
HIV? 
− What do you know about how HIV? How is it 
transmitted? What are the most frequent symptoms 
of HIV/Aids? What is the purpose of a CD4 test? Do 
you know side effects?  
 
− What name do people give the disease? What does it 
mean? 
− Has the attitude changed in recent years? How and 
why? 
− What do people think and believe about ARVs? What 
do people think is the effect of ARVs? What do you 
know about ARVs? 
− What do people think and believe about side effects 
of ARVs? What do you know about it? 
− If someone is sick, is he/she being supported in your 
household/community? Does it happen that sick 
people are left alone? In what cases? 
Tracing - After missing an ART appointment, have you ever 
been approached by a health worker? Do you know 
someone who has been contacted either by phone 
or at home? If not, how would you feel about this? 
What would be the advantages and disadvantages 
of such as system? 
- What do you know about what happens if an ART 
patient interrupts treatment? How can this best be 
prevented? Do you think tracing would be a good 
solution for the future? Under what circumstances?  
 
- Whom would you accept to approach you if you miss 
an appointment? 
- What do people think about tracing? 
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C. Closing 
 
− Do you want to add or correct something you have told me? 
− Do you have questions? 
− Thank you very much for taking part in this discussion! 
 
 
Field Note (observations & informal conversations before and after the FGD) 
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Appendix 7:  Narratives of patients who 
interrupted ART 
 
Batsirai, the abandoned young mother 
Batsirai was 22 years old, mother of a four months old baby, and severely ill. She 
looked wasted, had difficulties breathing and speaking and her voice was faint. We 
recruited Batsirai through CHASA Shorai who traced her. We collected Batsirai, her 
baby and her mother at their home around 50 kilometres from the hospital and took 
them to the ART clinic, where Batsirai was supposed to collect her CD4 results and to 
restart ART. Some of her answers were confusing, and it was only possible to establish 
her case consistently after the interview with her mother, who was a widow with very 
poor knowledge about ART, as the following quote shows: 
She’s taking some drugs but l don’t know the name or what they are treating but she’s 
taking them properly. There were times when she would forget to take the drugs but of 
late she has been taking them properly. [interview with Batsirai’s mother] 
Batsirai tested HIV and started ART when she was married with her first husband, with 
whom she had no children. After his death, Batsirai married again and became 
pregnant. She dropped ART because she feared her husband’s and his family's 
reaction.  
CHASA Shorai said Batsirai has been chronically non-adherent; each time she was 
registered in HIV care and tested CD4 she would throw away her card. Batsirai admits 
that she did not adhere to what I was told at the hospital. During pregnancy, she did not 
take the drugs she was prescribed to prevent vertical transmission because she did not 
like their taste, as she put it. Batsirai's husband worked in another town and she stayed 
at the abandoned homestead of her first husband's parents. After the birth of the baby, 
Batsirai became ill. Her in-laws started rejecting her, until her husband left her, as she 
explains in the following quote: 
He was perverted by his parents, (they) interfered. They said to him you are keeping a 
sick person what for? And he left me. [interview with Batsirai, ART patient who 
interrupted treatment] 
Her mother took her and the baby to her home. This is where CHASA Shorai traced 
her. Batsirai’s tragic case is a combination of various factors contributing to a steady 
decline of her health status, and, as we were informed later, led to her death a few 
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months after the interview. In her second marriage, Batsirai suffered under the 
resentment of her in-laws. To hide her HIV status, she had to stay away from ART. 
Stopping ART made her sick, and being sick she was considered a burden to the 
family-in-law, and her husband neglected and eventually abandoned her. After CHASA 
Shorai found her for the first time, she sent her to the hospital where she was taken 
blood for a CD4 cell count. She was sent home with an appointment to re-initiate ART. 
Batsirai never re-initiated ART. 
 
Chido, the primary school teacher 
Chido was a mother of three children. Her husband died, and the 9-year-old boy was 
HIV-positive and on ART. It worried Chido that she had not yet managed to tell him that 
he was HIV-positive. As a primary school teacher, she had a regular income, yet she 
was using most of her salary to support relatives, and there was not much money 
remaining at the end of the month. It was nurse Chenai at the local health centre who 
diagnosed Chido’s HIV status. Since then, the two women had kept a warm 
relationship, as the nurse expressed in the following quote: 
She knew I was never going to tell anyone so that is why we clicked. (#) I know her 
history, I understand her. [interview with Chenai, nurse] 
Chido had been on ART for two years when she travelled to Harare. At that time, life 
was rough in Zimbabwe; hyperinflation devalued the cash in Chido’s pocket, fuel 
became short, and public transport collapsed. Chido was not able to return to her home 
as planned. Without a referral letter from the hospital, Chido was not able to access 
HIV care at the public ART clinic in Harare. Stuck in the country’s capital city for a 
couple of weeks, she ran out of drugs, and an interruption of a few weeks turned into a 
serious crisis for Chido. She finally returned home to her ART clinic at the hospital with 
a treatment gap of a month. As a “defaulter”, she was given a two-week drug supply 
only instead of the routine two- or three-months. Yet, the economic crisis did not allow 
Chido to spend US$24 for transport there and back every two weeks, so she stayed 
away from ART for another 4 months. When her stomach started troubling her she felt 
desperate because of her son who also needed ART. She felt guilty and, eventually, 
went to nurse Chenai to ask for help. At that time, nurse Chenai’s health centre had 
become a decentralized ART site. Many ART patients comfortably collected their drugs 
locally. Yet, as a "defaulter" who had not been on ART for long enough, Chido did not 
qualify to be decentralized. She felt bitter about what she perceived a punishment by 
the nurse at the hospital, and about how she was treated: 
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They don’t want people to default, so when you do that they punish you by giving you 
small supplies like two weeks or one month while others are getting supplies for three 
months. They don’t deny your drugs but they just give you small supplies so that you 
have to come again and again. (#) If only they could use polite words even if one 
defaults, because there are certain words that you cannot use when talking to people. 
Even other staff members know that he is rough. When patients are not behaving they 
say we will call him to come and deal with you or close down this place. He sometimes 
send people out of the consultation room and says l will serve you later if you just have 
a small misunderstanding in answering his questions.  I was once offended when I had 
my child and they said those with children come this side. l went there but was not 
given the food package others were being given because they said I am a teacher. I 
have heard some saying there is a bus fare fund for children but l am afraid to ask the 
nurse because he is scary.  [interview with Chido, ART patient] 
Chido was re-initiated on ART only after an intervention of nurse Chenai through the 
hospital’s sister in-charge. Chido has fully recovered since and never missed a pill or 
an appointment again.  
 
Edzai, the brave widow 
We interviewed Edzai in a counselling room at the local health centre. It would have 
been impossible to visit her at home because her husband did not know that she was 
HIV-positive. Edzai was 34 years old and had a very poor socio-economic background; 
she dropped out of school early, not used to write nor read and not able to recall the 
year when she started ART. She had no income and stayed many walking hours away 
from the main road in her husband’s homestead where they lived from subsistence 
farming. At the interview, she looked wasted and her voice sounded feeble. Edzai had 
two boys aged 13 and 6 years from her previous marriage. After her first husband’s 
death, Edzai and her children returned to her parental home where they lived until 
Edzai remarried. After re-marrying, she moved to her new husband’s home and left her 
children behind. The older son was taken by the family of her first husband. The 
younger remained with her parents. Edzai was on ART, she used to collect the drugs 
for herself and for her son. She said she had always taken her drugs when she lived 
with her parents. But she feared that her new husband would want a divorce if she told 
him that she was HIV-positive. She hid the drugs outside the house for a while, but 
soon stopped taking them. She thought that her husband was HIV-positive too, 
because his former wife died and four children all died. Before they married, she 
suggested they could test for HIV together. But he refused saying he would only get 
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tested when he fell ill. Edzai did not have anybody to whom she could talk about her 
desperate and burdening situation. She could not even turn to her parents, who have 
been supportive to her, as she explained in the following interview section:  
Interviewer: So how do you plan to deal with your husband and your ARVs? 
Edzai: I wish he could agree that we get tested together. I had planned to just come 
and take drugs and show him that this is what I have done.  
Interviewer: Why are you having such thoughts?  
Edzai: I fear that if I continue not taking ARVs sooner or later I will fall sick and I won’t 
know where to start from if that happens. (#) 
Interviewer: Does your family know that you stopped ART and what do they say about 
that? 
Edzai: To be frank they don’t know that I am no longer taking my ARVs and they 
wouldn’t be happy that I stopped taking drugs. (#) It is difficult because I should have 
told my parents that I stopped but it’s not an easy thing to do. Sometimes I would come 
here at the clinic prepared to restart ART, prepared to take whatever comes, this is my 
way, even if it means divorce.  
A couple of months before the interview, health centre nurse Chamunorwa realized that 
Edzai was overdue and sent a village health worker to trace her at her home. She was 
found ill and the tracer encouraged her to resume treatment. She came to the health 
centre and was diagnosed with herpes zoster and pneumonia. The nurse said he 
treated her and advised her to urgently re-initiate ART. Edzai kept refusing. At the time 
of the interview, six months had elapsed since Edzai stopped ART. Her health had 
deteriorated and the fact that she was hiding her HIV status both to her husband and to 
her family members disconnected her from any social and psychological support. 
Edzai’s refusal to restart ART in spite of her ill-health and in spite of feeling guilty in 
front of her family underscores the power of HIV stigma in marriage, representing both 
a cause and a consequence of the colossal gender inequality in Zimbabwe’s society.   
 
Ega, the old man with the beautiful garden 
Ega was married and had seven children. He was an old man and proud of his garden 
"that beats everyone's garden even those who are not on ART" [interview with Ega, 
ART patient]. His wife was also HIV-positive and on CTX prophylaxis. She said she 
was due for a CD4 cell count recently, but she would only go to the hospital during the 
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school holidays when the children were at home to watch the garden, so the baboons 
would not take the chicken.  
Ega was nearly 70 years old when he became seriously ill. He said he had tried 
everything to get healed, including accusing relatives for having bewitched him. In 
2008, his son and his wife encouraged him to test HIV, and when he was tested 
positive, he was initiated ART. Ega had been on ART for four years, when he stopped. 
Whilst he did not give any plausible reason in the interview why he interrupted ART, his 
wife bluntly told us the church elders said he was healed and he should stop taking 
ART drugs.  Ega and his wife were members of an Apostolic Church community. Ega’s 
wife said her husband truly believed that he was healed because he felt strong and he 
would spend the whole day working in his garden. So he stopped ART and felt 
embarrassed about it, as the following quote shows: 
When I was asked why l defaulted, I lied saying I had gone to Mozambique because l 
didn’t have a good reason for defaulting. [interview with Ega, ART patient] 
Three months after stopping, he started feeling ill and developed a rash. In the 
meantime, other church members who were on ART had started opposing the church 
leaders’ order to abstain from ART. Ega's wife and the nurse in-charge of the local 
health centre convinced him to re-initiate treatment. Ega recovered well from this 
episode: 
My relatives and friends were saying I would die the next day. When I was in the 
hospital they kept saying let’s dig his grave he will come back dead, but they are the 
ones dead now and l am alive because of the drugs. [interview with Ega, ART patient] 
 
Fungisai, the woman who saw flames 
Fungisai was the sister of the nurse in-charge of a rural health centre. She said since 
the nurse was her brother, every health worker at the centre treated her like a relative. 
Fungisai was 45 years old and had two children; she recently became grandmother. 
She was married and left her husband during her second pregnancy. He later died. In 
2005, Fungisai tested HIV-positive and was put on CTX prophylaxis. During a stay in 
South Africa in 2008, she became ill and returned to her parents’ home in the district. 
She was admitted at the hospital and given the starting supply of ART. But Fungisai 
had become mentally ill to an extent that did not allow her to adhere to the drugs, as 
she explains in the following quote: 
I came back from South Africa very ill, I came to the clinic and I couldn’t even eat so I 
survived through drips. I went to the hospital and was initiated ART. I was given the 
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starter pack first. But I confused the drugs and when I went to the ART clinic and 
explained everything to the nurse she said what has happened has happened but I 
must be careful next time, then she gave me my second supply. I took it home and 
suddenly I started seeing the flames of fire turning blue. I went mad and from that time I 
interrupted ART. I was mentally disturbed for the whole year and I was admitted at the 
hospital so they would force me to take the drugs even in my madness.  
Later Fungisai was told that she "would beat people such that they would run away 
from me where ever I approached them." [interview with Fungisai, ART patient] Her 
mother and brother only found out after a few months that she was not taking her 
drugs. With assistance of her brother, Fungisai was admitted at the hospital again and 
diagnosed HIV encephalitis. She was successfully treated and restarted ART. 
Fungisai’s case raises the issue of HIV related mental illness impacting adherence and 
retention. Fungisai did not adhere to ART whilst her health deteriorated in spite of 
home care by her mother and direct access to the health system through her brother. 
Even though she was diagnosed an opportunistic infection, Fungisai still thinks that she 
became mentally confused because of the ART drugs.  
 
Jayaguru, the wealthy farmer 
CHASA Kutenda brought us to Jayaguru's farm where we interviewed him. The farm 
was a few kilometres from the hospital, and Jayaguru had lived there with his family 
since 1974. Jayaguru, who was 57 years old, was a relatively wealthy farmer. He had a 
nice piece of land, cattle and irrigated vegetable plantations; and he was well-known in 
the area for his tasty and affordable tomatoes. In 2010, Jayaguru became ill of 
tuberculosis. His brother advised him to test HIV. Jayaguru and his wife tested both 
HIV-positive, he started ART and she was put on CTX prophylaxis. The couple was 
member of an Apostolic Church community. Contrary to some other church members 
(see the case of Jekuche), Jayaguru and his wife did not follow the local church 
leader’s plea to abstain from ART. Jayaguru’s wife admitted that there was a time when 
she hid her status from the church community: 
Sometimes they discouraged us from taking drugs and later they said we can take 
drugs. At one time they said those who take drugs will be ordered to take down their 
garments (be excluded from the church). At that time I went to another another clinic so 
that I wouldn’t be seen by those who know me. [interview with Jayaguru’s wife, patient 
in HIV care] 
Jayaguru himself did not talk about his faith and whether it influenced his adherence to 
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ART. He interrupted ART because he ran out of drugs whilst working on a farm 200 
kilometres away from home. Having missed his follow-up appointment, he did not dare 
returning back to the hospital: 
When I returned I did not want to go back to the hospital in fear that I could be shouted 
at. (#) I had never heard of anything that could have happened to anyone who missed 
an appointment but when I was initiated l was told that I am not supposed to default so 
I felt guilty of doing that. I even had thoughts of going and starting afresh from blood 
tests as if I was a beginner. [interview with Jayaguru, ART patient] 
Jayaguru was on ART for more than a year when he stopped ART. He expressed that 
shame about being a “defaulter” was the reason why a delay of a few weeks developed 
into a treatment gap of six months. He was already classified lost to follow-up when the 
hospital sent CHASA Kutenda to trace him. Jayaguru expressed how grateful he was 
that the CHASA encouraged him to return to HIV care before he would have fallen ill:  
My guilty conscience made me think I would be questioned and even when the CHASA 
came to call me I thought I was going to be put under interrogation but we had a nice 
discussion and I was reinitiated. [interview with Jayaguru, ART patient] 
 
Jekuche, the religious teacher 
Jekuche was a 57 years old and a secondary school headmaster. He had been 
married for nine years and had six children from two marriages. Jekuche’s first wife left 
him when he married his current wife because she did not want to live in a polygamous 
marriage. In 2007 Jekuche became seriously ill, with diarrhoea and stomach pain. He 
“tried everything to get healed” [quoting Jekuche] but it did not help. Eventually, his wife 
encouraged him to test for HIV. He tested positive and initiated ART. His wife tested 
negative. Three years later, during one of her pregnancies, Jekuche’s wife tested 
again, but she was now HIV-positive.  
Jekuche was deeply religious. He and his wife were members of different Christian 
churches before they joined the African Apostolic Church in 2009. At a public ceremony 
of the church in June 2011, an Apostolic leader encouraged HIV-positive church 
members to stay away from hospitals and to stop ART, as he explains in the following 
interview section: 
 It was at a church function when we were misinformed. We were told that we have all 
been healed. And I accepted that and I went home, including my wife. After some time 
(#) I started feeling ill. Shaking and what and what. Then in January, it got worse, I 
  204 
 
 
started experiencing real shake-ups and a mild stroke. And I had wounds in the back 
which were serious and deep. So I had to come to the hospital. Then when I came to 
the hospital, they restarted me and I explained to them I had learnt my lesson, I will 
never ever drop these things again, for whatever reason. Now even our church leader 
explained that no, hospital was made by God, so people are healed by God (#).  
Jekuche was a wealthy and well educated Zimbabwean. As headmaster of the 
secondary school, he was a locally well-known and respected personality. He had been 
on ART for four years and he knew that ART saved his life. And yet, the announcement 
of the religious leader made him stop ART. Jekuche said he restarted ART after 
changing his mind. However, his wife underlined that he did not want to return to care 
as long as the church did not withdraw the announcement. It was her who ultimately 
convinced him that “he would die and leave me alone yet we have a lot of children” 
[interview with Jekuche’s wife] and took him to the hospital. Jekuche explained that 
after he restarted, the church reconciled spiritual healing with biomedicine by stating 
that hospitals were made by God. Jekuche enthusiastically defended his church, 
underlining that it was a misinformed leader who made the announcement without 
consulting his superiors: 
A lot of people died. And a lot of people are ill right now because of this problem. Now 
after this announcement was made, the church leader, he made the public 
announcement that people should go back to the hospital. Because this is wrong. 
Hospitals were made by God to assist people. This announcement was wrong. It was 
misplaced. It meant to kill people. And to make people stay away from the church. 
[interview with Jekuche, ART patient] 
At the time of the interview, the SMART programme considered Chido and Jekuche as 
retained patients, whilst Edzai was classified lost to follow-up. The cases of Chido and 
Jekuche show that retention does not indicate persistent adherence to ART drugs and 
appointments. They both had treatment interruptions of several months before 
restarting ART. The same was the case with eight other cases. Edzai, like four other 
cases, has been away from ART for many months without returning to care. Whilst 
Edzai and two others (Nashe and Chikonzi) restarted ART after the interview, Batsirai 
and Meso did not manage to return to care, and died a few months after our encounter. 
The narrative analysis of the cases suggests that understanding the determinants of 
long-term retention requires an investigation of two critical passages in the treatment 
career of an ART patient: firstly, the reasons why patients interrupt treatment, and 
secondly, under what circumstances patients return to care or turn a temporary ART 
interruption into a prolonged and potentially fatal therapy discontinuation. 
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Linda, the widow with the stick 
Linda was walking on a stick. She recovered quite well from a stroke she had five years 
ago, but she remained handicapped and had a minor speech difficulty. Her sister said 
she wished Linda had physiotherapeutic care. Linda travelled to hospital B every three 
months to collect her ART drugs, always escorted by her sister, who was her most 
important treatment supporter. Linda had no children. She lived with her sister’s family 
and her mother.  
Linda and her sister have always been very close to each other. They grew up in a 
family of 16 children in the countryside of Masvingo Province. Whilst her sister married 
in rural Masvingo, Linda became an international trader. She married, moved to Harare 
and got involved in cross-border trading with Namibia and Zambia. Buying consumer 
goods in bulks in the neighbouring countries and selling them on the market at home 
was a popular way of earning income in Zimbabwe. In her thirties, Linda made good 
business. After 6 years in marriage, she became ill. As her health deteriorated, her 
sister came to Harare to look after her. She took her to the hospital, where Linda tested 
HIV-positive and started ART. Linda's life changed abruptly. Her husband left her and 
her sister took her back to their mother's home in the village. Around half a year after 
starting ART and returning home to Masvingo, Linda became involved with a 
Pentecostal Church community. The bishop told her that drugs were not allowed, and 
that she would be spiritually healed. So Linda stopped ART. In February 2008, whilst 
she was staying with the bishop, she had a stroke. Linda's sister took her away from 
the bishop and brought her to her own home. She took her to the hospital where Linda 
restarted ART in 2010. Linda survived thanks to her sister, as the following quote of 
Linda’s sister shows: 
When she had stroked they called me because it was difficult, she couldn’t go to the 
toilet or bath alone, she messed herself, I had to go and wash her, and she messed 
herself again. She then resumed ART and she got better but she still had the stroke. I 
am always on the look-out to check if she takes her pills at eight in the morning; if she 
leaves her sadza, I heat it and feed her. If there is no sadza we make porridge and she 
eats and then takes her pills. If I am there everything is ok. [interview with Linda’s 
sister] 
Like many other ART patients, Linda quit ART due to the influence of her religious 
leader. In Linda’s case, interrupting ART made her particularly vulnerable because it 
concurred with a cerebrovascular accident. Linda became entirely depending on her 
sister. As her sister points out, Linda also had a network of friends and relatives whom 
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she had done business with or whom she had helped out in the past. Thanks to her 
social network, she had a safety net assisting her whilst recovering from the stroke and 
restarting ART: 
She was very kind to everyone when she was strong; she was very generous and she 
supported everyone through her businesses. So people send her blankets, shoes or 
clothes from Harare. Since she was a nice person she is getting help. She didn’t have 
a child, and she supported everyone even during funerals and she paid fees for 
children of our deceased family members so they take care of her. She has shown 
appreciation; she gave me one sheep and told me to sell it. (#) [interview with Linda’s 
sister] 
Not all family members were happy about the fact that Linda needed treatment, care 
and assistance. As her sister pointed out, the brother who lived with them in their 
family’s homestead considered Linda a burden to the family.  
 
Maidei, the mother who stopped drinking beer, and Chikonzi, the former prisoner 
Maidei was an illiterate 36-year old woman who grew vegetable and gathered insects 
for sale. She was once married with a man with whom she had five children. The man 
died in 2008, and one of the children from that marriage died very recently; the boy was 
eight years old and HIV positive. During the funeral, the child's late father's family 
accused Maidei for bringing HIV into the family, and causing the death of the boy and 
his father. Maidei was tested HIV-positive several times at antenatal care, and she was 
given ART to prevent vertical transmission as well as drugs for CTX prophylaxis. She 
only started ART after her first husband’s death, when she became ill with tuberculosis. 
After completing tuberculosis treatment and recovering, she dropped ART because she 
felt healthy. She started drinking.  
It was the devil. I wasn’t thinking clearly, I used to drink beer by then and taking ARVs 
together with beer would make me feel a burning sensation in my chest so I decided to 
stop the ARVs. I was later taught at the clinic that ARVs and beer don’t get along so 
when on ARVs one should stop beer, but by then l didn’t know. () All the money I got 
from the sale of garden produce and termites, I used to buy beer. [interview with 
Maidei, ART patient] 
Maidei was not only addicted to alcohol, she also lacked treatment literacy. She found 
it difficult to distinguish the different drugs.  
In 2010, during the time when she was drinking beer, Maidei married Chikonzi. He had 
just been released from prison, where he got infected with tuberculosis and started 
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ART. Access to ART was not a problem in prison and they had enough food, he said. 
Upon his release, the prison clinic referred him to the hospital to continue ART. 
Chikonzi moved to Maidei’s. After a first visit at the hospital’s ART clinic, he decided to 
drop therapy. He said he stopped ART because he did not have the money to pay for 
the bus fare. Chikonzi complained about the nurses at the hospital: 
I went there on the tenth of February and was told to come back on the sixth of March. 
When l got there they said I was late and didn’t consider the walking distance from 
where I was coming from. They gave me another appointment on the twenty-seventh of 
April, that time I had money and so I boarded a bus, but it had a breakdown on the 
way. But still I didn’t arrive there very late, they would have assisted me but they didn’t, 
I was given another date. I wouldn’t mind walking there to get drugs but I have a 
problem when people do favouritism and serve people who came after me first before 
they have served me. You see a nurse actually coming to the queue to collect a card 
for a certain person who is at the end of the queue. They favour those who pay them 
while some of us without money to pay them are skipped in the queue. 
Maidei eventually initiated ART before the birth of her last child. She stopped drinking 
beer and she wished Chikonzi could also restart treatment. She heard that their local 
health centre recently became an ART site, so that it would not be far and expensive to 
collect drugs in the future. She said that Chikonzi needed ART now because "he has 
gone dark in complexion and this shows that he is not well." [interview with Maidei, 
ART patient] 
 
Meso, the maltreated orphan 
We interviewed 18-year old Meso at the hospital when she came for her follow-up 
consultation. Meso had the appearance of a stunted child. She was skinny and wore 
untidy clothes that were far too large for her size. She was ready for the interview 
though not feeling well. She did not talk much, so that we reconstructed Meso’s story 
largely from the interview with her aunt.  
Meso grew up with her mother who had left her husband because she did not want to 
live in a polygamous marriage. Meso did not remember her father; he died when she 
was a baby. She had three older brothers who had different fathers. Her mother 
became ill when Meso was in grade 5. Meso dropped primary school to care for her 
dying mother. She does not know if she was vertically transmitted or if she was infected 
during childhood. Her aunt, a sister of Meso's late mother, said that Meso might have 
been infected when she was raped at primary school age. She said it might as well 
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have happened when Meso cared for her mother's open wounds. Meso’s mother died 
of AIDS in 2007 when she was 13 years old. She was taken by another sister of her 
mother’s who by then worked as a maid for a nurse. The nurse happened to be the in-
charge of the newly established ART clinic. Meso became ill with tuberculosis and it 
was this nurse who tested Meso, put her on treatment and later initiated her on ART. 
When Meso had recovered, her brothers claimed their father's spirit said they should 
look after Meso. They took Meso away from her aunt’s and she had to work in one of 
her brother's households. Her aunt says Meso was maltreated there and they did not 
give her proper food. Although her brothers told her not to marry due to her HIV status, 
Meso found a partner and married at the age of 18. This is when she stopped ART 
because she feared that her husband would leave her when he knew that she is HIV 
positive. Meso not only hid her status to her husband, as she explains in the following 
quote: 
Meso: I feared that I they (brothers and aunts) would ask me why I stopped. I was 
afraid they would be mad at me. 
Interviewer: why do so many women stop ART because of marriage? 
Meso: In fear that if he discovers he will dump you if he knows about your status. In my 
case, my brothers were discouraging me from getting married, saying you are HIV 
positive and no one will ever marry you. [interview with Meso, ART patient] 
Ironically, Meso’s husband became ill, tested HIV-positive and was initiated on ART 
himself. When they married, Meso was already pregnant. Before the baby was born, in 
December 2011, Meso’s husband died in a car accident. A few days later, Meso gave 
birth to a baby, but the baby died after three months. Still without ART, Meso became 
very ill and was admitted at the hospital, where she was kept with tuberculosis for one 
and a half months, and re-initiated on ART by the nurse whom she had known before. 
After being discharged from the hospital, she went back to live with her brother's family. 
Meso said she felt like a burden to that family and she wished she could leave the 
place to get some employment to be on her own. But her brother did not let her go. 
Meso’s aunt was worried about Meso’s situation at her brother’s, as the following quote 
shows:  
People just rush into marriage. If Meso had not been married maybe she wouldn’t have 
stopped or fallen sick. Right now we are not happy about her staying there with her 
brothers. They are not taking good care of her; they make her work hard and don’t give 
her good food. Recently she was complaining that she has got chest pains after they 
had made her carry a twenty litre bucket of water. The other brother’s wife once had a 
misunderstanding with Meso and threw out her clothes. The brother’s wife she lives 
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with now is not giving her proper food she sometimes comes here to ask for peanut 
butter or eggs. [interview with Meso’s aunt] 
Meso’s case is the story of an HIV positive orphan who was vulnerable in multiple 
ways. Given her fragile state of health and her minor age, she was in good hands living 
with her maternal relatives, where she was initiated on ART thanks to her aunt’s 
relation to the nurse of the ART clinic. When she was taken away from her care givers 
to her brother’s family, she got into an environment where she was exposed to 
maltreatment and hostility. Marriage was an opportunity to escape from her brother’s 
family. Meso’s case demonstrates that under circumstances of vulnerability and 
dependency, marriage can be a reason why women stop ART. Meso restarted ART 
only after her baby died and she was admitted at the hospital after her health had 
critically deteriorated. At the time of the interview, she had recovered and returned to 
her brother’s home. Her aunt said she wishes Meso could live with her. She was 
desperate about Meso's fate and said sometimes I even wish she would have died with 
her mother because the situation she is in now pains me [interview with Meso’s aunt].  
Meso died three months after the interview. 
 
Nashe, the labour migrant 
Nashe was a 39 year old man who grew up on his father’s farm. He was a certified 
steel binder. In recent years, he spent most of his time working on a farm in South 
Africa. He returned to Zimbabwe two years ago. Back in Zimbabwe, Nashe had no job 
and no income. Nashe was married and the couple had a two-year old child. We 
interviewed Nashe in his village at health centre B3. He did not give the impression of 
being able to handle reinforcing bars or carrying heavy boxes of tomatoes. He was 
limping, his appearance was fragile, his voice feeble, and he said he had chronic 
diarrhoea. Like many other Zimbabweans, Nashe worked as a labour migrant in South 
Africa, where he was tested HIV-positive and started ART at his workplace. In the 
interview, he did not like talking about South Africa, emphasizing how much he would 
like to restart ART: 
To tell the truth, sister (addressing translator), ART is good for me, I used it before and 
l saw its importance. (In South Africa) I got into ART and started gaining weight. 
[interview with Nashe, ART patient who interrupted treatment] 
Nurse Chenai and primary care counsellor Farai supposed that he infected his wife and 
felt ashamed about it. His wife said Nashe did not tell her about his HIV status. She 
only found out from his stepmother towards the end of her pregnancy, when Nashe 
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returned from South Africa. She was married before and had three children with her 
former husband. She tested HIV positive at antenatal care during her last pregnancy 
with the baby from Nashe. His wife said she had accepted her status and was happy 
that her baby was tested HIV-negative thanks to the drugs she took to prevent vertical 
transmission. Because her CD4 cell count dropped from 600 when she first tested to 
330, she was recently initiated on ART.   
Upon his return from South Africa, Nashe went to the hospital and was initiated on 
ART. Nashe stopped after two consultations because he could not afford 
transportation. Indeed, Zimbabwe was in deep crisis in early 2010 when Nashe 
returned to Zimbabwe, and the health centre was not providing ART services yet. He 
did temporary farming jobs here and there and thought he would resume ART when 
the family’s economic situation would have improved. But his health deteriorated, the 
leg got worse and he was not able work anymore. Transport to the hospital and back 
was US$24, an amount that the family could not afford:  
It’s difficult to channel the little money l get for transport to the hospital when the child is 
crying because of hunger. I cannot value my life over that of my child. So I would rather 
save money and buy food for my family than keeping it for bus fare to go to the 
hospital. [interview with Nashe, ART patient who interrupted treatment]  
Nashe’s health workers believed that there were other reasons why Nashe dropped 
ART. Nurse Chenai – we know her from Chido’s case – was an enthusiastic and warm 
hearted ART nurse who supervised the local HIV/AIDS support group. She was familiar 
with the background of her patients. She did not know Nashe well because he was in 
South Africa. But she knew that his parents died and his paternal relatives belonged to 
a church community that discouraged members from ART. She supposed this could 
have played a role in Nashe’s case. Primary care counsellor Farai was employed at 
health centre B3 to provide HIV testing and counselling and adherence support to ART 
clients. Farai himself had been on ART for four years and he emphasized that he had 
always collected his drugs at the exact appointment date [interview with Farai, primary 
care counsellor and ART patient], even if he had to walk to the hospital in a critical 
state of health. Farai said that neither the swollen leg nor the transport costs but an 
attitude problem was the true reason for Nashe's non-adherence. He believed that 
Nashe had not accepted his HIV status because he felt guilty about infecting his wife 
and having failed to disclose to her while she was pregnant. Farai believed that Nashe 
felt ashamed to confront himself with the truth.  
After the interview, we offered Nashe a ride to the hospital which he accepted. He 
stayed overnight and the next day, after an intervention of the study team at the nurse 
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in-charge, Nashe got reinitiated on ART and immediately down-referred to the health 
centre.  
A few weeks later, we accidentally saw Nashe’s wife at the ART clinic of the hospital. 
Whilst Nashe was down-referred, his wife was still going to the hospital for ART follow-
up. But that day, she did not come for her scheduled ART visit; she came because 
nurse Chenai had referred her. After starting ART, she developed a rash all over her 
body, and it had become painful. At this day, Nashe’s wife was not able to walk to the 
hospital because she was not feeling well. Nashe had sold maize to make US$24 
available for her transport. Normally, ART patients were required to come with their 
treatment partners. Obviously, Nashe’s wife could not afford to pay the bus fare for two. 
We witnessed the following incident at the OI clinic and present it from the field notes in 
some detail because it demonstrates how both Nashe and his wife were struggling with 
distance, indirect treatment costs and referrals. It was Tadisa, the nurse in-charge of 
the ART clinic, who attended Nashe’s wife. Tadisa was a committed and experienced 
ART nurse who had been among the pioneer nurses providing ART in the district. At 
the hospital, ART patients were initiated and managed entirely by nurses. Doctors were 
consulted in very rare cases. In such cases, the doctor did not see the patient in the 
ART clinic, but the patient was referred to the out-patient department where the patient 
had to queue a second time to see the doctor. Tadisa did not refer Nashe’s wife to a 
doctor, but prescribed her antihistamine and steroids. She said she was not sure if the 
rash was a side effect of the ART drug component nevirapine, or an effect of her recent 
malaria episode, or any kind of eczema. After the consultation with Tadisa, Nashe’s 
wife went to the hospital pharmacy to collect the prescribed drugs. There she was 
asked to pay US$13 for the drugs. Since she did not have that money she left the 
hospital and was about to travel back home, before we found her. She told us the story 
and we paid for her drugs. We later discussed the episode with Tadisa and she said 
that payment plans can be negotiated with the hospital administration if the patient 
cannot pay. Nashe’s wife did not know about this scheme and almost went home with 
her rash and no treatment. Due to our involvement in the case, Tadisa thereafter down-
referred her to the health centre. 
The cases of Nashe and his wife would have developed in a different way if the study 
team had not intervened. As far as Nashe is concerned, whatever reason made him 
stop ART after his return from South Africa, the critical question is why he did not 
restart for more than two years, in spite of his deteriorating condition. Was it because of 
the leg or the distance or a guilty conscience or the religious belief of his relatives? 
Whichever reason is true, it is apparent that Nashe had great difficulties to cope with 
his status and his wife was his only potential support. As a returning migrant, he was 
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isolated in the community, his parents were dead, his relatives did not approve of ART, 
and the adherence counsellor at the health centre considered him an irresponsible 
person with an attitude problem. The episode of his wife revealed that the hospital’s 
policy to down-refer patients only when they are stable does not necessarily assure 
good quality and good results of care. In the case of Nashe’s wife, she was properly 
referred from health centre to hospital but not seen by a medical doctor, and her rash 
would have remained untreated because she could not pay for the medication. The fact 
that she left the hospital without treatment underlines the critical situation of her family 
not allowing proper HIV care and treatment for both Nashe and his wife under their 
current circumstances.  
 
Pfuma, the illiterated mother 
It was a 20 kilometer four-wheel drive on a bumpy unpaved track from the rural health 
centre until we reached an even more remote health centre, where we meet Pfuma. 
She had been lost to follow-up and traced by a village health worker. It took her three 
hours to walk from her home to local health centre, where essential health services are 
provided including HIV testing and CTX prophylaxis, but no ART. Reaching the nearest 
ART site would have taken her another four hours, adding up to a full day walk from 
her home to the ART site. Pfuma was 26 years old and lived with her three children (9, 
7 and a baby) and with the second wife of her husband and her children in a remote 
mountainous homestead. Pfuma and her children lived in poverty; she was illiterate, 
her children did not go to school and her husband was in South Africa and did not send 
money to his wives. Pfuma made her living from subsistence farming and menial jobs 
here and there. She and her husband’s second wife were not in good terms. Pfuma 
would not leave her children back when leaving the homestead. 
During her pregnancy in 2011, Pfuma’s sister gave her money for transport to get to a 
health centre for testing. Her husband did not join her, as she explains in the following 
quote: 
When I went to the clinic they advised me to bring him along for testing and when I told 
him he showed no interest. He said if I feel that I am sick I should get tested myself and 
leave him out of it. I said to myself this is my life and I have to take care of myself, so I 
woke up the next morning and I went to the clinic for testing. I didn’t tell him about it. 
[interview with Pfuma, ART patient, interrupted ART 7 months ago, has not restarted] 
After being tested HIV-positive, Pfuma’s sister gave her again US$10 for the bus fare 
to travel to the hospital to register for HIV care. At the hospital’s ART clinic, she learnt 
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that she could have saved the trip to the hospital and instead registered at the health 
centre, where pre-ART services were provided such as CTX prophylaxis, CD4 test and 
pre-ART sessions. So Pfuma was given a box of CTX and referred back to the health 
centre. As Pfuma was tested HIV in a different district, she was not informed about the 
availability of decentralized HIV care at the health centre. So Pfuma travelled back 
home, then travelled to the health centre a few days later to give blood, and again a 
few days later to get the results. Since she had no money to hop on a vehicle on her 
way to and from the health centre, she walked and stayed at her aunt’s place. Pfuma’s 
CD4 cell count was 151 and she immediately received her first pre-ART session. After 
a second pre-ART session, Pfuma was initiated ART in January 2012 at the health 
centre by the hospital outreach team. She went home and started taking her drugs. 14 
days later, she was due for her first ART follow-up consultation. After another one-day 
walk, she did not directly go to the health centre, but attended a funeral and visited her 
aunt who was critically ill. As the funeral lasted until late, Pfuma came to the health 
centre only the next morning, one day after her appointment date. The nurse told her 
that her delay was not acceptable. She was informed that the ART initiation outreach 
team would only come two weeks later. Pfuma gave up and has been on CTX 
prophylaxis at the health centre since. She said it is troubling her and she wishes she 
had the means to restart ART. She said her parents, her sister and her aunt’s daughter 
keep reminding her she should get treatment, but she cannot afford the travelling. She 
said tracing was a good thing since “having someone to talk to in such situations would 
be very helpful.” [interview with Pfuma] 
 
Runako, the teenage orphan 
Swiss doctors have been working at the hospital since it was founded by missionaries 
in the 1940ies. Runako’s mother worked as a housemaid in one of the doctor’s houses 
for 23 years. She was married and had five children. In 2004, she became ill. The 
Swiss doctors encouraged her to test HIV. She and her husband tested positive. At the 
time, no ART was available at the hospital. In Harare, the drugs were too expensive. 
Her husband left her and did not want to take the children with him. The housemaid 
knew she would die. She proposed to the Swiss doctor to employ her husband’s sister 
in her stead, and she asked the sister-in-law to look after Runako and her brothers.  
Today, Runako was a 19-year old teenager. She was eleven when her mother died. 
After mother’s death, Runako’s father took the children to live with his new family in the 
neighbour district. She came regularly to the hospital to collect money from the Swiss 
doctor to pay for her school fees. Runako was not happy at her father’s home. After his 
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death, 14-year old Runako and her four young brothers were taken to live with their 
aunt in the mission. At the age of 17, Runako fell ill, and she was started on ART. Yet, 
she did not take the drugs. Instead, she started asking why she was infected with HIV 
and her brothers were not. Her aunt did not realize that Runako was not taking the 
drugs, as she explains in the following interview section:  
 
When she was in form four, she started saying how did I get sick when I am the eldest 
and my younger siblings are not infected? We told her we do not know. All along we 
thought she was taking her pills but she was not. (#) The nurses said I am the one 
who has the problem and I said how come? I told the doctor that the patient was not 
taking pills and that the nurses were accusing me. (#) I do not have any fault because 
I’m bringing her to the hospital. So I continued to go with her to the hospital until she 
started going back on ART. [interview with Runako’s aunt] 
 
The finger pointing on Runako’s aunt by the health workers shows the moral 
responsibility of Runako’s aunt to look after her brother’s children. From Runako’s point 
of view, the question “why me?” prevailed. At times, Runako would deny she was 
positive or she would claim that they must all be tested again to prove that it was only 
her being positive. Runako probably dropped ART and lied to her and the nurses 
because she was in denial about her status. It appears that during adolescence, 
Runako found a way to cope with the “why me” question, and this helped her stay on 
ART, as the following quote suggests:  
I would tell them that we are not the one who looked for the virus, it just came to us and 
it was not our fault. So we just have to keep taking drugs because that is how we keep 
alive .[interview with Runako, 19, ART patient] 
 
Simbisai, the rebel orphan 
The interview with Simbisai took place at the health centre, where she was re-initiated 
on ART only a week before the interview. She was coughing and looked wasted and ill. 
Simbisai was 18 years old, she lost her mother when she was eleven. Her father was 
on ART and visited her regularly. She thought that she was either infected at birth or 
when caring for her mother who was dying. After her mother's death, she and two of 
her six siblings lived with her grandmother. Only a few months after the death of her 
mother, in February 2006, twelve year old Simbisai became ill. She was admitted at the 
hospital and tested HIV-positive. Her health remained feeble, and two years later 
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Tuberculosis broke out. She was treated and initiated on ART. After completing 
tuberculosis treatment, she felt strong and she desperately wanted to go and live with 
her sister in Harare, as she explained in the following interview section: 
I just left them [the ART drugs] when l was called to Harare. I told myself that l had 
recovered and there was no need to continue taking the drugs. I even told my 
grandmother that I had finished taking the drugs so that I would be allowed to go to 
Harare. My grandmother eventually allowed me to go because I was persistent about 
going and I would actually cry over it until she allowed me to go. (#) I had finished 
ticking my card and so I told them that I was going to Harare. [interview with Simbisai, 
ART patient] 
So Simbisai stopped ART and went to Harare where she worked as a housemaid at 
her older sister’s family’s home. In the meantime, Simbisai had appeared on the list for 
ART patients to be traced at hospital A. CHASA Kutenda was sent to Simbisai’s 
grandmother’s home where he found Simbisai’s brother. He then called Simbisai in 
Harare and encouraged her to return home and to get back on HIV care. Simbisai 
refused and said, she would come back only when she falls ill. It did not take long until 
she did become ill. Her sister – a member of the apostolic church – told Simbisai she 
would be bewitched when she returned home. Instead, she took Simbisai to a “prophet” 
who came to her sisters’ home to sprinkle holy water for Simbisai’s healing. Simbisai’s 
health deteriorated, and eventually when the girl was seriously ill, her sister sent her 
back to her grandmother’s. The first part of Simbisai’s story is about an adolescent 
dropping out of HIV care after moving away from her care giver, the grandmother. The 
case of Simbisai shows the important role grandmothers play as care givers in a 
society where many children lost their parents due to HIV/ AIDS. The case also shows 
the vulnerability of adolescents on ART, especially if they move away from their 
supporting environment. Simbisai insisted to move to Harare, and nobody could 
change her mind. Neither did the health system ensure a formal referral of Simbisai to 
a clinic in Harare, nor did her new care giver, her sister, provide any adherence 
support. 
Back at her grandmother’s home, the misery continued. Simbisai went to the hospital 
and was prescribed tuberculosis treatment again. For unknown reasons, Simbisai was 
put on tuberculosis treatment at the hospital, but referred to the health centre for ART 
initiation, which was the nearest facility from her grandmother’s home. Only there and 
half a year after her return from Harare, the nurse realized that Simbisai’s tuberculosis 
was not cured and she was still not on ART. Only a week before the interview, Simbisai 
was identified and re-initiated on ART thanks to the newly introduced tracing 
programme. The second part of Simbisai’s story is a striking example how re-
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integration of a patient in HIV care can be delayed due to failed referrals between the 
tuberculosis and ART programme, and between the hospital and the health centre.  
 
Tomupeishe, the wealthy housewife 
We interviewed Tomupeishe at her home in the district’s main town, where she lived 
with her husband, who was the headmaster of the local primary school, and also on 
ART. The couple was educated and relatively wealthy with three children in the age of 
18, 13 and 3 who were all HIV negative. Tomupeishe and her husband tested HIV and 
started ART together back in 2005. In their history of ART, the two had always 
supported each other to adhere to pills and appointments. It was in 2007 when her 
husband's brother died and they attended the funeral a few hundred kilometres away 
from home. As they stayed with their relatives longer than planned, they returned home 
one week too late for their ART appointment. The one-week delay lengthened into a 
treatment interruption of seven months. The following section of the interview shows 
the couple’s fear to return to the ART clinic after having “defaulted”: 
Tomupeishe: It so happened that we were due for ART supply whilst we were still away 
and so we missed our appointments. (#) We defaulted by seven months because I did 
not know what to say because those who were dispensing the drugs were strict about 
dates.  
Interviewer: Do you think they would not have given you the drugs, what do you mean 
by “strict”?  
Tomupeishe: Maybe we just thought so, but when you are working with people you 
know their attitudes and a small thing like that turns out to be a big issue.  
Interviewer: Had you ever seen them shouting at other people who missed 
appointments or had you experienced it yourself?  
Tomupeishe: I was shouted at and told that we are not giving you any drugs. I was then 
assisted by another nurse. I was told that we want people who meet their 
appointments, I don’t know if the nurse who attended me would have held on to his 
word that l would not have been given any drugs. [interview with Tomupeishe, ART 
patient] 
Tomupeise and her husband interrupted ART for more than half a year simply because 
they feared repercussions by health personnel for having missed their appointment. It 
is remarkable that it was a wealthy and well educated couple who decided not to return 
to HIV care due to their fear of being insulted. Her husband underlined that apart from 
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the harsh remarks by a nurse to his wife, they had never experienced troubles at the 
ART clinic. Yet, they were overwhelmed by shame, as the following quote from the 
interview with Tomupeishe’s husband shows: 
 
It’s generally known that most people in the nursing profession are rude to clients. 
However, we had never experienced that in ART, we were being treated well (#) and 
they told us that ARVs are life-long. We were just overwhelmed by fear and I feel 
embarrassed by that as an educated person, how could how I have done that after 
being told that ARVs are life-long? [interview with Tomupeishe’s husband, ART patient] 
